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Haemodynamic monitoring and measurement of acid-base status are routine in the
assessment and management of the critically ill. It is known that tissue hypoxia
results in anaerobic metabolism, hyperlactataemia and lactic acidosis. The role of
the cardiorespiratory system in providing adequate oxygen to respiring tissues is
fundamental in physiology. Acute derangements of oxygen transport result in a
spectrum of disease from minor illness to life threatening conditions such as shock
and multiple organ failure. Despite this, it is only relatively recently that attempts
have been made to monitor and study systemic oxygen delivery (DO2) and oxygen
consumption (VO2) in the Intensive Care Unit. Studies of the sequential, concurrent
changes of cardiorespiratory and metabolic parameters, particularly in relation to
resuscitation, organ failure support or sedation have been lacking.
Methods are described for measurement of systemic haemodynamics, DO2, VO2,
arterial blood lactate and pyruvate concentrations, urinary kallikrein and plasma
renin activity (PRA).
In patients undergoing resuscitation from shock three groups were defined on the
basis of the responses of arterial blood lactate (ABL) concentrations. The first group
had hyperlactataemia which corrected following therapy which achieved significant
increases in mean arterial blood pressure (MAP: p<0.01) and DO2 (p<0.005).
Group two had similar lactate levels, but vigorous therapy, which increased MAP
significantly (p<0.05) did not increase DO2. ABL concentrations remained elevated,
and mortality was high. These differences emphasise the importance of
simultaneous reversal of hypotension and attainment of adequate D02- In the third
group, despite severe cardiorespiratory abnormalities hyperlactataemia was not
seen. Shock may occur with normal ABL concentrations. In patients with shock and
adult respiratory distress syndrome (ARDS) an elevated ABL has been proposed as
a marker of delivery dependent VO2, a potential indicator of tissue hypoxia. Septic
shock and ARDS patients were classified on the basis of normal or elevated ABL
concentrations. The level of ABL had no value in predicting the response of VO2 to
changing DO2 in either the grouped data, or in individual patients. The absence of
hyperlactataemia in ARDS does not preclude the presence of delivery dependent
VO2, and by implication tissue hypoxia.
The anaesthetic induction agent propofol has been used for sedation in adult
critically ill patients. In a group of ventilated, invasively monitored patients its effects
on cardiorespiratory function were documented. Heart rate and MAP fell
significantly (p<0.05) but DO2 and VO2 were unchanged despite a significant
increase in the sedation score (p<0.01), suggesting there was no improvement in
overall oxygen supply/demand balance.
Theoretical objections exist to the use of lactate-containing haemofiltration (HF)
fluids in shock with acute renal failure. Blood lactate rose during HF (p<0.001), with
haemodynamic stability and no deterioration of acid-base status.In an ovine model
of septic shock treatment with the protease inhibitor aprotinin had beneficial effects
on MAP, creatinine clearance and PRA. Kallikrein activation may be important in the
S/ABSf^°phySi0l°9y of septic shock, and afford a specific target for therapy. Us& fhjs sjde Qn]y
CHAPTER 1 RATIONAL FOR THE STUDIES AND REVIEW
OF THE LITERATURE
1.1. Cardiorespiratory and acid-base
physiology
1.1.1. Introduction
The maintenance of life is critically dependent on the
provision of adequate oxygen to the respiring cells of
the body (Barcroft 1920, Flenley 1978, Abraham 1986).
The adequacy of this supply depends on the balance
between oxygen requirements and the volume of oxygen
delivered to the tissues. The supply of oxygen depends
on the complex interactions of the elements comprising
the highly developed cardio-respiratory system, which
allows the transfer of atmospheric oxygen from alveoli
to mitochondria (Miller 1982). The individual parts of
this system are the lungs, heart and circulation.
Although in clinical practice these elements are often
regarded individually, they are functionally
indivisible. The dynamic physiological components of the
cardio-respiratory system are: cardiac output,
haemoglobin concentration, the percentage of haemoglobin
saturated with oxygen in arterial blood, dissolved
oxygen in arterial blood, the affinity of haemoglobin
for oxygen and the distribution of perfusion (which
relies on systemic blood pressure and the local balance
of vasoconstriction and vasodilatation). All but the
last of these can now be measured routinely at the
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bedside in critically ill patients.
The achievement of normal metabolism relies on the
ability of this system to deliver oxygen to the
appropriate sites, and in sufficient quantities to meet
demand. In clinical practice we can measure whole body
oxygen transport (Edwards 1990) but still rely on remote
and global markers such as blood lactate concentration
to assess the overall supply/demand relationship. The
dynamic relationship of blood lactate concentrations and
oxygen transport variables during resuscitation have
only recently been considered.
The fundamental importance of deficiencies in all
components of this system in critically ill patients
have been emphasised by Nightingale (Nightingale 1990)
and Lister (Lister 1991), but several crucial, practical
points are highlighted here.
1) It has been repeatedly demonstrated that clinical
assessment, even by experienced clinicians, is often
inaccurate in the acutely ill (Connors 1983, Eisenberg
1984) .
2) The ability of patients to maintain blood pressure by
vasoconstriction, to the detriment of flow and
perfusion, has been documented in Adult Respiratory
Distress Syndrome (ARDS), cardiogenic shock and multiple
trauma (Clarke 1991, Creamer 1990, Brown 1992, Edwards
1988). Conversely, in sepsis, hypotension may be
associated with a hyperdynamic circulation, but severe
regional blood flow maldistribution causes critical
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tissue hypoxia, despite the high cardiac output (Maclean
1967, Duff 1969) .
3) Measurement of urine output and documentation of
'vital signs' poorly reflect the adequacy of
resuscitation (Dries 1991).
Evidence is accumulating that survival rates can be
improved in sepsis, trauma, high-risk surgical patients
and low flow states if therapy is directed at improving
overall oxygen transport (Tuchschmidt 1992, Edwards
1991, Shoemaker 1988, Boyd 1993, Sumimoto 1991). This
evidence, coupled with the need to employ treatments
with a potential for worsening of the overall and
regional oxygen supply/demand balance such as
catecholamines and positive end-expiratory pressure
(PEEP), necessitate a low threshold for invasive
monitoring and oxygen transport measurement in the
severely ill, as advocated by the European Society of
Intensive Care Medicine (Bennett 1991 i). This has major
implications for the practice of, and the provisions
for, intensive care in the United Kingdom.
1.1.2. Tissue hypoxia
The basic nature of the circulation, cardiac function
and blood flow have been understood since Harvey's
original treatise (Harvey 1628). Priestley's discovery
of oxygen (dephlogisticated gas) in 1794 led rapidly to
its use in clinical practice by Beddoes and Watt
(Beddoes 1794). Despite these initial discoveries, it
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was not until early this century that the connections
between hypoxia, circulatory compromise and lactic
acidosis were first suggested (Macleod 1921). In 1920,
Barcroft stated that research into the supply of oxygen
to the tissues was "urgent, as at present there is too
great an element of assumption" (Barcroft 1920). He went
on to define three types of anoxaemia:
1) anoxic anoxaemia where arterial oxyhaemoglobin
saturation or arterial partial pressure of oxygen, or
both, are low
2) anaemic anoxaemia where the quantity of functional
haemoglobin is subnormal
3) stagnant anoxaemia where tissue perfusion is
inadequate.
These principles remain valid although, as Barcroft
himself pointed out, the mechanisms are not necessarily
mutually exclusive. In addition, interest in the
possibility of an intra-cellular block to oxygen
utilisation is returning, in the light of new evidence
(Gutierrez 1991, Boekstegers 1994). However, Barcroft's
statement that too much is left to assumption still
holds true, particularly if assessment of the critically
ill is based solely on clinical examination.
1.1.3. Principles of oxygen transport
The concept of whole body oxygen delivery (DO2) as the
product of cardiac output and arterial oxygen content
was proposed by Richards in 1944 (Richards 1944) . It is
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of fundamental importance to appreciate that this
measurement does not directly reflect the amount of
oxygen delivered to the tissues, as any maldistribution
of perfusion due to vasoderegulation will lead to
arterio-venous shunting.
In normal subjects, resting oxygen consumption (VO2) is
broadly unchanged over a wide range of values of DO2
(Cain 1967), the oxygen extraction ratio varying to
maintain a stable VO2• The normal physiological response
to a fall in DO2 is to increase oxygen extraction. As
Shibutani showed in patients anaesthetised for cardiac
surgery (Shibutani 1983), this mechanism is effective
until the DO2 falls to a critical level which was 330
ml/min/m2 in this and other studies (Komatsu 1987).
Below this DO2 oxygen extraction cannot increase further
and VO2 falls in parallel with DO2, such that there is
supply dependency of VO2 on DO2. Although it was
originally suggested that DO2 equated with oxygen
availability, and thus the adequacy of tissue
oxygenation, it is now recognised that tissue hypoxia
and dysoxia may occur in the presence of a normal or
high DO2, for the reasons outlined above.
In patients with septic shock it has long been
recognised that there is impaired VO2 which is probably
due to a combination of vasoderegulation (Duff 1969) ,
microvascular plugging (Messmer 1988) and increased
capillary to mitochondrial oxygen diffusion distance
(Sibbald 1989). Despite past scepticism, some
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investigators are returning to the theory of direct
mitochondrial dysfunction as part of the mechanism of
pathological oxygen supply dependency (Boekstegers
1994), and cytokines have been implicated in this.
In the normal situation, DO2 is determined by the
metabolic requirements of the tissues, with compensatory
increases in DO2 with increased VO2, as shown in
exercise (Hermanson 1972). The concept of a threshold
DO2 below which basal VO2, and thus normal aerobic
cellular metabolism, could not be maintained was shown
by Cain in a number of elegant animal studies using
anaemia, hypoxaemia, reduced cardiac output or
combinations of these to depress DO2 (Cain 1965, Cain
1967). There is accumulating evidence that in critically
ill patients with sepsis, ARDS and multiple organ
failure the critical threshold for delivery dependent
oxygen consumption may be at normal or high levels of
DO2 (Kariman 1985, Haupt 1985, Dantzker 1991, Clarke
1991) , resulting in pathological supply dependency of
VO2 on DO2. The use of the response of VO2 to changes in
DO2 in an attempt to disclose tissue hypoxia is under
investigation (Vincent 1990 i, Nimmo 1992).
To further complicate the interpretation of whole-body
oxygen transport variables there may also be
abnormalities of oxy-haemoglobin dissociation,
differential tissue oxygen requirements and
micro-vascular dysfunction, none of which are apparent
from global measurements (Ruokonen 1991).
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1.1.4. Tissue perfusion
Investigators have long sought indicators of the
adeguacy of tissue perfusion. Kasnitz suggested the use
of mixed venous partial pressure of oxygen (PVO2) as a
guide (Kasnitz 1976) but this has subsequently been
shown to be elevated or normal in septic shock patients
with tissue hypoxia (Miller 1982), rendering its
interpretation difficult.
The mixed venous oxy-haemoglobin saturation (SVO2) has
also been proposed as an indicator of the adequacy of
tissue oxygen supply, and several studies have shown
that in low flow states associated with acute myocardial
infarction and with intact vasoregulation SvC>2 may have
prognostic and therapeutic importance (Creamer 1990,
Sumimoto 1991). However, Richards and coworkers,
studying patients with chronic congestive cardiac
failure, failed to demonstrate a consistent relationship
between increases in DO2 and rising SvC>2 (Richards
1989) . These authors suggested that in some individuals
there was an oxygen debt, which was only paid-off with
the increased DO2. The usefulness of SvC>2 as an early
marker of tissue hypoxia in vasoderegulated states
remains unclear.
The measurement of tissue oxygen tension has been
studied in both the clinical and laboratory settings.
However, the clinical application of this technique, and
its relevance in the critically ill remain undefined.
Another proposed method of monitoring the adequacy of
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regional oxygen supply is gastric tonometry. In this
technique, gastric intra-mucosal pH (pHi) is calculated
using measurements of the arterial bicarbonate and the
pCC>2 of saline from the balloon of a tube in the gastric
lumen. Conflicting opinions regarding the place pHi
measurements have been expressed, and studies are
necessary to define its place in the monitoring of the
critically ill (Silverman 1991, Gutierrez 1992).
The pathophysiology of tissue hypoxia in critical
illness is so complex and variable, both within and
between subjects, that to believe in the ability to
monitor the situation with a single marker is at best
optimistic and at worst naive. An approach which
combines the synthesised measurements from a group of
appropriate monitors may be the most useful.
1.1.5. Anaerobic metabolism
Lactate is formed from pyruvate as a product of the
anaerobic oxidation of glucose. Huckabee pointed out in
1958 that the cellular consequence of oxygen deficiency
is the preferential shift towards the lactate
dehydrogenase (LDH) system, a metabolic dead end
resulting in increased lactate production (Huckabee
1958). The formation of lactate via pyruvate and its
metabolism to pyruvate, catalysed by LDH can be
summarised in the equation:
Lactate + NAD = Pyruvate + NADH + H+
Huckabee postulated that if the rate of this anaerobic
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metabolism could be defined, the extent of the tissue
oxygen debt could be deduced. The use of lactate alone
as a quantitative estimate of hypoxic anaerobiasis was
questioned, as other metabolic events leading to
elevated pyruvate concentrations would lead to increased
lactate by virtue of the above reaction where NADH is
nicotinamide adenine dinucleotide, and the enzyme
controlling the reaction is LDH. The relations of the
anaerobic and aerobic components of glycolysis are shown
in Figure 1.
Huckabee showed that hypocapnia, hyperglycaemia and
hyperpyruvataemia all resulted in hyperlactataemia, and
demonstrated the utility of Excess Lactate (XL) to
distinguish between non-hypoxic and hypoxic
hyperlactataemia (Huckabee 1958). The XL is the fraction
of lactate present in excess of that which would be
expected on the basis of the prevailing pyruvate
concentration, and is calculated from the equation:
XL = (Ln - Lo) - (Pn - Po) (Lo/Po)
where Ln and Lo are experimental and control (baseline)
lactate concentrations, and Pn and Po are experimental
and control concentrations of pyruvate, respectively.
The influence of lactate removal or metabolism in these
studies was not assessed, but it is widely recognised
that blood lactate concentrations are higher in patients
with hepatic dysfunction (Royle 1978, Kruse 1987), in
experimental animals with hepatic hypoxia (Tashkin 1972)
and in liver failure (Bihari 1985). This is likely to be
9
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due to a combination of reduced clearance, and to
hepatic lactate production per se.
Few clinical studies assessing the usefulness of XL have
been performed, but that of Broder and Weil in 1964
supported Huckabee's findings (Broder 1964). In this
study, serial XL measurements were made in 56 patients
with shock of varying aetiologies. The levels of XL were
found to correlate with the severity of circulatory
failure, and to have prognostic value. A major
impediment to the use of XL measurement in the
critically ill is the lack of baseline measurements.
More recently it has been suggested that the presence of
significant hyperlactataemia in shock of varying
aetiologies is an indicator of worse prognosis. Weil and
Afifi, using a haemorrhagic rat model (Weil 1970),
showed that cumulative oxygen debt correlated with log
lactate. In the same paper, they presented data from 142
patients with shock, showing that lactate concentrations
alone were equally good outcome predictors compared with
XL values. A number of studies from the same group have
confirmed these findings (Cady 1973, Shubin 1974). Other
investigators and reviewers have agreed with this
interpretation (Schuster 1984, Bakker 1991 i) and have
further stated that the response of blood lactate to
resuscitative therapy is an even better guide to outcome
(Vincent 1983, Cowan 1984). On the other hand, there is
some evidence that initial lactate concentrations do not





The development of metabolic acidosis in shock was
recognised by Cannon (Cannon 1920), and had been
demonstrated in a wide variety of causes of shock by
Cournand and colleagues in 1943 (Cournand 1943), and
again by Peretz and co-workers (Peretz 1965). Over the
next 20 years the usefulness of arterial acid-base
measurements became accepted as routine in the
monitoring and treatment of shock and critical illness.
However, it has been suggested that central or mixed
venous blood gases reflect tissue metabolism much better
than arterial in certain clinical situations (Weil 1987,
Adrogue 1989), although not in liver failure (Wendon
1991).
In critical illness the development of acid-base
disturbance is often multifactorial, and the relative
contributions of disturbances in the mechanisms detailed
below may be difficult to assess. In shock the commonest
derangement of acid-base physiology is metabolic
acidosis and, as Cohen and Woods have documented, this
is commonly due to hypoxic lactic acidosis (Cohen 1976).
1.1.6.2. Acid-base physiology
In normal health between 1200 and 1500 mmol of lactate
with an equal number of protons is produced by
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metabolically active tissues in a 70 kg human each day.
Approximately 12,000 to 15,000 mmol of CO2 is produced
from the combustion of carbohydrates and fats. The CO2
load is handled easily by the lungs with normal
ventilatory effort, avoiding a potentially overwhelming
acidosis. The protons produced in peripheral tissues are
titrated against local blood and tissue bicarbonate
along with other buffering systems, and the lactate ions
are removed by the liver, kidneys and heart. The hepatic
metabolism of lactate is mainly by gluconeogenesis, but
also by oxidation to CO2 and water. In either case one
proton is consumed per lactate ion metabolised,
resulting in the regeneration of bicarbonate in equal
quantities to that lost in the original peripheral
buffering, and maintaining acid-base homeostasis.
Deamination of amino acids in the liver produces
ammonium ions which enter the urea cycle, with the
consequent production of two protons for each urea
molecule. Systemic acidosis inhibits the production of
urea. Oxidation of dicarboxylic and sulphur containing
amino acids produces further protons, but oxidation of
neutral and basic amino acids produces an almost
equivalent load of HC03~ which balances the H+ produced.
Ammonium ions not channelled into urea synthesis are
scavenged and glutamine synthetase catalyses the
combination with lactate to form glutamine which is
transferred to the kidneys. Protons are removed in the
kidney by combination with phosphate, as ammonium ions,
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by exchange for sodium ions and by direct secretion. It
has been conventionally thought that glutamine is
deaminated to glutamate and ammonia in the kidney, the
ammonia then combining with H+ to form ammonium. However
it is now appreciated that at physiological pH the
ammonium ion is formed directly. Thus in acidosis,
ammonium is directed from the liver to the kidney in the
form of glutamine allowing its disposal without the
proton penalty incurred by urea synthesis. Cohen has
suggested that the liver is the prime regulator of
acid-base homeostasis, although the importance of renal
bicarbonate production and recovery is undisputed (Cohen
1991).
1.2. Pathophysiology of shock
1.2.1. Cardiorespiratory variables in shock
The common pathophysiological denominator in all types
of shock regardless of aetiology is imbalance between
oxygen requirements and oxygen transport. This may be
due to reduced or maldistributed DO2, increased but
unfulfilled metabolic needs, an intra-cellular block to
oxygen utilisation, or combinations of these factors
(Mackenzie 1964, MacLean 1967, Shoemaker 1973).
1.2.2. Low flow states
In haemorrhagic shock DO2 is reduced by the combination
of low arterial oxygen content (CaC>2) , mainly due to
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loss of haemoglobin, and depressed cardiac output
(Wiggers 1940).
The haemodynamic changes of cardiogenic shock (CS) have
been well documented (Forrester 1976). In major infarcts
involving the left ventricle, pump failure results in
reduced stroke volume and cardiac output, with elevation
of left ventricular end-diastolic pressure and
hypotension. Compensatory mechanisms are activated in an
attempt to maintain coronary and cerebral perfusion, and
result in peripheral vasoconstriction and increased
systemic vascular resistance. In contrast to the large
volume of laboratory and clinical studies on
haemodynamics in CS, the effects on oxygen transport
have only recently been described in detail. Muir and
colleagues described the relationship between SvC>2 and
cardiac output in myocardial infarction (Muir 1970).
Da-Luz and co-workers documented the finding of a
critically low SvC>2 in CS (Da Luz 1975) . In a study
detailing the oxygen transport changes of CS, Creamer
and colleagues demonstrated that compensatory mechanisms
exist which maintain oxygen consumption despite
depressed DO2 in this condition (Creamer 1990). They
showed that VO2 remained normal at the expense of
markedly increased oxygen extraction, resulting in
profoundly low levels of SvC>2. The prognostic importance
of SvC>2 in acute myocardial infarction (AMI) has been
highlighted by Sumimoto (Sumimoto 1991), and its
potential as an important pathophysiological monitor has
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been proposed (Gore 1984, Nightingale 1990).
In cardiogenic shock the fall in DO2 is due not only to
low cardiac output secondary to reduced stroke volume
and left ventricular stroke work index, but also to low
CaC>2 • The drop in CaC>2 is mediated by arterial
hypoxaemia which may be present even in the absence of a
critically elevated pulmonary artery occlusion (wedge)
pressure (PAOP) and pulmonary oedema (Da Luz 1975,
Edwards 1986). The arterial hypoxaemia is worsened by
the increased arterio-venous admixture present with
pulmonary oedema, and by the depressed CvC>2 and SvC>2.
There may be increased metabolic demands, particularly
in the respiratory muscles as they attempt to maintain
oxygenation and normocarbia in the face of increased
work of breathing and reduced compliance. It has been
shown experimentally that the terminal event in CS is
often respiratory arrest due to diaphragmatic fatigue,
rather than a primary cardiac event (Aubier 1982).
In both cardiogenic shock (Da Luz 1975) and haemorrhagic
shock (Edwards 1988, Rady 1991) there is an increase in
oxygen extraction in an attempt to maintain an adequate
VO2. As described above, this seemingly beneficial
response results in critical reductions in SvC>2,
sometimes as low as 25%, with the consequence that even
in the presence of intact vasoregulation some cells at
the distal end of the microcirculation will receive
blood containing little or no extractable oxygen. Unless
the defect of tissue oxygen delivery is rectified
16
cellular dysfunction becomes irreversible and ultimately
cell death will result.
1.2.3. Septic shock
1.2.3.1. Introduction
As causes of morbidity and mortality, septicaemia and
septic shock (SS) have become increasingly recognised
over the last 40 years. Gram-negative bacteraemia (other
than salmonella) was thought to be rare until the work
of Waisbren, who in 1951 reported 29 cases of
gram-negative septicaemia, heralding the acceptance of
these organisms as major pathogens (Waisbren 1951).
Although the terms gram-negative, endotoxic and septic
shock are commonly used interchangeably, the latter is
preferrable since the others are quite specific, and the
syndrome is not restricted to gram negative organisms.
The relative contribution of endotoxin to the
cardiorespiratory changes is difficult to gauge in
clinical practice.
1.2.3.2. Pathophysiology
The syndrome of SS is produced by the interaction of a
complex of distinct but linked mechanisms which result
in hypoxaemia, hypovolaemia, myocardial depression,
systemic vasodilatation, pulmonary hypertension and
impaired tissue oxygen extraction. These changes may be
due either to the direct action of the micro-organisms
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or their products, or to the effects of cellular or
mediator system activation which the infection provokes.
These interactions are represented diagrammatically in
Figures 2 and 3. Figure 3 also includes an overview of
current therapeutic options, as detailed below. The
importance of the distinction between the effects of the
organism or the effects of mediator activation lies in
the fact that eradication of the infection may not
produce reversal of the sepsis syndrome (Bone 1987),
with the continuing effects of an ongoing
'auto-inflammatory' response.
The presence of arterial hypoxaemia has long been
recognised as an early finding in SS (Maclean 1967,
Shoemaker 1973), and accompanies the tachypnoea which
occurs at an early stage of the disease. The decline in
arterial pC>2 is a consequence of a number of mechanisms,
but an increase in pulmonary venous admixture will occur
as a result of combinations of atelectasis, pneumonia,
ARDS and mediator induced vascular shunting.
It is in the nature of the disease process, and its
causes, that most patients with SS will have
intra-vascular volume depletion consequent to fluid
losses from combinations of fever, excess
gastro-intestinal secretions, intra-abdominal
collections and bleeding. The generalised capillary leak
seen in SS is probably initially mediated by kinins
(Colman 1977, Cumming 1992 i) and subsequently by
18
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cytokines, in particular interleukins. There is loss of
protein and fluid from the circulation even in the
presence of a normal colloid osmotic pressure. This
absolute hypovolaemia is compounded by systemic
vasodilatation, which by increasing the effective
intra-vascular space causes relative hypovolaemia.
One of the earliest haemodynamic changes in SS, systemic
vasodilatation often goes unrecognised as the fall in
systemic vascular resistance (SVR) is usually
accompanied, at least initially, by an increase in
cardiac output with consequent maintenance of blood
pressure (Astiz 1987). The initial vasodilatation is
probably due to endotoxin mediated activation of the
plasma kallikrein-kinin system and the generation of
potent vasodilator kinins as demonstrated by Mason and
colleagues (Mason 1970, Robinson 1975). A number of
cytokines such as Tumour Necrosis Factor (TNF) have been
shown to have similar effects, and to be present in
abnormally high concentrations in SS (Beutler 1987).
It is unusual to find a low or low normal cardiac output
in SS once hypoxaemia and hypovolaemia have been
adequately corrected, most patients having high cardiac
output. The original haemodynamic studies on septic
shock from Detroit (Wilson 1965) and Montreal (MacLean
1967) also demonstrated that the nature of the
cardiovascular response is unrelated to the type of
infecting organism, a fact which appears to have been
'rediscovered' (Ahmed 1991) . Despite the high cardiac
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output, myocardial depression is now recognised as a
major feature of the disease. Absolute myocardial
depression with a low cardiac output is occasionally
seen in patients with severe underlying cardiac disease
or a profound intra-abdominal catastrophe such as
infarcted bowel (MacLean 1967) but in the majority,
following volume loading, the circulation is
hyperdynamic with a low SVR and high cardiac output.
It seems paradoxical, but in hyperdynamic SS with a high
cardiac output severe myocardial depression can be
demonstrated. Elegant studies in both animals and humans
using radionuclide ventriculography have shown that both
right and left ventricular ejection fractions are
profoundly, although reversibly, depressed (Ognibene
1988). Parillo and colleagues have demonstrated that the
high cardiac output is attained by ventricular
dilatation with maintained stroke volume and an increase
in heart rate (Parker 1984). This depression of
myocardial contractility is likely to be multi-factorial
in aetiology. The existence of a circulating myocardial
depressant factor is now widely accepted, and several of
the cytokines are leading contenders for this role
(Parillo 1985). The significance of myocardial oedema is
still under investigation (Elkins 1973, Cunnion 1986).
The thromboxane and kinin mediated pulmonary
hypertension of SS will aggravate right ventricular
dysfunction directly (Reines 1982), and may affect the
left ventricle via septal motion abnormalities as a
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result of ventricular interaction.
In the midst of these abnormalities normal cellular
function is further compromised by the impairment of
oxygen utilisation discussed above (Duff 1969). The
finding of a narrowed arterio-venous oxygen difference
in SS in the presence of a high cardiac output and
oxygen delivery, but with lactic acidosis suggesting
ongoing tissue hypoxia, has been confirmed by other
groups. Many theories have been proposed to explain this
phenomenon, but it is likely to result from a number of
co-existent mechanisms.
Mediator activation and cytokine release cause
vasoderegulation, such that appropriate redistribution
of tissue blood flow as dictated by local metabolic
needs and effected by alterations in the balance of
vasoconstriction and vasodilatation is impaired.
Recently it has been shown that widespread oedema
affects many tissues and organs in SS, at least in part
due to the capillary leak mentioned above. This
peri-vascular oedema will result in an increased
capillary to cell diffusion distance for oxygen. At the
present time, it seems that these are the two main local
mechanisms interacting to cause defective oxygen
consumption. However, as mentioned previously, the
possibilty of an intra-cellular block to oxygen
utilisation is under investigation (Gutierrez 1991,
Harkema 1990).
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1.2.3.3. Mediators of septic shock
In the preceeding pathophysiological description of SS
the pivotal role of mediator systems in the syndrome is
highlighted. The initial sequence of events which
triggers the systemic responses to sepsis is complex
although bacterial cell wall products including
endotoxin are thought to be common initiators (Glauser
1991, Cohen 1991). Bacterial endotoxins are potent
activators of the contact system and inflammatory cells,
intravenous administration causing a syndrome of SS with
fever and hypotension in animals and humans alike
(McCabe 1971, Suffredini 1989).
The plasma contact systems are activated via Hageman
factor, with subsequent activation of the
kallikrein-kinin axis, the complement cascade and the
fibrinolytic system. Histamine release also occurs early
in SS and may contribute to vasodilatation. Activated
elements of the complement cascade result in the
generation of a variety of eicosanoids, and their
actions contribute to the cardio-respiratory changes of
SS. Thromboxane A2 causes pulmonary vasoconstriction,
and leucocyte/platelet aggregration will cause capillary
plugging leading to a worsening of the imbalance in
nutrient blood flow. Prostacyclin, the natural
antagonist to thromboxane, may appear in excessive
quantities in SS and contribute to vasodilatation and
vasoderegulation. The leukotrienes also promote
neutrophil adhesion, superoxide generation and may
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depress myocardial contractility.
The pathophysiology of septic shock and its treatment
have been reviewed in detail, with particular emphasis
on the place of immuno-mediator cascades in the
development of the syndrome, and on the therapeutic
potential of immunotherapy (Cohen 1991).
1.2.3.4. Clinical features
As stated above the clinical and haemodynamic syndrome
of septic shock can result from infection with a wide
variety of micro-organisms, including gram-positive
bacteria, fungi and protozoa. Shock is a syndrome in
which the cardiorespiratory system fails to deliver
sufficient oxygen to the tissues to maintain normal
aerobic metabolism and cellular function. If this
situation persists uncorrected, hypotension and organ
dysfunction will result. Rapid and efficient correction
of this oxygen supply/demand imbalance should reverse
functional organ failures, but if prolonged tissue
hypoxia has occurred then morphological damage to the
cells is evident, with cell death in extreme cases.
The diagnosis of septic shock (SS) is often made at a
relatively late stage, once circulatory decompensation
is manifested by hypotension. The basis of clinical
diagnosis is the presence of hypotension and organ
dysfunction in the presence of an infective focus and/or
positive cultures.
The clinical, haemodynamic and metabolic findings in
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septic shock are the result of the complex
pathophysiological response previously detailed. In many
patients with septicaemia prompt eradication of
infection in conjunction with active, basic
cardiorespiratory support using oxygen and volume
expansion will result in improvement. However in those
where this is not the case, when infection is difficult
to eradicate, the organism is extremely virulent or
mediator activation is overwhelming, intensive care is
necessary. Assisted ventilation, invasive haemodynamic
monitoring and vasoactive drug support will be required
with the aim of optimising cardiorespiratory function in
an attempt to restore adequate tissue oxygen delivery
(Abraham 1983, Edwards 1989 i). Manipulations of the
sepsis triggered auto-inflammatory process using
immunotherapy or other adjunctive techniques offer
further therapeutic possibilities.
1.3. Adult Respiratory Distress Syndrome
1.3.1. Pathophysiology
When ARDS was originally described by Ashbaugh and Petty
(Ashbaugh 1967) it was thought to be a predominantly
pulmonary problem, that is the association of hypoxaemia
refractory to oxygen therapy with non-cardiogenic
pulmonary oedema, in the setting of a recognised
predisposing condition. It is now clear that ARDS is an
inflammatory condition with multi-system involvement
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similar to the systemic response to sepsis, both in the
derangements of physiology and in the mechanisms
involved.
The risk factors for the development of ARDS are well
known, and listed in Table 1 (Fowler 1983) . From what
has been stated above, it is not surprising that the
sepsis syndrome, shock and multiple trauma are the
commonest causes. The criteria for diagnosis vary, but
Murray has suggested a scoring/diagnostic system which
if adopted could help clarify diagnosis and severity
(Murray 1988).
The major pulmonary abnormality in ARDS is diffuse
injury to the lung's alveolo-capillary barrier with
resulting pulmonary oedema due to increased
permeability. In addition there is acute pulmonary
hypertension (PHT), as in septicaemia, and bronchospasm.
The major extra-pulmonary finding is the aforementioned
defect in efficient oxygen utilisation in the peripheral
microcirculation, which is similar to that seen in
septic shock (Cain 1991). It is currently thought that
these responses are due to the activation of a major
host-response including the contact systems, kinins,
arachidonic acid products and cytokines. A number of
investigators including Snapper (Snapper 1983) have
shown that many of the features of ARDS can be induced
by the administration of endotoxin, and have proposed
that bronchoconstriction may be mediated by thromboxane
A2, and PHT by thromboxane B2. It has been suggested
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Table 1.
Risk factors for adult respiratory distress syndrome




























that the PHT in septic shock may be due to kinins
(Cumming 1992 i). The importance of PHT in ARDS is
highlighted by the studies of Sibbald (Sibbald 1978).
The peripheral defect of oxygen utilisation in ARDS is
linked to the generalised capillary damage which occurs
with the initiation of the disease process. There is a
whole body capillary leak syndrome, mirroring the events
in the lungs, which helps explain the high incidence of
extra-thoracic organ failures seen in the condition. The
same mediators as in septic shock are thought to be
implicated in ARDS, and these are discussed in section
1.2.3.
1.4. Principles and Practice of Therapy in
Shock and Critical Illness
1.4.1. Introduction
The treatment of specific disease states necessitating
intensive care will vary to some extent depending on the
underlying diagnosis. However, the basic principles of
therapy in intensive care are universally applicable
across the diagnostic range. The main components of
management include resuscitation, organ support, patient
comfort, specific diagnostic investigations, specific
interventions and nutrition. These broad categories are
complimentary and overlapping, and it is clear that in




Resuscitation in the critically ill follows the
fundamental sequence of 'airway, breathing,
circulation'. Initial treatment is directed at securing
the airway and to correcting hypoxaemia. Studies by
Aubier and colleagues have provided evidence that the
terminal event in cardiogenic shock is profound
diaphragmatic fatigue and ultimately apnoea (Aubier
1982, Roussos 1988). The institution of respiratory
support must be a priority in the management of
critically ill patients, not only to improve hypoxaemia
but also to assist or relieve the exhausted respiratory
muscles. The mode of ventilatory support chosen will be
dictated by the severity and type of illness, but in all
of the human studies in this thesis the patients were
ventilated using either controlled mandatory ventilation
(CMV) or synchronised intermittent mandatory ventilation
(SIMV) with varying levels of positive end-expiratory
pressure (PEEP). Oxygen therapy to achieve adequate
levels of Pa02 and Sa02 was universally required in
these patients, and many needed values of Fi02
approaching 1.0. Ventilatory support remains the
mainstay of respiratory management in general, adult
intensive care, and the use of specialised techniques
such as high-frequency jet ventilation, extra-corporeal
membrane oxygenation or carbon dioxide removal, and




Although priority is given to airway control and oxygen
therapy, and attention to the circulation is often
deemed secondary, in many clinical situations the
insertion of a large bore cannula for fluid infusion and
vasoactive drug administration must parallel airway
care.
Volume loading with colloid and blood is carried out in
conjunction with cardiac output and PAOP measurement. A
Sarnoff ventricular function relationship is constructed
allowing the lowest PAOP associated with the highest
left ventricular stroke work index to be found (Sarnoff
1954) . The choice of fluid for resuscitation in shock,
trauma and ARDS has been a matter of intense debate for
many years. It has been shown by Shoemaker and others
(Appel 1981, Gilbert 1986, Edwards 1989 ii) that colloid
solutions and blood produce more rapid improvements in
oxygen delivery than equivalent volumes of crystalloid
and that these effects are maintained for much longer.
The level of haemoglobin which is optimal for tissue
oxygen delivery is not known, and will depend on the
disease state. The ability to maintain bulk transport of
oxygen must be offset against the potential detrimental
effects on micro-circulatory flow of increasing the
haematocrit. In those patients in whom DO2 can be
increased by elevating cardiac output, it has been
suggested that the optimal haemoglobin concentration
will need to be defined in the individual using
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appropriate monitoring (Shoemaker 1988). In those
patients with a limited ability to increase cardiac
output in response to inotropic agents it may be
appropriate to maintain a higher haemoglobin
concentration.
1.4.4. Vasoactive drug therapy
In many patients with shock or ARDS suboptimal levels of
cardiac output, oxygen delivery and blood pressure
persist despite oxygenation and optimal volume loading
(Edwards 1989 i, Mackenzie 1991 i, Redl-Wenzl 1993). The
work of Shoemaker and colleagues showing that the
maintenance or achievement of high levels of DO2 in
conjunction with normalisation of blood pressure results
in considerable improvements in survival in critically
ill surgical patients has highlighted the need for
resuscitation based on measured physiological variables
(Shoemaker 1988) . Uncontrolled (Edwards 1989 i) and
controlled (Tuchschmidt 1992) studies of this approach
in severe septic shock have shown similar results. The
achievement and maintenance of high levels of DO2 with
simultaneous reversal of hypotension improves survival.
In order to achieve these cardiorespiratory 'goals' in
severe septic shock and ARDS vasoactive drugs will be
required, and have been used effectively in low flow
states (Coffin 1965), sepsis (Talley 1969) and ARDS over
many years (Gilbert 1986).
Vasoactive drugs may theoretically affect oxygen
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transport in a number of ways. In diseases associated
with pathological delivery dependent oxygen consumption
such as ARDS and septic shock the increase in DO2 should
be accompanied by an increase in VO2• If, however, the
patient's DO2 is adeguate to meet tissue oxygen demands
and vasoregulation is intact a drug-induced rise in DO2
would be accompanied by a fall in oxygen extraction
ratio, with no change in VO2. Some catecholamines have
unpredictable general or regional vasoconstrictive
effects which may lead to tissue hypoxia by worsening
maldistribution of blood flow (Talley 1969, Meadows
1988, Takala 1991, Mackenzie 1991 i). In addition, all
catecholamines have the ability to increase overall
metabolic oxygen reguirements to some extent, and if the
tissue oxygen supply is not increased by a commensurate
amount, tissue hypoxia may result. Since most vasoactive
drugs affect the pulmonary as well as systemic
circulations, inappropriate pulmonary vasodilatation or
vasoconstriction may occur and cause increases in
pulmonary shunt fraction (Qs/Qt) which will affect
arterial oxygenation (Jardin 1979, Shoemaker 1986).
The approach to manipulation of the circulation using
these agents will depend on the measured cardiovascular
variables, but in general septic and ARDS patients
reguire concurrent inotrope and vasoconstrictor therapy.
This may be achieved with an ino-constrictor agent such
as adrenaline (Mackenzie 1991 i) or with a combination
such as dobutamine and noradrenaline (Edwards 1989 i,
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Vincent 1990 ii). The latter combination has the
significant benefit of titration of the individual
effects, a technique described by Talley and colleagues
in 1969 (Talley 1969). In patients with high filling
pressures and non-critically depressed blood pressure an
ino-dilator effect may be appropriate, and can be
achieved with dobutamine (Vincent 1990 ii), a
phospho-diesterase inhibitor such as enoximone (Vincent
1988) or a combination of the two. The effects of these
agents in critically ill patients are unpredictable, and
in addition to inter-individual variation there is
intra-subject variation as the disease state changes.
The prior correction of hypoxaemia, hypovolaemia and
electrolyte abnormalities is mandatory and this combined
with the use of invasive monitoring will enhance the
chances of therapeutic success, and reduce the risks of
serious adverse effects. The appropriate combination of
vasoactive drugs for an individual patient will only be
found by titration against repeated cardiorespiratory
measurements (Talley 1969, Edwards 1991). There has been
concern over the detrimental effects of vasoconstrictor
drugs on renal function and acid-base status (Cohen
1976). There are now a number of studies showing the
improvement in renal function using adrenaline or
noradrenaline in hyperdynamic appropriately volume
resuscitated patients (Redl-Wenzl 1993). Initial studies
of the effects of these agents on acid-base status and
blood lactate concentrations are contained in this
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thesis.
1.4.5 Cardiorespiratory optimisation in
Cardiogenic Shock
Much of the preceding text is more relevant to high
flow, vasoderegulated shock than to low flow states. A
detailed description of the treatment of CS is
appropriate to highlight the potential differences in
treating different shock states.
The aim of treatment in CS is to combine good symptom
control with maximal survival whilst minimising
myocardial damage. Appropriate analgesia, thrombolysis
and other specific interventions, for example aspirin,
are crucial in the overall management.
The specific physiological goals are to provide adequate
perfusion pressure and DO2 simultaneously, without
worsening the myocardial oxygen supply/demand balance.
In order to achieve this safely, 5 lead ST segment
analysis is required, in conjunction with systemic and
pulmonary arterial catheters to allow measurement of
systemic haemodynamics and oxygen transport. Details of
monitoring are contained in Chapter 2.
1.4.5.1. Therapeutic approach
Oxygen and ventilation
Hypoxaemia should be corrected with high flow oxygen,
and consideration should be given to early paralysis and
mechanical ventilation (Roussos 1988). Several
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beneficial effects can be expected from this:
1) improved oxygenation with the ability to deliver high
concentrations of oxygen, and the option of using PEEP
2) reduced metabolic demand with removal of the work of
breathing
3) the redistribution of better oxygenated blood from
the respiratory muscles elsewhere. In CS about 20% of
the cardiac output may be required to supply the
respiratory muscles, a ten-fold increase from normal
(Aubier 1982).
Cardiac filling pressures
If the PAOP is low, controlled volume expansion with
colloid should be instituted. The compliance of the
ventricles may be low, resulting in large rises in
pressure with small changes in volume, so small aliquots
should be titrated against repeated measurements of
cardiac output and PAOP. The correction of anaemia with
blood will result in improved DO2 with no myocardial
oxygen demand penalty. If PAOP is critically elevated,
vasodilators such as intravenous nitroglycerin can be
used, but perfusion pressure may be further compromised.
Cardiac output and blood pressure
Correction of hypoxaemia and optimisation of PAOP may
improve CO. Control of arrhythmias, particularly by
electrical means, can improve CO. The use of sequential
atrio-ventricular pacing has been advocated for its
increased efficiency over standard ventricular pacing in
certain situations (Donovan 1991). Over-drive pacing for
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tachy-arrhythmias is not associated with the negative
inotropic effects seen with most anti-arrhythmic drugs.
Hypotension may improve with increasing CO, but
vasoconstrictors or mechanical circulatory support may
also be necessary. Blood pressure must be measured
invasively because of the inaccuracy of cuff
measurements in high SVR shock (Cohn 1967). Correction
of hypokalaemia, and the administration of magnesium may
have beneficial effects on arrhythmias.
Forrester and colleagues showed that survivors of AMI
had a higher CO than non-survivors (Forrester 1976). On
the basis of this the successful use of a therapeutic
protocol involving the above measures and the use of
positive inotropic drugs has been reported. Combinations
of drugs are titrated to the individual haemodynamics
aiming for cardiac index >2.2 1/min/m2 and MAP >80 mmHg
(or higher if previously hypertensive). Depending on the
situation, GTN was used to lower PAOP, dobutamine to
increase CO and noradrenaline to maintain MAP (Creamer
1990). In some situations adrenaline, dopamine or
phospho-diesterase inhibitors may be useful (Vincent
1988) . It is interesting to note, as detailed above,
that in one of the original clinical studies of dopamine
in shock the authors concluded that in the most
critically ill patients combinations of catecholamines
would be necessary to optimise flow and pressure
independently, and that resuscitation should be guided
by repeated measurements of invasive haemodynamics
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(Talley 1969). No evidence has been produced that low
dose dopamine selectively improves renal perfusion in CS
independent of effects on CO or MAP. Dose response
curves have not been constructed for dopamine in CS.
In certain situations mechanical circulatory support
such as intra-aortic balloon counterpulsation may be
appropriate. The place of early coronary balloon
angioplasty or revascularisation is undefined as yet.
Oxygen transport
The use of catecholamines in CS may be associated with
worsening of myocardial ischaemia, by increasing
contractility or heart rate. In order to use an
effective dose, whilst not overtreating, the use of a
target CO is useful. However, from the basic
pathophysiology it is clear that SVO2 may provide a
further objective guide in titrating therapy. If
vasoregulation is intact, the achievement of an SVO2
>60% implies that DO2 to the perfused tissues is likely
to be adeguate. Correction of lactic acidosis using
sodium bicarbonate has no beneficial effect on
cardiorespiratory function in low flow states, and some
investigators have shown it to be detrimental (Bersin
1989, Cooper 1990). Until recently the therapy of CS has
been largely piecemeal, with ill-defined therapeutic
targets. Evidence is appearing that manipulation of the
oxygen transport system may be beneficial in CS, with
SvC>2 a crucial measurement.
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1.4.6. Sedation in intensive care
During resuscitation, and throughout the stay in
intensive care, it is crucial that the patient is
comfortable and pain-free. Communication should be
continued with frequent explanation and reassurance. The
majority of patients will receive a continuous low-dose
opiate infusion for analgesia, and to depress the cough
reflex in order to help in tolerating the endotracheal
tube. These agents are often supplemented by boluses or
continuous infusions of a benzodiazepine such as
midazolam, or the anaesthetic induction agent propofol.
The level of sedation is assessed using a linear scale,
ideally aiming for a degree of sleepiness from which the
patient is easily rousable into a cooperative and
communicative state (Ramsay 1974). In patients who are
not critically unstable but who require continued
ventilatory support, such as Guillain-Barre syndrome or
severe COAD, there may be no need for continuous drug
administration, especially if a tracheostomy has been
performed. Full neuromuscular paralysis is not necessary
in the majority of patients after their initial
resuscitation and stabilisation unless there is a
specific indication. Deeper levels of sedation may be
specifically indicated for certain disease states such
as tetanus or in conditions with raised intracranial
pressure. The benefits to be gained from sedation in
terms of the oxygen supply demand balance have not been
rigorously investigated.
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1.4.7. Renal replacement therapy in the
critically ill
The requirement for safe, practical and efficient renal
replacement therapy (RRT) in critically ill patients
with respiratory failure and haemodynamic instability
has led to a search for alternatives to haemodialysis.
In many of these patients the use of haemodialysis is
severely limited by the hypotension (Vincent 1982) and
worsening of hypoxaemia (Jones 1980) which have been
documented. Alternative techniques involving
haemofiltration have become popular, and may be
continuous (Kramer 1983, Simpson 1987) or intermittent
(Davenport 1989, Mackenzie 1991 ii). These have been
shown to be well tolerated and to provide adequate
biochemical control and fluid balance (Kramer 1983,
Mackenzie 1991 ii). There are however theoretical
concerns over the use of replacement fluids which
contain lactate as the buffer source (Davenport 1989).
1.4.8. Advances in therapy: Immunomodulation
A further development in the management of critically
ill patients with septic shock has been the introduction
of monoclonal antibodies to cytokines such as TNF and
IL6. More recently a human monoclonal antibody against
endotoxin has been developed, although initial studies
have been greeted with such concern that the agent has
been withdrawn from clinical use (Ziegler 1991).
However, there are several established, safe drugs which
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may have beneficial effects on either mediator cascades
or end-organ damage. These include the
phospho-diesterase inhibitor pentoxyfilline (Bennett
1989 ii, Tighe 1990) and non-steroidal anti-inflammatory
drugs such as ibuprofen (Haupt 1991). We have chosen to
study the effects of aprotinin, an agent extensively
used in humans, and with a proven record of safety.
The next decade should show whether these and related
agents (Baumgartner 1985) offer hope of improved
survival, although the mainstay of intensive therapy is
likely to remain adequate, early resuscitation in
combination with scrupulous supportive care.
It is on the basis of this, and in an attempt to improve
our understanding of currently available treatments,





The measurement of systemic haemodynamics and whole body
oxygen transport has become an integral part of the
management of critically ill patients, and the
techniques used are described below. Blood gas and
acid-base measurements are performed routinely using
standard, automated equipment and no details of this are
presented here. The assays of lactate, pyruvate,
kallikrein and plasma renin activity are detailed.
2.2. Overview of monitoring in the critically
ill
Monitoring is used in intensive care on three levels:
1. To identify events which might trigger injury
producing processes eg tachycardia in patients with
coronary artery disease.
2. To quantify ongoing injurious processes eg raised
intracranial pressure.
3. To assess the presence and severity of established
processes eg cardiogenic shock, ARDS.
From this it can be seen that surveillance with real
time monitors such as invasive blood pressure,
continuous oximetry (invasive or non-invasive, arterial
or mixed venous) or intracranial pressure measurement
will allow the early detection of otherwise unrecognised
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yet important events. This increased certainty of
physiological status will only be of value if effective
therapeutic interventions to modify these events are
available, and appropriate endpoints have been defined
and are used to guide treatment. The use of continuous
electrical cerebral function monitoring combined with
dual (jugular venous and systemic arterial) oximetry and
intracranial pressure measurement in the monitoring of
head injuries exemplifies this.
The responses of the measured variables to different
therapeutic manoeuvres clarifies the pathophysiology
over short periods of time and allows the appropriate
choice of intervention to achieve the primary aim, that
is a minimisation of secondary insults, in the above
situation brain ischaemia.
The use of monitors in severe sepsis and ARDS tends to
occur once there is already injury, usually with at
least two organ system failures present, most commonly
acute cardiorespiratory failure.
There is general agreement that in these patients the
use of an indwelling arterial line and a thermodilution,
flow directed pulmonary artery catheter are mandatory
for assessment of pressures, flow (cardiac output) and
circulatory function in terms of oxygen transport, and
the subsequent titration of appropriate combinations of




The technique of arterial cannulation has been used for
many years, and has been routine in intensive care for
over 25 years. An indwelling arterial catheter allows
measurement of MAP, used to calculate derived
haemodynamic variables, and repeated atraumatic blood
sampling. The larger and more proximal to the aorta the
artery used, the more likely the waveform and pressures
recorded will be similar to those of the central aorta,
particularly in patients with abnormalities of blood
pressure. The majority of patients in these studies had
femoral arterial lines, a few having radial artery
catheters. These were inserted percutaneously using the
Seldinger technique (Seldinger 1953). In the ovine
studies, the common carotid artery was dissected out,
two silk slings were used to control it and it was
cannulated under direct vision, again using the
Seldinger method, the line then being advanced into the
aorta.
2.2.2. Pulmonary artery catheterisation
Percutaneous catheterisation of the right heart and
pulmonary artery using a multi-lumen, balloon tipped,
flow directed catheter has become a well established
haemodynamic monitoring technique since its introduction
over 20 years ago (Swan 1970). In the human studies
access to the central veins was by the internal jugular
route, into which a percutaneous 8.5 Fr introducer
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(Baxter Edwards, Irvine, California) was inserted by the
Seldinger technique. The external jugular vein was used
in the ovine studies. A 4 lumen PAC was floated in under
pressure-waveform guidance, and position was checked on
chest x-ray. The catheter was used to measure pressures
(CVP, MPAP, PAOP), cardiac output and for mixed venous
blood sampling. Cardiac output was determined by
thermodilution in triplicate using cold injectate. An
in-line heat exchange coil and ice-bucket (Co-set,
Baxter Edwards, Irvine, California) and in-line
thermistor system were used. Dextrose 5% in 10ml boluses
was injected, curves displayed and values within 5%
accepted. Right ventricular ejection fraction was
determined in a small group of patients, using specially
modified PACs with fast-response thermistors (Ref
catheters, Baxter Edwards, Irvine, California).
Pressure measurements and cardiac outputs were stored by
the integrated modular bedside monitor (7200 series,
Marquette Electronics, Milwaukee, Wisconsin). Heart rate
was measured automatically by the monitor, and using
these measured variables the haemodynamic derived
parameters were calculated (Table 2). Table 2 contains
ranges of normal values for these parameters.
2.3. Oxygen Transport
Samples of mixed venous and arterial blood were taken
for blood gas analysis within one minute of the last
cardiac output. Haemoglobin concentration and arterial
45
Table 2 : Haemodynamic Variables - Basic Equations and
Normal Values.
Mean Arterial Pressure (MAP) : 80-100 mmHg
Central Venous Pressure (CVP): 1-6 mmHg
Pulmonary Artery Occlusion Pressure (PAOP) : 4-12 mmHg
Mean Pulmonary Artery Pressure (MPAP) : 11-15 mmHg
Cardiac Output (CO) : 4-6 1/min
Cardiac Index (CI) = CO / BSA : 2.8-3.6 l/min/m2
Stroke Volume (SV) = CO / HR : 50-100 ml
Stroke Volume Index (SVI) = CI / HR : 50-70 ml/m2
Right Ventricular Ejection Fraction (RVEF) : 50-70%
Systemic Vascular Resistance (SVR) = 79.92(MAP-CVP)/CO
dyne.sec/cm5
Systemic Vascular Resistance Index (SVRI) =
79.92(MAP-CVP)/CI
2180+/-210 dyne.sec/cm5.m2
Left Ventricular Stroke Work Index (LVSWI) = SIxMAPxO.0144
50-62 g.m/m2
Right Ventricular Stroke Work Index (RVSWI) =
SIxMPAPxO.0144
7.8-9.0 g.m/m2
BSA = Body Surface Area
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and mixed venous oxyhaemoglobin saturations were
measured using a co-oximeter (Ciba-Corning Diagnostics,
Halstead, UK). The oxygen content of arterial (Ca02) and
mixed venous (CVO2) blood, and the derived oxygen
transport parameters (DO2, VO2, OER, Qs/Qt) were
calculated using standard formulae. By convention
cardiac output is indexed for body surface area, thus
DO2 is the indexed product of Ca02 and cardiac index
(CI). Oxygen consumption is obtained using the inverse
Fick relationship:
VO2 = CI x arterio-venous oxygen content difference
(Table 3). Ranges of normal values are included in the
table.
In the physiology laboratory VO2 has traditionally been
measured by analysis of expired gas using a Douglas bag.
This method becomes less accurate as the inspired oxygen
concentration rises, making it unsuitable for many
critically ill patients.
It has been suggested that since the calculations of VO2
and DO2 involve shared variables, most notably CI, the
finding of increases in VO2 with increases in DO2 may be
linked mathematically rather than physiologically.
Detailed investigations have been carried out on this
basis, and debate has been widespread. The fact that
many studies have demonstrated the existence of groups
of individuals in whom changes in VO2 do not parallel
changes in DO2 may be sufficient to refute the validity
of mathematical coupling.
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Table 3 : Oxygen Transport - Basic Equations and
Normal Values
Ca02 (ml/dl) = (Hb(g/dl)xSa02xl.39) + (PaC>2 (mmHg) xO . 003)
~ 20 ml/dl
Cv02 (ml/dl) = (Hb(g/dl)xSv02xl.39) + (Pv02(mmHg)xO.003)
~ 15 ml/dl
DO2(ml/min/m2) = CI x Ca02 x 10 :520-720 ml/min/m2
VO2 (ml/min/m2) = CI x (Ca02 - CvC>2) x 10 :100-180 ml/min/m2
Reverse Fick Equation
OER(%) = (Ca02 - Cv02) / Ca02 : 22-30 %
Qs/Qt = Cc02 - Ca02 / Cc02 - CvC>2 : 0-5 %
CaC>2 = arterial oxygen content
CvC>2 = mixed venous oxygen content
Cc02 = capillary oxygen content
SaC>2 = arterial haemoglobin oxygen saturation
SvC>2 = mixed venous haemoglobin oxygen saturation
PaC>2 = arterial partial pressure of oxygen
PvC>2 = mixed venous partial pressure of oxygen
OER = oxygen extraction ratio
Qs/Qt = pulmonary venous admixture
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2.4. Assays used in this project
2.4.1. Lactate
2.4.1.1. Introduction
It has been suggested that lactate sampling should be
from the mixed venous blood in preference to arterial.
It has been demonstrated that in patients with severe
pulmonary pathology arterial lactate concentrations
exceed mixed venous levels as a result of lactate
production in diseased lung (Rochester 1973). We
examined the relationship between arterial and mixed
venous whole blood lactate concentrations in critically
ill patients.
It has been shown that patients suffering from lung
cancer and pulmonary tuberculosis produce lactate in
locally diseased areas of lung and that occasional
patients have a significantly higher arterial lactate as
a result (Rochester 1973) . Despite this, these workers
showed no overall significant arteriovenous difference
in lactate concentrations in their study. However some
investigators have used mixed venous samples, in
preference to arterial, to measure lactate
concentrations in critically ill patients (Kox 1991). We
performed this study to see whether this was appropriate
or necessary in intensive care patients.
2.4.1.2. Patients and methods
We studied 22 consecutive admissions to a general
intensive care unit on one occasion each. The mean age
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was 60 years, range 39-80. All patients were
mechanically ventilated and had arterial and pulmonary
artery catheters in situ for standard, clinical
monitoring. Underlying diagnoses were septic shock
(n=16), ARDS (n=18), severe acute left ventricular
failure (n=4) and pneumonia (n=2). Some patients fell
into two diagnostic groups. Arterial and mixed venous
samples were drawn simultaneously into heparinised
syringes and analysed as detailed below.
Statistical analysis was by the graphical method of
Bland and Altman (Bland 1986) and standard correlation
coefficient. The technigue of Bland and Altman requires
the plotting of information derived from pairs of data
points, the mean of the two values being plotted against
their difference. The results are expressed as bias
(mean difference) and limits of agreement (mean
difference + 2SD).
2.4.1.3. Results
The arterial lactate concentrations were 2.1 + 0.31
mmol/1, and the mixed venous 2.0 + 0.32 mmol/1 expressed
as Mean + SEM. The degree of correlation was excellent
(r=0.99) as depicted in Figure 3. As shown in Figure 4
the bias was 0.09, and the limits of agreement + 0.38
(range -0.47 to 0.29), which are well within the range
of clinically important changes in lactate
concentration.
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Arterial and mixed venous lactate : Bland and Altman plot
2.4.1.4. Discussion
Rochester and colleagues demonstrated the potential for
diseased lung to produce lactate (Rochester 1973). They
concluded that this was a reflection of increased lung
metabolism and speculated that the degree of
arteriovenous difference in lactate might reflect the
extent of diseased lung. We have been unable to
demonstrate any difference between arterial and mixed
venous lactate in a group of critically ill patients
with much higher mean lactate concentrations than in the
Rochester study, and with quite different pathology. It
would appear from these results that arterial lactate
concentration is at least as useful as mixed venous in
these patients. It is also of interest to note that
those investigators who have suggested levels of lactate
which might be deemed significant have used arterial
measurements (Weil 1970, Groeneveld 1987).
Arterial sampling for blood lactate determination is
clinically and experimentally relevant and practical.
2.4.2 Lactate measurement
Arterial blood samples were drawn, and 1.5 ml placed
into pre-weighed glass tubes containing 5 ml of cold
(4° C) 5% perchloric acid, immediately refrigerated and
subsequently analysed. The principle of the technique
involves the conversion of lactate to pyruvate in the
presence of LDH and NAD, the buffer pH driving the
reaction in favour of lactate oxidation. Lactate was
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measured using a Cobas Bio (Roche) centrifugal analyser,
monitoring the rate of reduction of NAD to NADH
fluorimetrically at an excitation wavelength of 340 nm
in 0.5M glycine buffer (pH 9.6) in the presence of .2M
hydrazine tartrate and lactate dehydrogenase. Lactate
standards from 50-1200 umol/1 were used. Whole blood
lactate was then calculated after correcting for
dilution of the sample with 5% perchloric acid.
Interassay C.V. over the working range is <10%.
2.4.3. Pyruvate measurement
Samples were those collected as above, and used for
lactate measurement. Pyruvate was measured using the
Cobas Bio centrifugal analyser with fluorimetric
attachment, as described above. The principle of the
assay is the conversion of pyruvate to lactate in the
presence of NADH. Interassay C.V. over the working range
is <10%.
2.4.4. Urinary kallikrein
This was measured by the method of Amundsen et al
(Amundsen 1979). This assay has been validated by
comparison with measurement of urinary kininogenase
activity using a kinin radioimmunoassay (Bonner 1981).
Urine for kallikrein estimations was taken directly into
plastic containers, and frozen at -20 C after a maximum
of 24 hrs at room temperature. Samples were thawed at
20 C, and centrifuged prior to assay; all samples were
53
assayed within 4 hrs of thawing.
Urinary kallikrein was measured using the chromogenic
substrate S-2266 (H-D-Val-Leu-Arg-pNA) (AB Kabi
Diagnostica). A Tris buffer, pH 8.2, was prepared as
detailed elsewhere (Cumming 1989 i).
A Trasylol (lyophilised aprotinin, Bayer, FRG) buffer
was prepared to a concentration of 20 KlU/ml. This was
added to a sample blank for each assay. Since aprotinin
is a potent inhibitor of urinary kallikrein, but does
not inhibit urokinase, the only other alkaline esterase
enzyme in urine, subtraction of the result of this blank
from the sample value increased the specificity of the
assay, in addition to correcting for the intrinsic urine
colour.
Determination of urinary kallikrein
H-D-Val-Leu-Arg-pNA + H20 urinary kallikrein peptide
+ pNA
500 ul of buffer at 37* C was added to 400 ul urine and
incubated at 37cC for 5 minutes. 100 ul of S-2266 was
added and incubated for 30 minutes. The reaction was
then stopped by addition of 100 ul of 50% acetic acid. A
sample blank was prepared, identical other than the use
of aprotinin buffer. The absorbance of each sample was
read against its blank at 405 nm. Results were expressed
as nkat/1, one nkat being the amount of glandular
kallikrein which cleaves 0.05 umol of substrate per
minute under the given conditions. This was calculated
as nkat/1 = 146 x absorbance.
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Urinary kallikrein was stable at -20°C for up to one
year; all samples were assayed within 3 months.
Interassay CV was 8.2%, intraassay CV 4.5%.
2.4.5. Plasma renin activity
Plasma renin activity was measured by radioimmunoassay
(Haber 1969).
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CHAPTER 3 SERIAL CHANGES IN OXYGEN TRANSPORT AND
BLOOD LACTATE DURING RESUSCITATION IN
SHOCK
3.1. Introduction
An elevated blood lactate concentration in clinical
shock has traditionally been said to indicate a grave
prognosis whatever the underlying aetiology (Mackenzie
1964, Peretz 1965, Weil 1970). However, arterial blood
lactate (ABL) is not universally measured as a routine
in acutely ill patients. One of the reasons for this is
the potential difficulty in interpretation of elevated
blood lactate concentrations because of a number of
factors apart from tissue hypoxia which may result in
hyperlactataemia. These and the fact that the measured
ABL concentration reflects the balance between
production due to tissue hypoxia and other factors, and
its clearance (Cohen 1976), notably by the liver (Royle
1978), complicate the interpretation of high ABL.
In an attempt to improve the usefulness of lactate
measurement, and to unravel the pathophysiology of
lactic acidosis, detailed animal studies investigating
the serial relationship between DO2, VO2 and ABL have
been conducted. Many are confined to hypoxic,
haemorrhagic (Cain 1965, Cain 1991), and endotoxin
(Blair 1971) models, and until recently there were
relatively few clinical studies.
The use of serial measurements allows more accurate
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prediction of outcome (Vincent 1983, Cowan 1984) but
even their value has been undermined by the proposal
that a "lactate wash-out" phenomenon may occur (Cohen
1976, Puri 1980). It has been hypothesised that improved
perfusion of previously hypoxic tissues as a result of
successful resuscitation may cause a rising ABL
concentration in a similar manner to that demonstrated
following exercise in animals and humans (Hermanson
1972, Zapol 1987). It is suggested that this occurs as a
result of improved tissue perfusion rather than because
of persisting or worsening tissue hypoxia. Experimental
work has produced conflicting results (Puri 1980, Falk
1985) but the phenomenon of lactate washout has yet to
be convincingly demonstrated in clinical shock.
In this study the relationships between serial
measurements of oxygen transport variables and ABL in a
consecutive series of 40 patients with shock of diverse
aetiologies were examined.
3.2. Patients and methods
3.2.1. Patients
Forty critically ill patients (mean age 61.4, range
19-80) admitted to one of two intensive care units who
required immediate haemodynamic monitoring, and in whom
serial ABL measurements were performed, were studied.
The clinical details of this heterogeneous group of
surgical and medical patients are given in Table 4.
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Patients were excluded if they had additional reasons
for hyperlactataemia. Those with hyperglycaemia, known
liver disease, or who had received catecholamines or any
other pharmacological support of the circulation prior
to initial measurements were therefore excluded. No
patient received sodium bicarbonate or any other buffer
before or during the study period.
3.2.2. Protocol
All patients were invasively monitored as detailed in
Chapter 2. Simultaneous samples of arterial and mixed
venous blood were taken and oxygen tensions, haemoglobin
concentration and oxy-haemoglobin saturations measured.
Arterial and mixed venous oxygen contents, VO2, DO2 and
oxygen extraction ratio (OER) were calculated from the
standard formulae (Methods: Table 3). Cardiac output was
indexed to body surface area which was determined from
standard nomograms and measurements of height and
weight. Serial measurements of oxygen transport
variables and ABL concentration were made as clinically
indicated during resuscitation.
3.2.3. Resuscitation
Standardised resuscitation protocols were used in all
patients. In those patients with septic shock, ARDS and
trauma the aim of therapy was to reverse hypotension and
maintain high CI and DO2 concurrently. Following
correction of hypoxaemia with high inspired oxygen
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concentrations, tracheal intubation and ventilation,
controlled volume expansion was performed with colloid
and blood. Once the PAOP had reached 15 mmHg or the left
ventricular stroke work index had stopped rising in
response to fluid infusion, vasoactive drug therapy was
started. The choice of catecholamine was dependent on
the haemodynamic profile after volume administration,
and combinations of inotrope (dobutamine),
vasoconstrictor (noradrenaline) and inoconstrictors
(adrenaline, dopamine) were used to aim for previously
defined cardiorespiratory therapeutic goals of
CI >4.5 1/min/m2, DO2 >600 ml/min/m2 and MAP >80 mmHg.
In the patients with cardiogenic shock more appropriate
physiological endpoints were the goals of therapy. After
initial correction of hypoxaemia and optimisation of
cardiac filling pressures, inotropic therapy was
titrated against cardiac output and SVO2 aiming for CI
>2.2 1/min/m2; SvC>2 >60%; MAP >80 mmHg.
There is no consensus on the threshold level of
hyperlactataemia which is clinically significant (Peretz
1965, Weil 1970), and the effects of factors which alter
metabolic rate and thus oxygen demand on this threshold
are currently under investigation. It is clear however
that changes in body temperature, sedation, paralysis
and assisted ventilation in most modes may alter the
oxygen supply/demand relationship (Aubier 1982, Lister
1991). In this study a threshold value of 1.5 mmol/1 was
chosen in accordance with other investigators (Peretz
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1965). Acute Physiology and Chronic Health Evaluation
scores (APACHE II) were recorded in each unit (Knaus
1985), and as in the other clinical studies detailed in
this thesis that documented here is the worst in the
first 24 hours.
3.2.4. Statistical analysis
All results are expressed as mean + SEM. The paired data
obtained before and after resuscitation were compared
with the Wilcoxon signed rank test, and differences were
considered significant at p<0.05.
3.3. Results
Three groups of patients could be identified according
to their initial or subsequent ABL concentrations.
Patients in Group I (n=20) had elevated ABL, mean 3.3 +
0.4 mmol/1 which fell to 1.5 + 0.2 mmol/1 in response to
successful resuscitation, as evidenced by a rise in MAP
from 65+3 mmHg to 82 + 3 mmHg with a concurrent
increase in DO2 from 435 + 52 ml/min/m2 to 600 + 46
ml/min/m2. Eight of these patients survived.
Group II patients (n=14) had elevated ABL levels, mean
3.2 + 0.8 mmol/1 which increased significantly to
3.9 + 0.6 mmol/1 despite active resuscitation. MAP rose
from 63+4 mmHg to 77 + 6 mmHg, but there was an
insignificant change in DO2 from 499 + 58 ml/min/m2 to
568 + 68 ml/min/m2. Only two of these patients survived,
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and they both had low Apache II scores of 3.
Group III patients (n=6) had ABL concentrations of less
than 1 mmol/1 throughout the course of the study, mean
0.7 + 0.1 mmol/1, despite simultaneous clinical and
cardiorespiratory features of shock. All of these
patients survived.
The haemodynamics, oxygen transport variables and ABL
levels before and after resuscitation in each group are
shown in Table 5, and results are depicted in Figures 5,
6 and 7.
In summary, in Group I there were increases in blood
pressure, CI, DO2, SVO2 with decreases in OER. In Group
II although blood pressure increased, there were no
concurrent improvements in other haemodynamic or oxygen
transport variables and there was a tendency to
increasing ABL concentrations. In Group III there were
significant increases in MAP, CI and DO2 with
significant falls in OER leading to increases in SVO2.
3.4. Discussion
The relationship of the cardiorespiratory variables and
ABL in hypoxia, hypovolaemia and shock has been
comprehensively documented in a number of elegant
laboratory experiments (Cain 1965, Cain 1967). Following
on from this the clinical studies of Maclean and
colleagues (Maclean 1967) demonstrated that in
hyperlactataemic septic shock patients who responded to
resuscitative therapy with falls in lactate, there was a
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50% mortality compared to 100% in patients in whom
lactate remained high. This group subsequently went on
to demonstrate an inverse relationship between VO2 and
initial blood lactate concentrations in a comparable
patient group (Duff 1969). We have confirmed that
hyperlactataemia can be reversed with improvement in MAP
and CI. Motsay and colleagues (Motsay 1970) also
demonstrated falls in lactate concentrations as VO2
increased in some individual cases of septic shock.
Nishijima has suggested that there are significant
differences in lactate between survivors and
non-survivors and that survivors of septic shock had a
higher cardiac index than non-survivors (Nishijima
1973). In contrast, Blair (Blair 1971) showed no
correlation between initial lactate concentration and
cardiac output in 30 septic shock patients, and
non-survivors7 had a higher cardiac index.
Interpretation of the blood pressure and vascular
resistance data from this paper is complicated by the
prior administration of vasoconstrictor drugs in most
patients.
In all of the studies cited above the aim of
resuscitation was to increase blood pressure, with no
attempt to maintain or increase cardiac output, and thus
DO2. The differing results in these and contemporary
studies (Vincent 1981, Vincent 1990 ii) may therefore be
a reflection of the unpredictable cardiac output and
oxygen transport responses to fluid administration
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(Shoemaker 1985, Edwards 1989 ii) and vasoactive drug
infusion in shock (Talley 1969, Meadows 1988, Mackenzie
1991 i).
In the present study blood lactate concentrations and
oxygen transport variables were measured as soon as
invasive monitoring was established on admission to ICU.
None of the patients had received exogenous
catecholamines. We documented the simultaneous responses
of ABL and oxygen transport variables during
resuscitation using a previously agreed therapeutic
protocol constructed to aim for increases in cardiac
output and DO2 whilst concurrently reversing
hypotension.
A number of retrospective studies documenting the
relationship of cardiorespiratory variables and ABL have
been published (Groeneveld 1987, Rashkin 1985).
Groeneveld and colleagues studied 50 patients with
circulatory shock, measuring cardiorespiratory and
metabolic variables before and during resuscitation.
They demonstrated falls in ABL in patients with
non-septic causes for shock, but not in those with
septic shock. In the light of our finding that lactate
falls with concurrent increases in DO2 and reversal of
hypotension it may be important to note that the mean
post-resuscitation MAP in their study was 67 mmHg.
The importance of reversal of hypotension was
demonstrated in the landmark study of Maclean and
colleagues (Maclean 1967). They showed that lactate
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concentrations only fell in the groups where flow and
pressure were improved together, and that isolated
increases in flow did not reverse hyperlactataemia.
Indeed, it is now accepted that in hyperdynamic sepsis
with a high cardiac output and a very low systemic
vascular resistance the use of appropriately monitored
vasconstriction, following correction of hypoxaemia and
hypovolaemia, to reverse profound hypotension is often
beneficial in terms of the metabolic state and renal
function (Desjars 1987, Redl-Wenzl 1993). This is
usually the case even when there is a limited reflex
fall in cardiac output, so long as the cardiac output
remains higher than normal when perfusion pressure is
increased. However, the potentially catastrophic effects
of vasoconstriction on tissue oxygen supply is one of
the cardinal reasons why vasoconstrictor therapy should
be monitored by measurement of flow-related variables,
and not just by blood pressure measurement.
As previously detailed, the prognostic significance of
hyperlactataemia in groups of patients in shock is
repeatedly cited. Vincent's group (Vincent 1983) and
Cowan and colleagues (Cowan 1984) measured serial
lactate concentrations during resuscitation from shock
using oxygen, mechanical ventilation, fluids and
vasoactive drugs. The conclusion of both groups was that
changes in lactate concentration provided an early and
objective evaluation of response to therapy and ultimate
prognosis. In both studies, failure of lactate
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concentrations to fall was associated with poor outcome.
More recently, Vincent's group have compared the
prognostic value of ABL compared to oxygen transport
variables during resuscitation from septic shock (Bakker
1991). They failed to show any difference in
haemodynamics or oxygen transport between survivors or
non-survivors, either before or after resuscitation.
They did show that non-survivors had significantly
higher ABL at all stages compared to survivors. The
haemodynamic and oxygen transport findings of this study
are in direct contradiction to the work of Tuchschmidt
(Tuchschmidt 1992). In their prospective, randomised
study comparing normal and supra-normal DO2 in septic
shock patients, there was a significant fall in
mortality with higher DO2.
Other groups have studied the relationship between
oxygen transport variables and ABL (Astiz 1988). In 50
patients with sepsis and 50 with myocardial infarction,
the majority of whom were not in shock, they measured a
full cardiorespiratory profile and ABL on admission to
the intensive care unit. In neither group could they
define particular values of SVO2, DO2 or VO2 which
protected against hyperlactataemia. The major
shortcomings of this study are its adynamic nature, in
clinical conditions which are continually altering, and
the assumption that all patients in a particular group
are at the same stage in the pathophysiological
evolution of the disease state. Careful scrutiny of the
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patient groups, particularly the septic group, reveals
different patterns of oxygen transport and haemodynamics
to those detailed in many other studies (Maclean 1967,
Shoemaker 1983, Edwards 1989). In particular, the levels
of CI and SvC>2 are lower than those commonly found in
sepsis. These observations indicate that the conclusions
must be viewed with caution.
Rashkin (Rashkin 1985) retrospectively studied isolated
measurements of lactate in a heterogeneous group of
patients, mainly with respiratory failure, of whom a few
were in clinical shock. In 24 of the 44 patients, oxygen
transport variables were also recorded. Patients with
mild to moderate liver failure were included. There was
a statistically demonstrable threshold DO2 value of 8
ml/kg/ min, below which hyperlactataemia appeared. On
the basis of this small, retrospective case review the
authors proposed that this DO2 could be the optimal
value to aim for in critical illness. Its applicability
and relevance in general ICU is questionable.
In our present study of a heterogeneous group of 40
shock patients no particular value of oxygen transport
which protects against hyperlactataemia could be
identified agreeing with the findings of Astiz (Astiz
1988). However our results do suggest that the adequate
DO2 level in the individual can be determined by
sequential measurements of oxygen transport variables
and ABL during therapy. A confounding factor in our
study is the clinical heterogeneity of the patients, and
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the use of different end-points for resuscitation in low
flow and high flow shock.
The effects of volume loading, blood transfusion and
catecholamines on oxygen transport and lactate have
previously been studied in patients with sepsis or ARDS
(Haupt 1985, Gilbert 1986). These studies were performed
after initial resuscitation and using fixed volumes of
fluid or limited drug dosages titrated against blood
pressure, perhaps limiting their clinical relevance in
shock.
Two studies from Watson's group have attempted to
further investigate the relationship between the
metabolic and cardiorespiratory parameters during
resuscitation (Hayes 1993, Hayes 1994). The two patient
groups are similar and they will be considered together.
The aim of the studies was to evaluate the responses to
therapy aimed at achieving high CI and DO2, and
comprising fluids, dobutamine and noradrenaline. The
patients included a large number of post-operative cases
and a mixture of other pathologies including ARDS and
sepsis. Not all of the patients required ventilation,
all received dopamine at 2ug/kg/min and no specific
details of analgesia, sedation or neuromuscular blockade
are provided. In the latter study there is no
documentation of blood pressure.
Two groups of patients were identified in both studies.
In the first, retrospective study (Hayes 1993) they
confirmed the findings of Shoemaker (Shoemaker 1988) and
72
Boyd (1993), showing the prognostic benefit of the
achievement of increased DO2 and VO2 concurrent with
adequate MAP, The mean initial MAP was 84 mmHg in one
group, and 73 mmHg in the other. The second study was
randomised prospectively and the authors concluded that
aggressive attempts to increase VO2 may have been
detrimental. It is possible that the very large doses of
dobutamine used (up to 200 ug/kg/min), whilst not
resulting in adequate CI did vasodilate, necessitating
the high doses of noradrenaline used. This combination
could well have worsened the tissue oxygen supply/demand
balance. Rather than struggling to elevate cardiac
output in these patients, it may be safer and more
logical to attempt to increase nutrient tissue blood
flow by fluid manipulation or with other vasoactive
agents. Well conducted research is urgently required in
this area.
In the light of the work summarised above, it is of
interest to examine the findings in each of our patient
groups in more detail.
In Group I significant increases in CI and DO2 were not
associated with overall increases in VO2, probably
reflecting the heterogeneous nature of the patient
population. It has been shown that significant increases
in DO2 in cardiogenic shock are associated with
substantially increased SvC>2 and reduced OER, but with
much less significant increases in VO2 (Creamer 1990).
In keeping with these findings, in our study there were
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consistent increases in SvC>2 and reductions in OER
reflecting increased oxygen availability with
improvement of tissue hypoxia as evidenced by the falls
in lactate concentrations. It could be argued that
resuscitation had resulted in improved splanchnic and
liver perfusion, leading to increased lactate clearance.
This is a likely component of the resolution of
hyperlactataemia, and further study would be of
interest.
In Group II no significant increases in CI or DO2 could
be achieved, and SvC>2 and OER remained unchanged with
persisting hyperlactataemia despite an increase in MAP.
In these patients vigorous resuscitation failed to
reverse tissue hypoxia, as indicated by unchanging
levels of SVO2 and OER. In 6 of these patients MAP was
increased to over 85 mmHg, but there was no simultaneous
increase in CI and DO2 and all 6 patients died.
It has been generally accepted that an elevated blood
lactate concentration is an essential inclusion in the
definition of shock (Shubin 1976, Rackow 1986). The
patients in Group III had profound hypotension (mean MAP
54 mmHg) along with clinical signs of shock such as
oliguria and altered conscious level, and inadequate CI
and DO2 with elevated OER and reduced SVO2. However, ABL
concentrations were within the normal range and all of
these patients survived.
In our study no patient was identified in whom the ABL
concentration rose when treatment led to concurrent
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improvement in both haemodynamics and oxygen transport
variables. We found no evidence of a lactate wash-out
phenomenon. However, repeated sampling at short time
intervals, perhaps every 10 or 15 minutes, would be
necessary to exclude the possibility that if such a
phenomenon occurs it may be early, and transient. It is
possible that even if lactate is washed out of
reperfused tissues, the improved hepatic perfusion and
function which accompanies successful resuscitation
would result in an increase in clearance of lactate,
thus preventing a rise in ABL concentration.
In conclusion, we have defined three patterns of
response of lactate and cardiorespiratory variables
during the resuscitation of shock.
If resuscitation leads to reversal of hypotension and
improved DO2 hyperlactataemia resolves. The patients in
whom blood pressure or flow could be improved
individually but not concurrently had persisting or
increasing hyperlactataemia. These findings highlight
the need to measure and manipulate CI and DO2
simultaneously with blood pressure. This approach has
been further emphasised (Grootendorst 1990).
It appears that patients may have clinical and objective
physiological evidence of shock without elevation of
blood lactate concentrations. This reflects the complex
processes which affect ABL, and the realisation that
both the hypoxic threshold and lactate clearance




CHAPTER 4 THE RELATIONSHIP OF BLOOD LACTATE
CONCENTRATIONS AND PATHOLOGICAL DELIVERY
DEPENDENT OXYGEN CONSUMPTION IN SEPTIC
SHOCK AND ARDS
4.1. Introduction
In Chapter 3 the findings of a study relating oxygen
transport to blood lactate concentration in a
heterogeneous group of patients with shock are detailed.
The lack of a relationship between increases in DO2 and
hyperlactataemia could reflect the mixture of low and
high flow shock, and the accompanying abnormalities of
vasoregulation in the septic patients. A number of
investigators have stated that pathological supply
dependency of V02 on D02 is predicted by
hyperlactataemia in sepsis and ARDS. In this study we
examine this relationship.
Hyperlactataemia is known to be a conseguence of tissue
hypoxia (Huckabee 1958, Weil 1970). There are,
however, many causes of hyperlactataemia other than
tissue hypoxia and these include hyperglycaemia,
hypocapnia, toxins and liver dysfunction (Figure 1;
Huckabee 1958, Cohen and Woods 1976). The clinical
classification of lactic acidosis proposed by Cohen and
Woods (Cohen and Woods 1976) attempted to separate those
patients with tissue hypoxia from those without. The
clinical distinction between the groups was on the basis
of the simple clinical parameters of pulse, cuff blood
pressure, the presence or absence of cyanosis, skin
turgor, skin temperature in the extremities and urine
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output. The cases which were used to separate the two
classes, Type A (shock) and Type B (no shock), were
collected retrospectively from a number of publications
between 1961 and 1975. A major problem with this data is
highlighted by the authors themselves when discussing
blood pressure, skin turgor and colour, and peripheral
perfusion:
"we have again arbitrarily accepted that no gross
abnormalities were present unless specifically noted by
the authors". In a number of these patients blood
pressure was not documented at all. However, these
points and the arbitrary threshold for hypotension as
cuff systolic BP of < lOOmmHg are less relevant in the
light of current knowledge. It is now apparent that
tissue hypoxia may be present without the clinical
criteria of shock which are detailed (Arieff 1992). Even
using sophisticated invasive monitoring it can be
difficult to assess the adeguacy of oxygen transport.
The cardiorespiratory findings in septic shock and ARDS,
especially after volume resuscitation, may include
increased cardiac output and normal or increased oxygen
delivery.
Despite the presence of an apparently adequate DO2
there is an impediment to normal tissue oxygen
utilisation which has long been recognised but is still
not fully understood (Duff 1969, Danek 1980)). Whatever
the mechanisms increases in VO2 can often be achieved by
increasing DO2 using fluids, blood or vasoactive drugs,
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even when DO2 is considerably higher than the normal
levels at which delivery dependence has been shown to
occur (Mohsenifar 1984, Clarke 1991). This delivery
dependent oxygen consumption is a pathological state
which is in stark contrast to the norm where VO2 is
independent of DO2 above a critically low level
of 330 ml/min/m2 (Shibutani 1983). Subsequent work has
suggested that elevated ABL concentrations characterise
those patients with shock or ARDS who exhibit delivery
dependent VO2 (Vincent 1990 i, Kruse 1990). However, as
detailed in Chapter 3, hyperlactataemia is not a
universal finding in shock.
In this study the association between ABL concentrations
and the DO2/VO2 response to resuscitation was examined
to determine whether hyperlactataemia predicted delivery
dependence.
4.2. Patients and methods
4.2.1. Patients
Twenty three patients (mean age 55, range 33-81)
requiring intensive care, invasive haemodynamic
monitoring and mechanical ventilation for the management
of septic shock (n=21) and ARDS (n=23) were studied.
Septic shock was defined as MAP <70 mmHg with oliguria
despite controlled volume expansion to an optimal
pulmonary artery occlusion pressure, in the presence of
positive bacteriology.
ARDS was defined as severe hypoxaemia requiring
ventilation with Fi02 >50% to maintain PaC>2 >10 kPa;
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diffuse infiltrates on CXR ; Qs/Qt >30%; PAOP <18 mm Hg;
in the presence of reduced compliance and a known risk
factor (Table 1).
4.2.2. Protocol
All patients were sedated with continuous infusions of
an opioid (papaveretum 3-5mg/hr) and a benzodiazepine
(midazolam 1-3 mg/hr) and paralysed with atracurium.
No changes in rates of infusion were made during the
study period, and the only adjustments to ventilator
settings were of FiC>2 • All patients were studied during
the first six hours of resuscitation following admission
to ITU. All patients had femoral arterial and
thermodilution pulmonary artery flotation catheters, and
cardiorespiratory measurements and ABL measurements were
made as described in Chapter 2.
4.2.3. Resuscitation
Following baseline measurements, controlled
volume expansion was performed in all patients after
comparison of the haemodynamic profile with previously
described therapeutic goals; MAP >80 mmHg, CI >4.5
1/min/m2 and D02 >600 ml/min/m2 (Shoemaker 1973).
Combinations of colloid and blood were used
depending on haemoglobin level. Once volume expanded,
all patients received suitable combinations of
vasoactive drugs depending on the haemodynamic profile,
and these were then titrated against the observed
haemodynamic effects aiming for the defined therapeutic
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goals. The baseline variables were compared to the
variables associated with maximal DO2 within the first
six hours of resuscitation. Patients were divided into
two groups on the basis of initial ABL concentrations.
Group 1 had ABL concentration <2 mmol/1, and Group 2 had
ABL concentration >2 mmol/1. This threshold for
significant hyperlactataemia is that previously
described by Vincent and colleagues (Vincent 1990 i) in
the same patient population.
4.2.4. Statistical analysis
All results are expressed as mean + SEM. Baseline data
from the two groups of patients were compared by means
of the Wilcoxon rank sum test, and the paired data
obtained before and after resuscitation were compared
with the Wilcoxon signed rank test. Differences were
considered significant at p<0.05.
4.3. Results
The 23 patients (11 female) were each studied on one
occasion. Clinical data including Apache II
scores are shown in Table 6, and haemodynamic and oxygen
transport data in Tables 7 and 8. Baseline measurements
were compared in the two groups. Group 2 had
significantly higher heart rate and DO2 with lower blood
pressure. Lactate concentrations were significantly
higher in Group 2.
Following resuscitation there were significant
comparable increases in CI, SvC>2 and DO2, and falls in
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Table 6.
Clinical details : Group 1 ■
Patient Age Sex Primary diagnosis Apache Vasoactive Outcome
IX drug
(ug/kg/min)










2 63 F Pneumonia
Cardiorespiratory arrest
SS
15 DOB 10 S
3 68 M Faecal peritonitis
ARDS
22 DOB 3 S















6 54 F Pneumococcal pneumonia
SS, ARDS
10 NOR 0.07 NS





8 57 M Perforated diverticulum
ARDS
3 DOB 5 S














11 65 F SS, ARDS 21 DOB 5 NS
12 64 F SS (enterococci), ARF 25 DOB 15 NS
13 45 M Necrotising fasciitis, SS, 16 NOR 0.05 S
ARDS
Clinical details : Group 2.
14 81 F Faecal peritonitis 18 ADR 0.04 NS
Respiratory arrest, SS
15 59 F Empyema, SS (beta- 27 DOB 5 NS
haemolytic streptococci) ADR 0.06
Squamous carcinoma of lung




17 65 F Necrotising fasciitis
Q Q
20 DOB 12 S
18 73 M SS (coliforms) 31 ADR 0.4 NS
Indwelling urinary NOR 0.9
catheter
19 75 M Faecal peritonitis 18 NOR 0.14 NS
Infarcted colon, SS
20 58 M Ulcerative colitis 21 NOR 2 NS
Infarcted small bowel
21 80 M Pneumonia 33 NOR 0.04 NS
SS ADR 0.06
22 42 F Post colectomy 15 DOB 5 S
SS NOR 0.3
23 70 M Post cystectomy (carcinoma 35 ADR 0.15 S
bladder) NOR 0.2
SS
SS, septic shock; ARDS, adult respiratory distress syndrome; ARF, acute
renal failure; DOP,dopamine; DOB, dobutamine; ADR, adrenaline; NOR,
noradrenaline; S, survivor; NS, nonsurvivor.
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Table 7.
Haemodynamic variables at baseline and after initial
resuscitation
Group 1 Group 2
(Lactate < 2 mmol/1) (Lactate > 2 mmol/1)
n = 13 n = 10
Baseline Resus Baseline Resus
HR
(beat/min)
109 (6) 117 (5) 128 (5) 127 (4;
MAP
(mmHg)
70 (3) 78 (4)* 63 (2) 69 (5;
PAOP
(mmHg)
13 (2) 15 (1) 13 (2; 13 (1)
CI
(l/min/m2)
3.7 (0.4) 5.0 (0.2)* 3.9 (0.4) 4.9 (0.3)
Difference from baseline : * p < 0.05;
Between group comparison : p < 0.05.
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Table 8.
Lactate and oxygen transport variables at baseline and after
initial resuscitation.
Group 1
(Lactate < 2 mmol/1)
n = 13
Group 2
(Lactate > 2 mmol/1)
n = 10













484 (36) 730 l[44)** 549 (54) + 779 (54) *
137 (7) 147 (6) 145 (12) 133 (6)
29 (2) 21 (1)* 28 (3) 18 (2)*
69 (2) 77 (1)* 71 (3) 80 (2) *
28 (3) 32 (3) 27 (3) 34 (3)
..2 (0.1) 1.1 (0.1) 3.7 (0.4)+ 3.7 (0.4)
Difference from baseline : *p < 0.05, **p <0.005;
between group comparison : +p < 0.05
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oxygen extraction in both groups. In both groups
resuscitation with colloid, blood and vasoactive drugs
resulted in significant increases in DO2: Group 1 from
484 + 36 to 730 + 44 ml/min/m2 p<0.005 ; Group 2 from
550 + 54 to 780 + 54 ml/min/m2 p<0.05 but in neither
group was there a significant change in VO2.
These pooled data obscure the finding that in both
groups there were individual patients who exhibited VO2
delivery dependency. Only in Group 1 was there a
significant increase in MAP (p<0.05). There were no
significant changes in VO2 or ABL concentration in
either group, although there were marked individual
changes in VO2 in some patients in each group. Pooled
data for Groups 1 and 2 are represented diagramatically
in Figures 8 and 9 respectively, with the individual
patient DO2/VO2 responses in Figures 10 and 11.
4.4. Discussion
It has been recognised for many years that inefficient
utilisation of oxygen is a fundamental defect in septic
shock (Duff 1969). This finding has been confirmed
recently and a similar situation has been described in
ARDS (Edwards 1989 i, Clarke 1991). The
pathophysiological abnormality is characterised by
dependence of VO2 on delivery at levels of
DO2 which are well above the previously described
critical level (Shibutani 1983). Oxygen consumption can
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thus be increased by increasing delivery, suggesting
that tissue perfusion is inadequate.
The mechanisms of this phenomenon are not completely
clear but probably involve a combination of factors
including :
1. Maldistribution of tissue blood flow due to
vasoderegulation (Abraham 1983). Passage of excess blood
through areas of low metabolic activity results in a
fall in oxygen extraction ratio, while relative lack of
blood flow through areas of high metabolic activity may
result in delivery dependence. The balance of these
factors will determine the response to resuscitation.
2. An increase in capillary to cell diffusion distance
caused by the interstitial oedema associated with
capillary leak (Ellman 1984) .
3. Dysfunction of organelles as a result of the
mediators and toxic elements generated and released in
the inflammatory response to sepsis and ARDS (Schumer
1983) .
In addition the balance of oxygen supply and demand may
be adversely affected by the increased tissue oxygen
requirements generated by fever, shivering or rigors
(Skootsky 1988) .
It has been suggested that it is only in those
individuals with severe tissue hypoxia and critically
elevated ABL concentrations that VO2 rises significantly
in response to increases in DO2. This is in accordance
with the study of Duff (Duff 1969) who showed that
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septic patients with the highest ABL concentrations had
the lowest VO2 levels. There is, however, some
disagreement about the value of hyperlactataemia as a
predictor of supply dependency in sepsis and ARDS.
Vincent and colleagues have used low dose dobutamine (5
ug/kg/min) to perform a short oxygen flux test in an
attempt to disclose supply dependency of VO2 in stable
patients with heart failure or sepsis (Vincent 1990 i).
Dobutamine resulted in significant increases in CI and
DO2, but VO2 increased only in those patients with
elevated ABL concentrations.
Gilbert and colleagues also demonstrated increased VO2
with increased DO2 in response to infused catecholamines
in septic patients with hyperlactataemia (Gilbert 1986).
Further evidence for "occult" tissue hypoxia comes from
the work of Bihari and co-workers (Bihari 1987). These
investigators examined the hypothesis that inadequate
tissue oxygenation may occur in critically ill patients
despite the presence of an apparently adequate systemic
blood flow, blood pressure and arterial oxygen tension.
Twenty seven patients requiring assisted ventilation for
respiratory failure were studied, 22 fulfilling criteria
for ARDS. Full cardiorespiratory profiles were obtained
at baseline, and then a low-dose prostacyclin infusion
was given with repeat measurements at 30 minute
intervals throughout. The infusion resulted in
significant falls in blood pressure and PaC>2 in
survivors and non-survivors.
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Mean baseline DO2 was 420 ml/min/m2 in survivors, and
375 ml/min/m2 in non-survivors. Prostacyclin resulted in
increases in these variables to 552 ml/min/m2 and 408
ml/min m2 respectively. There was a significant rise in
VO2 in the non-survivors (132 ml/min/m2 to 164 ml/min/
m2) but not in the survivors. No details of ABL
concentrations were presented although this study has
been quoted as further evidence of the predictive value
of hyperlactataemia for pathological supply dependency
(Mizock 1989, Arieff 1992). There are a number of
features of this study which limit its usefulness.
Systemic hypotension was defined as MAP <45 mmHg, and
hypovolaemia as PAOP <6 mmHg, both much lower than most
investigators would accept. Additionally, the baseline
levels of oxygen transport and cardiac index for a group
of patients predominantly with volume and catecholamine
(dopamine 3-12 ug/kg/min) resuscitated ARDS are lower
than has been suggested is optimal (Shoemaker 1988).
In the light of these observations, and the fact that
the non-survivors had a metabolic acidosis throughout as
evidenced by mean base deficit levels (-6 mmol/1), it
could be suggested that the study did not detect occult
tissue hypoxia, but simply unmasked significant, primary
under-resuscitation. The ABL concentrations which are
not available in this study would be of great interest.
Our previous work has suggested that the relationship
between tissue hypoxia and hyperlactataemia in shock is
much less clear cut than has previously been suggested
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(Chapter 3).
There is a subgroup of patients with the clinical and
haemodynamic features of shock who have normal ABL
concentrations.
Since the presence of subclinical tissue hypoxia is
likely to be integral to the development of multiple
organ failure, in the light of the conflicting evidence
and the possibility that unrecognised tissue hypoxia may
be present even in the absence of a critically elevated
ABL this study was performed to assess the usefulness of
initial ABL concentrations as a guide to those patients
with pathological delivery dependence of VO2. We chose
to include unstable patients during initial
resuscitation in contrast to most of the investigations
mentioned above, in which relatively stable,
resuscitated patients were studied. We were particularly
interested in the DO2/VO2 response in patients without
hyperlactataemia over this initial period.
The timespan of study was similar to that of previous
work (Broder 1964, Kruse 1990). It might be suggested
that overall oxygen demand could change substantially
over the study period described. This is a valid point,
although work with continuous SvC>2 monitoring and
continuous on-line VO2 measurement shows that oxygen
demand can change significantly from minute to minute in
otherwise apparently stable patients (Nelson 1987,
Skootsky 1988).
Unlike many other investigators we have carefully
93
documented other factors which may affect VO2 or lactate
independently. Patients with hyperglycaemia and liver
failure were excluded, and all patients were sedated and
mechanically ventilated. The contribution of work of
breathing to VO2 and lactate production has been shown
clinically and experimentally to be considerable (Aubier
1982) .
We divided our patients on the basis of ABL
concentration rather than the type of resuscitation
therapy received. Previous studies have concentrated on
the use of either volume or vasoactive drugs. The
D02/VC>2/lactate relationships of our patients to the
combination of volume loading with colloid and blood,
and the subsequent addition of vasoactive drugs was
assessed. In both groups significant increases of CI and
DO2 were achieved, but in the hyperlactataemic patients
the rise in blood pressure achieved was not significant
despite the vigorous administration of fluids and
vasopressors. As documented in Chapter 3 it appears that
hyperlactataemia will be reliably cleared in shock
patients only when flow, DO2 and blood pressure are
increased concurrently. This hypothesis is supported by
the results of those studies where CI and DO2 have been
increased with no accompanying improvement in MAP from
low levels (MacLean 1967). In patients remaining
hypotensive despite significantly increased blood flow,
ABL concentrations remained high or rose further with
100% mortality.
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The controversies surrounding the DO2/VO2 relationship
in SS are as marked as those in ARDS. Silverman has
demonstrated that changes in VO2 with increased DO2 are
independent of ABL concentrations, and suggests that
optimal levels of VO2 are variable, and that serial
lactate determinations should be used to assess adequacy
of resuscitation (Silverman 1991). Bakker and co-workers
have compared oxygen transport variables and ABL
concentrations in 48 patients with SS, and have shown
that DO2 and VO2 are poor predictors of mortality, but
that ABL concentrations, particularly trends, are good
prognostic indicators (Bakker 1991). From this they
conclude that lactate measurement alone can serve as a
reliable guide to therapy. We and other investigators
have not found this to be the case. A prospective
randomised study of therapy aiming for supranormal DO2
versus conventional goals in SS documented a reduction
in mortality and organ failure in the group with DO2
increased to supranormal values by therapy appears to
emphasise the importance of achieving high levels of CI
and DO2 (with concurrent reversal of hypotension) in
this condition (Tuchschmidt 1992). In addition the study
of Boyd and colleagues repeating the earlier studies of
Shoemaker in high risk surgical patients, and confirming
the ability to reduce morbidity and mortality by
appropriate cardiorespiratory manipulation, provides
further persuasive evidence of the importance of oxygen
transport measurement and manipulation (Boyd 1993).
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In their study of 2 0 patients with severe ARDS, Clarke
and colleagues showed that supply dependency persisted
despite levels of DO2 up to 1550 ml/min/m2 (Clarke
1991). They also failed to demonstrate a plateau in the
DO2/VO2 relationship, a phenomenon which continues to be
described using 'pooled' group data. Russell and
colleagues investigated the DO2/VO2 relationship using
indirect calorimetry to measure VO2, and thermodilution
to measure DO2 (Ronco 1991). Interestingly, they showed
no delivery dependency, even in those patients with
significant hyperlactataemia. They suggested that
mathematical coupling of DO2 and VO2 could explain the
findings of previous studies. It is notable that an
earlier study from the same workers showed both
pathological delivery dependence, and the ability of
hyperlactataemia to predict it (Fenwick 1990). The
results of our study suggest that ABL concentrations
fail to predict delivery dependent oxygen consumption,
but in contrast to Russell's findings, there are
increases in VO2 with increased DO2 in patients with
either normal or elevated lactate concentrations. The
interpretation that this suggests the presence of covert
tissue hypoxia despite normal ABL concurs with the work
of Dantzker (Dantzker 1991).
In our study the inability to improve flow and MAP
together in 6 patients was associated with increasing
ABL concentrations and death. The influence of the
underlying disease process, the inability to eradicate
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sepsis and preexisting severe cardiorespiratory
dysfunction on the response to therapy have all been
suggested as potential reasons for the poor outlook of
these patients.
Examination of the DO2/VO2 relationships of individual
patients reveals another fascinating discrepancy. The
pooling of data for statistical analysis obscures
individual idiosyncratic responses of VO2 to DO2. In
particular, VO2 increased by between 17 and 35% in 6
patients with normal lactate levels. There were no
increases in lactate and this suggests that the increase
in VO2 was not demand led by a catecholamine induced
rise in metabolism. It is possible that unrecognised
tissue hypoxia is present in critically ill patients
even in the absence of critically elevated ABL
concentrations. As the production of hyperlactataemia in
experimental models often requires combinations of
severe anaemia, hypoxia, reduced cardiac output and
profound hypotension the finding of hyperlactataemia in
clinical situations is likely to indicate an advanced
degree of tissue hypoxia.
The finding of normal ABL concentrationsin patients with
acute cardiorespiratory failure due to sepsis and ARDS
may not, thus, preclude the presence of a tissue oxygen
debt (Nimmo 1992, Arieff 1992).
Basic therapy in these patients should therefore be
directed to improving DO2 and blood pressure
concurrently whilst attempting to correct or remove the
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underlying cause. The levels of DO2 and MAP required in
any individual situation remain very difficult to
determine although a randomised study has shown an
improvement in survival when supranormal DO2 is achieved
(Tuchschmidt 1992). This suggests that although the
presence of hyperlactataemia remains a serious finding,
the absence of hyperlactataemia does not preclude
delivery dependence of VO2 with the attendant potential
for tissue hypoxia.
It appears clear that the finding of a normal ABL
concentration should not encourage complacency.
It is probably fair to suggest that oxygen transport
variables and lactate should be measured, repeatedly,
together, and that no single parameter can be absolutely
relied upon to guide resuscitation and correct tissue
hypoxia.
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CHAPTER 5 THE EFFECTS OF PROPOFOL SEDATION ON
HAEMODYNAMICS AND OXYGEN TRANSPORT IN
CRITICALLY ILL ADULTS
5.1. Introduction
As documented in Chapters 3 and 4 maintenance of tissue
oxygen delivery at a level sufficient to meet demand is
pivotal to survival from critical illness. As previously
described, in many clinical situations, such as septic
shock (SS) and ARDS, there is a defect of tissue oxygen
utilisation so that VO2 is dependent on oxygen delivery,
even with levels of DO2 which are normal or supra-normal
(Kariman 1985, Clarke 1991). Conversely, in low cardiac
output states such as cardiogenic shock oxygen
extraction is generally maintained or increased with
resultant reduction in SVO2. In either situation the
balance of oxygen delivery to consumption is critical,
and may be crucially affected by changes in either
oxygen delivery or tissue oxygen demand. Factors which
can affect demand include sedation, muscle relaxation
and mechanical ventilation.
Propofol (2,6 Di-isopropylphenol), a phenol derivative,
was identified as a potentially useful intravenous
anaesthetic agent in 1977, and has become widely used in
general anaesthesia. It is being increasingly used as a
sedative agent in the intensive care unit (Newman 1987).
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Like other agents with sedative activity, it has the
potential to affect the oxygen supply/demand
relationship both detrimentally by decreasing cardiac
output and thus DC>2, or beneficially by reducing oxygen
demand.
When used for induction and maintenance of anaesthesia,
it has been shown to have a number of haemodynamic
effects including substantial reductions in heart rate,
cardiac output, blood pressure and systemic vascular
resistance (Foex 1991). However, the precise
cardiorespiratory effects of the subanaesthetic doses
used for sedation in critically ill adult patients
dependent on vasoactive drugs for haemodynamic stability
have not been rigorously investigated.
The aim of this study was to document the effects of a
sedative infusion regimen of propofol on haemodynamics,
oxygen transport and blood lactate concentrations.
Futhermore, in an attempt to unravel the mechanism of
any effect on VO2, resuscitation with fluid and/or
vasoactive drugs was used after 3 hours sedation to
restore MAP, cardiac output and DO2 to baseline levels.
Subsequently, any residual decrease in VO2 could be
attributed to a decrease in oxygen demand. Blood lactate
concentrations were measured as a further index of the
adequacy of tissue oxygenation.
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5.2. Patients and methods
Ten severely ill patients requiring mechanical
ventilation and with femoral and pulmonary artery
catheters in situ for standard clinical monitoring were
studied. The mean age was 56 (range 38 to 80) , and 5
were female.
Protocol
All patients had been initially resuscitated using
combinations of colloid and blood to achieve optimal
PAOP with the addition of an inotrope and/or vasopressor
to achieve a stable CI >4 1/min/m2 with MAP >80 mmHg.
They had all achieved haemodynamic stability, and were
on unaltered doses of vasoactive agents for at least 2
hours prior to the start of the study.
All patients received papaveretum at a fixed infusion
rate for 6 hours before and throughout the study. Other
sedation was discontinued several hours prior to the
study, and the study began when further sedation was
required. No muscle relaxants were used.
Immediately before commencement of propofol infusion a
full baseline cardiorespiratory profile, as detailed in
Chapter 2, was performed. Simultaneously, assessment was
made of conscious level using the Ramsay sedation score
(Ramsay 1974) and arterial whole blood was drawn for
lactate measurement.
Following these baseline measurements, propofol was
infused according to a decreasing infusion rate regimen
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designed on the basis of known pharmacokinetic data to
rapidly achieve and thereafter maintain a blood level of
1 ug/ml (Albenese 1990). This consisted of 4 mg/kg/hr
for 10 minutes, 3mg/kg/hr for 50 minutes and then
2mg/kg/hr for the remaining 5 hours of the study.
Cardiovascular measurements were repeated 10 and 30
minutes after commencement of the propofol infusion, and
then all measurements (haemodynamic, oxygen transport,
lactate and sedation score) were repeated at 1 hour, 3
hours and 6 hours. In 6 patients modified PACs with fast
response thermistors were inserted and right ventricular
ejection fraction (RVEF) and volumes were measured
(REF-1, Baxter Edwards, Irvine, California). No patient
had to be withdrawn from the study because of clinically
important falls in MAP or cardiac output. After 3 hours
of propofol sedation, cardiac output and DO2 were
restored to as near baseline as possible using a
combination of colloid to restore PAOP and/or vasoactive
drugs as appropriate.
Statistical analysis was carried out using the Wilcoxon
signed rank test to compare data at baseline and 3
hours. All values are expressed as mean + SEM. Variables
at 6 hours were not analysed since manipulation had
resulted in a restoration to initial values.
5.3. Results
The clinical details of the patients studied are shown
in Table 9, and the cardiorespiratory data at the
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individual study points are detailed in Table 10 . Heart
rate, MAP, cardiac output and SVR are shown graphically
in Figure 12, and DO2, VO2, ABL concentration and Ramsay
sedation score in Figure 13.
Infusion of propofol was associated with significant
reductions in HR, MAP and SVR. Stroke volume and, in the
6 patients where it was measured, RVEF were unchanged.
There was no significant change in CVP and PAOP from the
pooled data, but in 3 patients (nos. 2, 7 and 10) there
were marked falls requiring fluid infusion to restore
filling pressures and cardiac output at three hours but
not before.
There was a trend towards a reduction in both CO and DO2
at 3 hours, but neither achieved statistical
significance. There was a similar trend in VO2• There
were no significant changes in ABL concentration. As
anticipated the Ramsay sedation score changed
significantly from 2.65 + 0.27 to 5.0 + 0.29.
The therapeutic interventions required to restore
cardiac output and DO2 are shown in Table 9, and their
effects on haemodynamics and oxygen transport in Table
10 and the Figures 12 and 13.
Heart rate, MAP and DO2 were successfully restored to
baseline, DO2 and VO2 rising in parallel, and there were


































































DOB, Dobutamine; DOP, Dopamine; ADR, Adrenaline;
NOR, Noradrenaline; PPS, Plasma protein solution.
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5.4. Discussion
We have demonstrated that propofol given by infusion in
a regimen designed to rapidly achieve and maintain a
blood level of lug/ml is not associated with clinically
significant haemodynamic or oxygen transport effects in
adequately resuscitated adult critically ill patients.
The haemodynamic effects of propofol anaesthesia have
been extensively investigated and are well documented
(Foex 1991). The induction of anaesthesia using propofol
as a bolus produces a dose related reduction in blood
pressure which has been attributed both to reduced
cardiac output and to a reduction in SVR (Coates 1987,
Gauss 1991). The mechanism of the reduction in cardiac
output is a direct depression of myocardial
contractility, which according to some workers may be
coupled with decreased preload (Lepage 1988).
Nevertheless, many investigators have found no effect on
preload, attributing the fall in cardiac output to a
direct negative inotropic effect alone (Coates 1987,
Gauss 1991).
During continuous intravenous propofol infusion to
maintain anaesthesia, SVR tends to rise back towards
baseline or above, especially with surgical stimulation,
and cardiac output remains below baseline (Stephan 1986,
Coates 1987). HR tends to decline during propofol
maintenance, due to both increased vagal tone and to the
resetting of baroreceptor reflex activity (Cullen 1987).
Propofol has been introduced as a sedative agent for use
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in the intensive care unit. Initial studies have
reported a hypotensive effect, sufficient in one study
to prompt infusion rate reductions in some patients
(Newman 1987). Other investigators have found little
difference in cardiovascular effects when comparing
propofol with midazolam (McMurry 1990). Given the
accepted importance of the maintenance of supranormal
cardiac output and DO2, whilst concurrently assuring an
adequate MAP, in the treatment of patients with many
types of critical illness (Shoemaker 1988), it is
surprising that until now there has been little detailed
data on the cardiorespiratory effects of propofol in
such patients. This study has shown that propofol is
well tolerated in a group of extremely sick patients,
dependent on vasoactive drugs. The study protocol
avoided the use of bolus doses since it is our clinical
experience that even doses as low as 0.5 mg/kg given
intravenously over 1 minute may lead to significant
hypotension.
The infusion protocol was based on pharmacokinetic data
from critically ill patients, and was geared to achieve
and maintain a blood concentration of lug/ml (Albanese
1990). In fact all patients were excessively sedated at
this concentration, probably reflecting their severity
of illness (Apache II mean 23; range 15-31) since it has
been shown that the higher a patient's Apache II score
the less will be their sedation requirements (Bion
1986). At the end of the study period, propofol infusion
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rates were reduced to provide a clinically appropriate
level of sedation.
In no patient did the infusion rate require reduction
from the protocol level as a result of severe adverse
haemodynamic effects. The minimal fall in blood pressure
was acceptable as the MAP remained close to the level
aimed for with resuscitation, while cardiac output did
not fall to a statistically significant degree.
Interestingly, stroke volume and RVEF were maintained,
any reduction in cardiac output being attributable to
the fall in HR. It may be that afterload reduction
allowed maintenance of stroke volume despite myocardial
depression. Although pooled group data on filling
pressures did not show any overall change, 3 patients
suffered substantial reductions of PAOP which without
volume expansion would have led to reduced cardiac
output.
Overall, our results show that propofol in sedative
dosage is free from significant myocardial depressant
effects, but that hypotension occurs due to the
combination of a reduction in heart rate, and hence
cardiac output, and a slight reduction in SVR, possibly
as a consequence of reduced sympathetic activity. The
finding of 3 patients with falls in PAOP suggests that
in less well fluid resuscitated patients, venodilatation
and reduced filling pressure is a potential problem.
Reattainment of the baseline values of cardiac output
proved straightforward, requiring fluid in 3 patients
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and small increases in inotrope infusion rate in 7.
The importance of achieving and maintaining a high
oxygen delivery when treating critically ill patients
with sepsis and ARDS has been emphasised by a number of
workers, and is detailed in the previous chapters (Haupt
1985, Clarke 1991, Tuchschmidt 1992). As described in
chapters 2 to 4, pathological delivery dependence is due
to an inability of some tissues to regulate oxygen
extraction normally, and may imply a persistent tissue
oxygen debt, with oxygen demand in excess of actual
consumption. We have shown that this abnormality may be
present despite normal blood lactate concentrations, as
described in chapter 3.
In the normal human where oxygen consumption meets
demand, sedation, anaesthesia, muscle relaxation and
assisted ventilation should all reduce VO2 because of
the fall in requirements. Similarly, in patients with
low flow conditions, such as cardiogenic shock, where
critical reductions in D02 are present and V02 is
maintained by avid oxygen extraction, mechanical
ventilation will reduce the oxygen cost of breathing and
thus tissue oxygen requirements with improvement in the
oxygen supply/demand balance (Aubier 1982). It is less
clear, however, how sedation affects the balance of
oxygen supply, utilisation and demand in critical
illnesses such as septic shock and ARDS.
Studying patients undergoing major vascular surgery,
Gavin and colleagues showed a major reduction in V02
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during anaesthesia (Gavin 1991). This reduction was
associated with muscle paralysis and mechanical
ventilation. It is possible that it is the active use or
non-use of the respiratory muscles which influences
oxygen demand and VO2, rather than sedation or
anaesthesia.
The fact that sedation is generally associated with
cardiovascular depression and thus with decreased
myocardial oxygen demand, and with reduced cerebral
metabolic rate for oxygen suggests that there should be
a beneficial reduction in whole body VO2. Conversely, if
the sedation also results in falls in cardiac output and
DO2 in the presence of pathological delivery dependent
oxygen consumption, VO2 may fall to a greater extent
than demand, with aggravation of the oxygen shortfall.
This study does not reveal a significant reduction in
DO2 associated with propofol sedation. However, there is
a trend towards a parallel reduction in both DO2 and
VO2. Therapeutic interventions which restored DO2 also
tended to increase VO2, although sedation level was
unchanged. No significant changes in blood lactate
concentrations, which might have helped clarify the
effects on tissue oxygenation, occurred.
In critically ill patients with pathological delivery
dependent VO2, sedation may lead to reductions in VO2
which are linked to changes in DO2 and not oxygen
demand, but in the low dosage used in this study the
changes were small. A case report from Kaufman and
112
colleagues (Kaufman 1991) clearly demonstrated
beneficial effects on tissue oxygenation and ABL
concentrations from sedation in a very agitated patient.
Conversely, our experience of a patient with
pneumococcal septicaemia, meningitis and status
epilepticus requiring propofol in high dosage
(8mg/kg/hr) to achieve EEG burst suppression showed that
the consequent reduction in cardiac output and DO2 led
to a tissue oxygen debt manifested by an elevated blood
lactate concentration (unpublished observation).
On balance, it is unlikely that changes in sedation from
Ramsay level 2-3 to 5 as in this study, significantly
affect the oxygen demand/consumption balance. Extreme
agitation and conversely cardiac depression should be
avoided. Patients in whom DO2 is markedly reduced should
be mechanically ventilated if evidence of a tissue
oxygen debt is apparent as suggested by elevated lactate
concentration or critically low SVO2.
In summary, controlled propofol sedation is well
tolerated in appropriately monitored and resuscitated
patients, even when they require cardiovascular support
with catecholamines. It is likely that there is no
clinically significant effect on global oxygen
transport.
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CHAPTER 6 THE EFFECTS OF HIGH VOLUME
HAEMOFILTRATION ON ACID-BASE STATUS AND
CARDIORESPIRATORY FUNCTION IN CRITICALLY
ILL PATIENTS
6.1. Introduction
The last decade has witnessed major changes in the
pattern of renal replacement therapy (RRT) use,
particularly in unstable and severely ill patients
(Brazilay 1989). This has been in large part due to the
greater haemodynamic stability which we and others have
demonstrated with haemofiltration as opposed to
haemodialysis (Baldamus 1983, Mackenzie 1991 ii).
Since the introduction of continuous spontaneous
haemofiltration by Kramer there has been a rapid
adoption of haemofiltration techniques in intensive care
units and acute nephrology wards (Kramer 1977).
Refinements and advances in the form of continuous
(spontaneous or pumped) haemodialysis and intermittent
machine pumped high volume haemofiltration (HVHF) have
logically followed (Geronemus 1984, Simpson 1987). The
choice of treatment modality will be influenced by
individual and local factors such as the patient's
clinical state and underlying diagnosis, the type of
unit and the availability of staff trained in the use of
different types of RRT. We use HVHF with lactate
containing replacement fluid for our patients with acute
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renal failure (ARF) as part of multiple organ failure.
It has been suggested that critically ill patients may
not tolerate lactate administration because of failure
to metabolise it, with resultant haemodynamic
instability and worsening of metabolic acidosis
(Davenport 1989).
We investigated the acid-base and cardiorespiratory
effects of treatment with HVHF and lactate containing
replacement fluid in critically ill patients with
multiple organ failure.
6.2. Patients and methods
Twelve patients with multiple organ failure undergoing
intermittent pump-driven, veno-venous HVHF were studied
on one occasion each. Clinical details of the patients,
including Apache II scores, are given in Table 11.
Haemofiltration was undertaken as treatment for ARF in
11 patients and in an attempt to improve gas exchange in
1 patient with severe ARDS. All patients were
mechanically ventilated and had femoral arterial lines
and thermodilution pulmonary artery flotation catheters
for standard clinical monitoring. Cardiorespiratory
status was optimised before haemofiltration in all
patients. Fluids and vasoactive drugs were titrated to
achieve previously described therapeutic goals, (CI >4.5
1/min/m2; DO2 >600 ml/min/m2; MAP >80 mmHg; Shoemaker
1988) .




Sex Age Diagnosis Apache Outcome
II
1 F 63 Shock, rhabdomyolysis 43 S
2 F 53 ARDS, septic shock 21 S
3 M 80 Septic shock, ARDS 29 NS
4 M 63 Septic shock, ARDS 21 NS
5 F 54 Septic shock, ARDS 18 S
6 M 77 Septic shock, ARDS 41 NS
7 F 58 Septic shock 27 S
8 M 72 Acute pancreatitis, 20 NS
septic shock
9 F 68 Candida, septic shock, 29 NS
ARDS
10 F 65 Septic shock, ARDS 25 NS
11 M 73 Septic shock, ARDS 33 NS
12 M 68 Septic shock, liver 21 NS
failure
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until one hour after its finish. During this period
there were no changes to sedation, ventilator settings
or increases in catecholamine infusion rates, although 3
patients required reductions in these because of rising
blood pressure during HVHF. Extra fluid administration
by bolus was not required in any patient.
Haemofiltration was performed using a Gambro AK 10
system with a FH 77 hollow fibre filter and vascular
access was through a double lumen catheter in an
internal jugular or subclavian vein (Gambro AB, Lund,
Sweden). A blood flow rate of 200-300 ml/min and
transmembrane pressure of 300-400 mmHg were used to
achieve an initial filtration rate of 100-120 ml/min,
although the filtration rate tended to fall as the
treatment progressed. Anticoagulation was with heparin
administered into the afferent limb of the circuit to
achieve an activated clotting time (ACT) 30s above
baseline, or over 180s. The replacement fluid was
Haemofiltrasol 22 (Gambro) containing lactate 45 mmol/1,
Na+ 140 mmol/1, Ca++ 1.6 mmol/1, Mg++ 0.75 mmol/1, Cl"
100 mmol/1 with potassium added as clinically indicated.
The mean duration of treatment was 3hrs 50mins (range 2
hrs 30 mins to 6 hrs 15 mins) and mean lactate infusion
was 696mmol (range 450 mmol to 1080 mmol).
Prior to haemofiltration a full cardiorespiratory
profile was obtained as described in Chapter 2.
Oxygen tension (PO2), oxyhaemoglobin saturation (SO2),
carbon dioxide tension (PCO2), hydrogen ion
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concentration ([H+]) and haemoglobin concentration were
measured in arterial and mixed venous blood. At the time
of blood sampling 1.5ml of arterial blood was placed
into pre-weighed glass tubes containing 5ml 5%
perchloric acid, immediately refrigerated and
subsequently analysed for lactate by the method
described in Chapter 2. All measurements were repeated
hourly during HVHF and at 1 hour after treatment.
Statistical analysis was by a Wilcoxon signed rank sum
test comparing pretreatment values with those at each
hour during and following HVHF. All results are
expressed as mean + SEM.
Differences were deemed significant with p<0.05.
6.3. Results
The results for the ARDS patient were similar to the 11
ARF patients, and the results are presented together,
and summarised in Tables 12 and 13. Haemofiltration was
well tolerated in all patients. There were minor falls
in MAP, CI and DO2 but these were not statistically
significant. SVRI and VO2 showed increases during the
treatment, but these changes were not significant.
Lactate concentrations rose quickly (Pre 1.7 +
0.3mmol/l; lhr 5.6 + 0.4mmol/l; p<0.0001) and were still
elevated, although not significantly (2.6 + 0.4 mmol/1;
p=0.06), 1 hour after HVHF. Baseline arterial and mixed
venous [H+], [HCC>3_] and pCC>2 were not significantly
different. Arterial and mixed venous [H+] tended to
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fall, and [HCO3-] tended to rise although none of these
achieved statistical significance. There were no
significant changes in blood gas measurements. Four of
the 12 patients survived.
6.5. Discussion
In this and a previous study (Mackenzie 1991 ii) we have
demonstrated that HVHF is well tolerated in a
potentially unstable group of patients with multiple
organ failure. In our previous group of patients, there
were significant falls in CVP and CI with blood pressure
maintained by vasoconstriction. In the present study we
have not confirmed these findings, and this probably
reflects the clinical and haemodynamic heterogeneity of
small groups of critically ill patients. What we have
confirmed is the haemodynamic stability of HVHF in these
patients.
The mechanisms for the handling of blood lactate in
critically ill patients with multiple organ failure are
widely discussed, but are still incompletely understood
(Simmons 1978, Rashkin 1985, Cohen 1991). The ABL
concentration is a reflection of the balance of lactate
entering the circulation (exogenous or endogenous) and
lactate removal, mainly by the liver. As detailed in
chapters 3 and 4, in shock, sepsis and ARDS, splanchnic
blood flow is abnormal and the ability for the tissues
to utilise oxygen is impaired (Duff 1969, Dahn 1988). In
view of this there are theoretical concerns over the
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ability of the liver to handle the large, acute lactate
load which is administered during HVHF. Davenport and
colleagues have shown that in their patients with ARF,
with or without liver failure, there were significant
falls in MAP and serum (arterial) bicarbonate (Davenport
1989). In the hepatorenal group there was a significant
rise in [H+]. In contrast, our studies have not shown
any significant hypotension, although in both of our
studies the initial MAP was lower than in their ARF
group, and equivalent to that of the hepatorenal group.
In our current study we have shown that there is no
deterioration in arterial or mixed venous acid-base
status during HVHF, despite higher peak lactate
concentrations than in Davenport's study at 6.9 + 0.3
mmol/1 at 3hrs.
We chose to measure mixed venous gases and acid-base
status based on the studies of Adrogue (Adrogue 1989)
and Weil (Weil 1986), which have suggested that the
central or mixed venous sampling site is more sensitive
to the acid-base changes in the microcirculation, than
is systemic arterial sampling. We have shown that this
is not the case for blood lactate concentrations, as
detailed in Chapter 2 (Nimmo 1993 i). In the current
study we showed no significant difference between
arterial and mixed venous acid-base parameters
throughout the study period, and there were no adverse
effects on [H+] or [HCC>3~] in our patients.
It has been suggested that the adverse acid-base
122
responses and hypotension seen in previous studies may
be due to reduced tissue oxygen delivery (Davenport
1989). This seems likely, although the absence of
appropriate monitoring of flow and oxygen transport in
Davenport's study allows no more than speculation on
this point.
It is widely accepted that MAP may be reasonably
maintained despite low cardiac filling pressures, CI and
DO2. In our patients these variables were measured prior
to haemofiltration, and appropriate resuscitation was
carried out in an attempt to increase CI and DO2 whilst
maintaining MAP near normal. In contrast to our study
population, that of Davenport and co-workers contained 6
patients with overt hepatic failure. These patients are
notoriously resistant to resuscitation, even with high
doses of vasopressors. It would, however be of interest
to study this group of patients in the manner which we
have described. The addition of acetyl cysteine infusion
in those with hepatic failure secondary to
self-poisoning with paracetamol, in view of its
documented benefits on haemodynamics and oxygen
transport in these patients, would also be of
considerable interest (Harrison 1991).
We conclude that HVHF with lactate-containing fluid in
critically ill patients is appropriate and that no
deterioration in acid-base status or cardiorespiratory
function accompanies this treatment, despite theoretical
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objections concerning the exogenous lactate load. This
is likely to be a reflection of prior resuscitation,
aiming to maintain high DO2 and normal MAP.
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CHAPTER 7 THE HAEMODYNAMIC AND RENAL EFFECTS OF
APROTININ IN AN OVINE MODEL OF SEPTIC
SHOCK
7.1. Introduction
Previous studies have documented activation of protease
enzymes such as the plasma kallikrein-kinin system in
endotoxaemia and sepsis, and have shown that activation
is associated with important biological effects (Colman
1977). There is a clear association between endotoxaemia
and sepsis, and activation of the plasma
kallikrein-kinin system as shown in septic shock (Colman
1977). A number of investigators have described reduced
plasma concentrations of plasma prekallikrein, increased
"kallikrein-like activity", and decreased kallikrein
inhibitory activity, probably as a result of
endotoxin-induced activation of Hageman factor (Webster
1959, Neiss 1968). Kinins probably mediate several
important features of septic shock, a number of their
proven effects being implicated in the pathophysiology
of the syndrome. In particular, kinins are potent
systemic vasodilator peptides, but cause pulmonary
vasoconstriction in most species (Mason 1970). They
cause increased capillary permeability, and stimulate
release of arachidonic acid from cell membranes, leading
to increased prostaglandin and thromboxane synthesis
(Mason 1970). It is not certain, however, whether the
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reduced plasma prekallikrein in sepsis is wholly due to
kallikrein-kinin system activation, or whether it in
part reflects reduced prekallikrein synthesis (O'Donnell
1976). It is also unclear whether kallikrein-kinin
activation is directly involved in the pathogenesis of
septic shock. Experimental studies involving the
response to endotoxin infusion have failed to support
this hypothesis, although because of the lack of
specific, potent kallikrein-kinin antagonists, direct
evidence is lacking (Marceau 1983, Cumming 1984).
Aprotinin is a broad-spectrum serine protease inhibitor
with some kallikrein-inhibitory activity (Kaplan 1977).
The affinity of aprotinin for kallikrein is less than
that for some proteases (Kaplan 1977), and it is now
recognised that previous studies using this agent have
used doses of aprotinin which inhibit plasma kallikrein
poorly, if at all (Fritz 1983). We chose to investigate
the effects of aprotinin, at a dose known to inhibit the
plasma kallikrein-kinin system maximally, in a large
animal (ovine) model of intra-peritoneal and systemic
sepsis which has been shown to reproduce the important
features of clinical septic shock (Richmond 1985).
Sepsis and acute renal falure are frequently associated,
and up to 50% of cases of acute renal failure are due to
septic shock (Wardle 1982). The pathogenesis of this
syndrome is poorly understood, but some investigators
have suggested that the systemic arterial vasodilatation
which occurs in early sepsis may be the principal
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stimulus causing the kidney to retain salt and water
(Beaman 1987), leading to "functional" renal failure
associated with reduced glomerular filtration and sodium
retention (Cumming 1988). Several studies have suggested
that this renal response may reflect renin-angiotensin
activation, together with reduced activity of the
intra-renal tissue kallikrein-kinin system, which
normally acts to preserve renal function during
hypoperfusion (Richmond 1985, Cumming 1988). It was
therefore important to discover whether aprotinin
treatment, which could further reduce renal kallikrein
activity, adversely affected renal function in
intra-peritoneal and systemic sepsis.
The overall hypothesis of the studies was that aprotinin
therapy would prevent or ameliorate hypotension and
systemic vasodilatation in the initial study, and that
it might reverse hypotension and systemic vasodilatation
in the study of intervention in established septic
shock. It was hypothesised that these beneficial actions
on the systemic circulation, and thus renal perfusion,
would outweigh any adverse effect of local renal tissue
kallikrein inhibition. A similar effect has been
demonstrated by ourselves and others using the
potentially nephrotoxic catecholamine vasoconstrictors
noradrenaline and adrenaline in hyperdynamic septic
shock (Cumming 1989 ii, Redl-Wenzl 1993).
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7.2. Materials and methods
The technique of surgical induction of peritonitis was
modified from that of Wichterman (Wichterman 1980).
Twelve healthy sheep aged 12-18 months and weighing
40-50 kg underwent general anaesthesia with halothane,
nitrous oxide and oxygen, to allow cannulation of the
common carotid artery with a 16 F single lumen line, and
the pulmonary artery via the external jugular vein with
a triple lumen balloon-tipped, thermodilution PAC. The
bladder was catheterised per urethra. After recovery
from anaesthesia, animals were housed in metabolic cages
and volume loaded with 6 litres of compound sodium
lactate solution intravenously over 24 hours.
Crystalloid was used as it was the fluid used in the
initial studies validating the model (Richmond 1985).
After control haemodynamic measurements and blood and
urine sampling, animals underwent a second general
anaesthetic when peritonitis was induced by caecal
ligation and puncture. Post-operatively all animals
received 50 mg pethidine IV, and were continued
thereafter on an IV infusion of pethidine at a rate of
50 mg/6 hrs. IV infusion of compound sodium lactate (150
ml/hr) continued for the duration of the experiment, and
the rate of additional fluid supplements was adjusted to
maintain the previously determined optimal PAOP for
individual animals. Haemodynamic measurements were made
hourly, and blood and urine collections were made 4
hourly after the induction of sepsis.
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Animals were supervised continuously during the studies.
Any animal seen to be restless, agitated or showing
other evidence of discomfort despite pethidine infusion
was sacrificed immediately by IV bolus injection of
pentobarbital. Animals surviving through 12 hours were
sacrificed in the same manner. An open renal biopsy was
taken at the time of death. Haemodynamic variables
measured were those detailed in Chapter 2 and included
MAP, CVP, PAM, PAOP, CI and SVRI. Blood samples were
drawn through the aortic cannula. Plasma creatinine,
sodium and osmolarity were measured by standard
autoanalyser techniques, and plasma renin activity was
measured by radioimmunoassay. Urine volume was recorded
and urine creatinine, sodium and osmolarity measured.
Urinary kallikrein was assayed as detailed in Chapter 2.
Kidney tissue was examined by light microscopy using
standard methods (Solez 1980).
Protocol Study 1: In the treatment group (n=6),
aprotinin was infused intravenously, commencing 30
minutes after the completion of the surgical induction
of peritonitis. A loading dose of one million kallikrein
inhibitor units (KIU) was given, followed by a
continuous infusion of 200,000 KlU/hr for the duration
of the study. In control animals (n=6), the saline
vehicle alone was infused at the same rate.
Protocol Study 2 (intervention): Peritonitis and septic
shock were induced as described above (n=5). Once
volume-resistant hypotensive septic shock had developed
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as determined by a fall in MAP >40 mmHg, unresponsive to
further volume loading, a bolus of aprotinin, one
million KIU, was given IV followed immediately by a
continuous infusion of one million KlU/hr for the
duration of the study.
Statistics
Study 1: for the purposes of analysis, for each
variable, the values included were those values at
baseline (presepsis) and observations made at 4 and 8
hours postoperatively and at the termination of the
study (12 hours postoperatively). Two-way analysis of
variance for repeated measures was used to assess the
significance of changes with time for each variable in
the treatment and control groups, and the significance
of between-group (aprotinin treatment) effects. Values
for p<0.05 were considered significant. Results are
shown as mean + SEM.
Study 2: Two-way analysis of variance for repeated
measures was used to assess the significance of changes
with time for each variable, comparing time points with
baseline. Significance was defined as above.
7.3. Results
As in the studies performed to establish and validate
this experimental model (Richmond 1985, Cumming 1988),
all animals developed a polymicrobial peritonitis and
bacteraemia; organisms grown on blood culture included
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Escherichia coli, Serratia, Enterobacter, Pseudomonas
and Bacteroides species, and autopsy showed generalised
purulent peritonitis and an inflammatory mass in the
right lower quadrant. PAOP was maintained in the range
10-20 mmHg during the study, and adjusted to the optimal
level with respect to cardiac output.
Study 1: Results for systemic haemodynamics and renal
function at baseline and during the study are shown in
Figures 14 to 19. In the control animals (n=6) there
were significant falls with time in blood pressure
(Figure 14) and systemic vascular resistance index
(Figure 16), and an early increase in mean pulmonary
artery pressure (Figure 17), with a reduction in
creatinine clearance (Figure 18) and fractional sodium
excretion (Figure 19). None of these parameters altered
significantly in the aprotinin-treated animals (n=6).
Cardiac index (Figure 15) and urine volume did not
change significantly with time in either group. There
was a statistically significant effect of aprotinin
treatment, in a two-way analysis of variance, for the
parameters mean arterial pressure (p<0.05) and mean
pulmonary artery pressure (p<0.01).
In the control group, urinary kallikrein excretion
tended to fall during sepsis, and there was a
significant increase with time in plasma renin activity
(Table 14), changes which have been previously described
in this model (Cumming 1988). Aprotinin treatment was

































28 26 24 22 20 18 16 14 12





















ON.S. p=0.034 r 3
FractionalSodiumExcretion(%) Baseline123
Table14 Urinekallikreinexc tionata dplasmareniac vityico trold aprotinintreatedg ups(mea+/-SEM) Urinekallikrein (nkatxlO-3/min) Plasmarenin activity (ng/ml/hr) Plasmarenin activity (ng/l/sec)ControlAprotinin Baseline 2.67+/-1.40 0.21+/-0.01 0.06+/-0.003Sepsis 1.67+/-0.91 6.34+/_0.92* 1.76+/_0.25*
Baseline
1.76+/_l.00 0.20+/_0.01 0.06+/-0.003
Sepsis 0.70+/-0.49 1.78+/-0.69** 0.49+/_0.19**
*p<0.05frombaseline;**.frcontrols.
during sepsis, although the difference was not
statistically significant. Plasma renin activity did not
rise significantly in the aprotinin treated group, and
plasma renin activity was significantly lower in this
group at the conclusion of the study (Table 14).
Intervention study: Results for systemic haemodynamics
at baseline, following the development of
volume-resistant septic shock, and during aprotinin
treatment are shown diagrammatically in Figures 20-22.
There were significant reductions in MAP and systemic
vascular resistance index, with an immediate and rapid
increase in both (Table 15), in some animals virtually
to pre-sepsis levels following aprotinin (Figures 23 to
25). Cardiac index did not change significantly during
aprotinin infusion (Figure 21).
No consistent or striking changes in renal histology
were noted in treatment or control groups, in keeping
with previous studies. Those changes which were observed
included mild tubular dilatation, occasional foci of
tubular regeneration and patchy interstitial infiltrates
of mononuclear cells. These changes were evenly
distributed between all the groups.
7.4. Discussion
Clinical studies of pharmacological intervention in
human septic shock are complicated by lack of pre-sepsis
baseline parameters, problems in assessing the
evolutional stage of the sepsis, difficulty in assessing
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Pre-aprotinin - 53.8+/-4.6 - 714+/.75
During aprotinin -12.6+/-5.0* - 281+/-36*
Post aprotinin - 49.8+/_10.8** - 636+/-180**
*p < 0.01 vs. pre-aprotinin; **p < 0.01 vs. aprotinin.
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the severity of the shock syndrome and the multiple
treatments required. The experimental model of sepsis
utilised in these studies overcomes these difficulties,
and differs from many other experimental models of
sepsis and endotoxaemia in that it reproduces the state
of volume-resuscitated, hyperdynamic, and vasodilated
septic shock commonly seen in clinical practice. Use of
an ovine model allows detailed haemodynamic monitoring
and provides sufficient sample size to permit assessment
of renal function and vasoactive hormone systems.
The initial events which trigger systemic vasodilatation
in sepsis are unclear. However, bacterial endotoxins are
potent activators of the plasma "contact systems",
including the kallikrein-kinin system, through Hageman
factor (Kaplan 1977). Plasma kallikrein is a serine
protease, generated from an inactive precursor,
prekallikrein, by the action of a Hageman factor
fragment, prekallikrein activator. It acts primarily on
high molecular-weight kininogen to form bradykinin
(Kaplan 1977). It is known that the plasma
kallikrein-kinin system is activated in septic shock,
and kinins could mediate the systemic vasodilatation and
increased capillary permeability seen in sepsis (Regoli
1980). We were unable to measure plasma prekallikrein or
plasma kallikrein activity in this experimental model
because of the very low activity of sheep kallikrein
against the chromogenic substrate, S2302, used to
measure plasma prekallikrein/kallikrein activity (Bonner
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1981). Previous studies of patients with septic shock
have shown depressed levels of plasma prekallikrein
during sepsis, suggesting activation of the plasma
kallikrein-kinin system, with survivors showing a return
to normal during recovery (Cumming 1984). Studies of the
effect of protease inhibition in the experimental model
of septic shock were therefore of interest.
Aprotinin is a polypeptide protease inhibitor derived
from bovine lung. It is active against a number of
serine proteases including trypsin, chymotrypsin,
plasmin, and plasma and tissue kallikreins. Some studies
have shown benefit from its use in acute pancreatitis,
and it is now widely used to inhibit blood loss during
cardiac surgery (Philipp 1978, Royston 1987). Our
results suggest that the hypotension and systemic
vasodilatation in early septic shock are prevented by
aprotinin. In addition, these changes appear to be
reversed by aprotinin given as an intervention once they
have become established. These effects could be due to
inhibition of any of the above protease enzymes, and our
results do not allow discrimination between them. It is
also possible that inhibition of neutrophil-derived
proteases could be involved (Niehaus 1990). Plasma
kallikrein is known to be generated in septic shock, and
to be associated with appropriate biological effects.
Experimental intravenous injection of kallikrein induces
a picture resembling septic shock, with hypotension and
increased capillary permeability (Mills 1979). It is
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therefore possible that the beneficial effects seen in
our studies reflect, at least in part, inhibition of
endotoxin-induced prekallikrein activation. Studies
using more selective inhibitors of the plasma
kallikrein-kinin system in small animal models of
endotoxaemia support a role for kinin generation in
endotoxic shock (Noronha-Blob 1991).
While aprotinin has been suggested to be useful in a
wide range of disease states, it has yet to become
routine therapy in any but cardiac surgery. This is
probably due (at least in part) to the use of
inappropriately low doses in previous studies, such as
the trials in acute pancreatitis (Philipp 1978, Fritz
1983). The dose regimes used in these studies were
calculated on the basis of the affinity of aprotinin for
glandular kallikrein (Ki 9xl0-11), but the affinity of
aprotinin for plasma kallikrein is considerably lower
(Ki 3xl0~8, Fritz 1983). It is therefore likely that in
previous studies, adequate inhibition of the plasma
kallikrein-kinin system was not achieved (Philipp 1978).
Recent work has demonstrated the feasibility and safety
of using doses of aprotinin of the order of 20-fold
higher than previously (Maier 1985). We have used such
high doses in these studies, with apparent efficacy and
no evidence of adverse effects.
As described above, the affinity of aprotinin for
glandular (including renal) kallikrein is greater than
for plasma kallikrein. In our studies urinary kallikrein
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excretion, which is thought to reflect activity of the
renal kallikrein-kinin system, was lowest while the
animals were receiving aprotinin. It is believed that
the renal kallikrein-kinin system, which is anatomically
and functionally distinct from the plasma system,
promotes renal vasodilatation and increased sodium
excretion (Niehaus 1990). It is therefore theoretically
possible that aprotinin could adversely affect renal
function during sepsis. However, we found evidence of
improved renal function in the aprotinin group in Study
1. It has been suggested that the renal vasodilator
function of the renal kallikrein-kinin system only
becomes important in the face of reduced renal perfusion
and/or activation of the renin-angiotensin system, in a
manner analogous to the role of renal prostaglandins
(Nasjletti 1981). Indeed, kinins are a potent stimulus
to release of renal vasodilator prostaglandins. It seems
likely that in these studies, any potential adverse
effect of renal kallikrein-kinin inhibition was
outweighed by the improvement in systemic haemodynamics,
and hence in renal perfusion, and the reduced plasma
renin activity, in the treatment group in Study 1. This
corresponds to situations in which potentially
nephrotoxic vasoconstrictors, noradrenaline and
adrenaline, have been used to reverse hypotension in
hyperdynamic septic shock with documented improvement in
renal function (Hesselvik 1989, Redl-Wenzl 1993). Again,
it is suggested that the improvement in global
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haemodynamics outweighs any detrimental effect on the
intra-renal circulation. However, aprotinin may be a
more appropriate agent to use, since it is associated
with less potential for indiscriminate vasoconstriction
of non-pathologically vasodilated blood vessels than are
the catecholamines.
In Study 1 we showed that the rise in plasma renin
activity which is a typical feature of experimental
septic shock, and was present in controls, was prevented
by aprotinin treatment. This probably reflects the
maintainance of adequate blood pressure in the treatment
group. It should be noted however, that kallikrein may
be an important activator of prorenin, as kinins are
known to stimulate renin release, and aprotinin has been
shown to reduce plasma renin activity in normal man
(Seto 1983). It has been suggested that renin and
angiotensin II are important in the pathogenesis of
acute renal failure, and angiotensin II potentiates
sympathetic nervous system activity, which may also be
important in the sepsis/acute renal failure syndrome
(Cumming 1988). Prevention of renin-angiotensin
stimulation may therefore represent an additional
beneficial effect of aprotinin treatment in sepsis.
The apparent effect of aprotinin in preventing the rise
in pulmonary artery pressure, maximal at 4 hrs
post-operatively, is of some interest. It has been shown
that the increased pulmonary lymph flow seen 2-6 hrs
after administration of endotoxin to sheep is reduced by
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protease inhibition (Traber 1984) . It is thought to be
likely that changes in pulmonary haemodynamics and
permeability during sepsis reflect primarily cellular
mechanisms, such as stimulation of neutrophils by
complement activation (Shale 1987). Our results suggest
that pulmonary hypertension may reflect activation of
protease enzymes against which aprotinin is effective.
These may be circulating cascade systems or could
include neutrophil enzymes, although the affinity of
aprotinin for neutrophil elastase and Cathepsin G is
relatively low (Fritz 1983). Tissue kallikrein has
recently been detected in the cytoplasm of human
neutrophils (Figueroa 1989). It is known that kinins
have differing effects in various vascular beds, and
cause pulmonary vasoconstriction in most species (Regoli
1980). This effect of aprotinin could be beneficial in
the course of septic shock, since it would be predicted
to reduce lung water and improve respiratory and right
ventricular performance.
From these studies we conclude that in the early stages
of septic shock a number of the characteristic
pathophysiological features may be due to activation of
protease enzyme systems, including the kallikrein-kinin
system. In an animal model developed to mimic human
septic shock, administration of the protease inhibitor
aprotinin benefits systemic and pulmonary haemodynamics
and renal function with no adverse effects. Prospective,
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randomised clinical studies are required to confirm
these effects in patients, and to define the place of
this agent in human sepsis.
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CHAPTER 8 ARTERIAL AND MIXED VENOUS ACID-BASE
STATUS AND LACTATE METABOLISM IN SEPTIC
SHOCK
8.1. Introduction
Throughout this thesis the proposal that tissue hypoxia
is a fundamental cause of multiple organ failure is
repeatedly stated. In view of this contention it is no
surprise that many studies have been carried out in the
guest for reliable, practical markers of tissue hypoxia
in the clinical setting (Haljamae 1991). The serial
measurement of arterial blood gases is an established
technigue used to assess gas exchange and the acid-base
status of the critically ill, and to guide therapy.
However, a number of investigators have shown
differences between arterial and mixed venous acid-base
parameters in cardiac arrest and low flow states, and
have suggested that the measurement of mixed venous
acid-base status may reveal otherwise unrecognised
abnormalities of tissue oxygen metabolism (Weil 1986,
Adrogue 1989, Bleich 1989). In experimental haemorrhagic
shock an inverse relationship between cardiac output and
increases in PvCC>2 and veno-arterial PCO2 difference
(P(v-a)CC>2) has been demonstrated, with a decrease in
both on reinfusion of shed blood (Halmagyi 1970).
Hyperventilation had no effect on the elevated PvCC>2.
Furthermore, it has been proposed that circulatory
failure be defined not only in terms of oxygen lack but
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also as carbon dioxide excess, manifested by an
increased P(v-a)CC>2 difference above the normal of
0.8kPa (Johnson 1991). We have studied these
relationships in human septic shock during
resuscitation, and in addition measured excess lactate
in a sub-group of these patients.
8.2. Patients and methods
Twenty three patients with septic shock, ventilated and
invasively monitored were studied during resuscitation
with fluids and vasoactive drugs, as described in
Chapters 2 and 4. The mean age was 62 years (range 37 to
84), and 12 were female. Eighteen patients had aerobic
Gram-negative infection (16 intra-abdominal), 8 had
Gram-positive infection and one had Candida septicaemia.
The mean Apache II score was 22.
Protocol
All patients were intubated and mechanically ventilated,
following which fluid resuscitation with colloid and
blood was carried out, in conjunction with catecholamine
therapy to reverse hypotension and increase DO2 as
described previously (Nimmo 1992). Full
cardiorespiratory profiles were obtained prior to
resuscitation, and subsequently at around 2 and 8 hours
into treatment, and at the same times as acid-base
measurements were made. In eleven patients excess
lactate was calculated according to the equation in
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Chapter 1.
Statistical analysis was carried out using the Wilcoxon
signed rank test to compare paired data at baseline, 2
and 8 hours. All values are expressed as mean + SEM.
8.3. Results
Resuscitation resulted in global improvements of MAP,
CI, SvC>2 and DO2, with no significant change in VO2
(Table 16). The acid-base variables are also documented
in Table 16.
The initial P(v-a)CC>2 difference was at the upper limit
of normal (0.8kPa), and there was no significant change
with time, being 0.7kPa at both 2 and 8 hours. The
relationship between individual P(v-a)CC>2 and cardiac
index is depicted in Figure 26. There is no direct
relationship between these variables in sepsis as there
is in low flow shock.
At baseline there was no significant veno-arterial [H+]
difference, and no significant veno-arterial [HC03-]
difference. These did not change over time. Arterial
[H+] increased along with PaCC>2 over time (44.7 + 2.5 to
48.7 + 2.4 nmol/1, p<0.01).
Excess lactate
Excess lactate concentration had no better predictive
value for delivery dependence of DO2 on VO2 than lactate
alone (Table 16), as described in Chapter 4.
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Table 16
Cardiorespiratory, arterial and mixed venous acid base
variables during resuscitation of septic shock.
Initial 2 Hours 8 Hours
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In contrast to studies of patients with low flow shock
or cardiac arrest we have failed to demonstrate
significant differences in acid-base status between
arterial and mixed venous blood. This finding is similar
to that of Wendon and colleagues in patients with
fulminant hepatic failure (Wendon 1991). However, unlike
that study, we failed to demonstrate global increases in
VC>2 with increased DC>2. As we have previously commented,
this may reflect the heterogeneity of critically ill
patients in terms of their response to a
pathophysiological stimulus (in this case sepsis), in
the temporal relationships of study and illness, and in
the individual's response to therapy.
Several groups have demonstrated venous hypercarbia and
a raised P(v-a)CC>2 in human septic shock, but only in
those patients with a cardiac output significantly lower
than those without venous hypercarbia (Mecher 1990,
Bakker 1992). Just as the interpretation of
hyperlactataemia may be confounded by multiple factors
in addition to tissue anaerobiosis in septic shock, so
the interpretation of changes in P(v-a)CC>2 in sepsis is
complicated by the effects of impaired myocardial
performance, hypermetabolism with increased CO2
production, buffering of lactic acid and abnormal CO2
excretion. It appears that there is a fundamental
interplay between the circulatory and ventilatory
mechanisms in determining the PCO2 in arterial and mixed
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venous blood in states of acute cardio-respiratory
failure. Venous hypercarbia results from a combination
of factors including increased CO2 production by the
tissues (both as a result of buffering and of
ischaemia), increased uptake of CO2 into capillary blood
and abnormal pulmonary blood flow causing impaired CO2
excretion.
As mentioned in other chapters, the control of minute
ventilation is fundamental to the unravelling of the
mechanisms of tissue hypoxia and hypercarbia in the
unstable situation of acute cardio-respiratory failure.
In studies where mechanical ventilation has been used to
control minute ventilation, it has been shown that
P(v-a)CC>2 increases as cardiac output falls. Our finding
that the grouped P(v-a)C02 gradient is normal in human
septic shock patients who are intubated and mechanically
ventilated is in keeping with these other studies.
However scrutiny of the relationship between cardiac
output and P(v-a)C02 in individuals shows that there is
no clear relationship between cardiac output and
P(v-a)C02 difference in this study.
In conclusion, we have demonstrated no increase in
venous PCO2 or P(v-a)C02 difference in a group of
patients with septic shock. In addition, levels of
excess lactate were calculated but showed no benefit
compared to lactate concentrations in predicting
delivery dependence of DO2 on VO2. None of these markers
can be recommended for routine use in this group of
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patients. Further work is required to define their place
in clinical monitoring.
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CHAPTER 9 FUTURE DEVELOPMENTS AND FURTHER
RESEARCH
9.1. Introduction
The studies detailed in this thesis cover a range of
aspects important to intensive care treatment. As with
much previous research, many questions have been raised in
the course of the studies, and further investigation will
be of interest in many of the areas discussed.
9.2. Shock and oxygen transport
As more studies showing the importance of high DO2 in
septic shock and critically ill surgical patients have
been published, it has become routine clinical practice in
many centres to use measurement of oxygen transport to
guide therapy in these conditions. However, the effects of
vasoactive drugs on individual organ blood flow and
metabolism requires to be addressed. There are few
clinically applicable techniques available which would
allow direct monitoring of this at present, and efforts
should be directed at this. The use of gastric
intra-mucosal pH measurement as a guide to splanchnic
perfusion has been advocated, and we have assessed the
effects on this of noradrenaline therapy in septic shock
(submitted 1995).
Although preliminary work has highlighted the importance
of SVO2 measurement in low flow states such as cardiogenic
shock, there are no large clinical studies of its use as
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part of a management protocol aimed at reversing
hypotension and critical tissue hypoperfusion
simultaneously. The findings of such an investigation
would have significant implications for the management of
acute myocardial infarction and low flow shock.
9.3. Lactate and critical illness
The place of lactate measurement remains ill-defined. If
the concentration is very high, it is useful. However, if
the concentration is borderline high or 'normal' it may be
of little prognostic relevance, either way. This is
probably for one of two reasons. Firstly, certain
treatments which reduce oxygen requirements such as
paralysis, can improve the oxygen/supply demand balance.
In addition while certain organs are net producers of
lactate others are utilising it, and in order for ABL to
rise these mechanisms must be severely affected. It will
be of interest to examine individual organ and tissue
lactate kinetics.
It may be necessary to redefine levels of significant
hyperlactataemia in different, well defined disease
states.
The routine use of intra-venous sodium bicarbonate as a
buffer agent in the treatment of hypoxic lactic acidosis
has been shown to have no benefit in whole body or
intra-cellular terms (Kette 1990, Arieff 1991), and in
many situations has been shown to be detrimental (Graf
1985, Bersin 1989, Ritter 1990). Despite initial promise
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(Stacpoole 1983) , studies of dichloroacetate (a stimulator
of lactate metabolism by enhancing the effect of pyruvate
dehydrogenase) have failed to show any clinical
improvement (Stacpoole 1988, Stacpoole 1992). It would be
of considerable interest to study these agents in hypoxic
lactic acidosis, combining their use with full invasive
monitoring, cardiorespiratory optimisation, and the use of
mechanical ventilation to compensate for any excess CO2
production.
Another interesting agent undergoing trials at present is
carbicarb. This eguimolar compound of sodium carbonate and
sodium bicarbonate elevates blood pH with little increase
in PCO2 compared to sodium bicarbonate (Sun 1987, Bersin
1988). As yet, only preliminary data are available.
9.4. Altering the oxygen supply/demand
balance
Although theoretical advantages might accrue from the use
of procedures to limit oxygen requirements in critical
illness, eg hypothermia, muscle relaxation, sedation,
clinical studies demonstrating benefit still require to be
carried out.
9.5. Immunomodulation and mediator
blockade
Current thinking regarding the use of immunomodulation is
influenced to some extent by the ability to measure
certain mediators, and more so by the commercial
production of a variety of mediator and receptor blockers.
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Many authorities have suggested that the use of a
'mediator blocking cocktail' may improve outcome,
particularly in sepsis and ARDS. The introduction of these
treatments is complicated by the difficulty we face in
assessing at what pathophysiological stage the individual
is, and in determining which mediators have detrimental
rather than beneficial effects. The place of well-tried,
relatively inexpensive agents such as aprotinin requires
to be defined in clinical practice.
9.6. Summary
The monitoring of shock and critical illness has evolved
rapidly in the last 25 years, no more so than in the late
1980s and early 1990s. Following the pioneering work of
Shoemaker, many groups of investigators and clinicians
have studied and utilised oxygen transport in a more
cohesive manner than heretofore. The use of these
measurements to guide resuscitation has become routine in
many places, although certain groups still advocate the
utility of isolated lactate measurements. Until individual
organ and tissue blood flow, oxygen transport and lactate
metabolism are clinically measurable, global measurements
provide us with the most accurate guide to the adequacy of
the cardiorespiratory system, and should probably be used
earlier and more widely than is currently the case. These
suggestions are not novel (Gurd 1966, Talley 1969).
However until the realisation of new treatments or
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strategies the timely provision of adequate oxygenation,
volume resuscitation and appropriate cardiorespiratory
support to the critically ill should prevent the
development of multiple organ failure, hopefully with
improved survival the logical reward.
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The relationship of blood lactate concentrations, oxygen delivery and
oxygen consumption in septic shock and the adult respiratory distress
syndrome
G. R. NIMMO, S. J. MACKENZIE, S. W. WALKER, J. CATNACH, M. NICOL, I. R.
ARMSTRONG and I. S. GRANT
Summary
Tissue hypoxia is thought to be pivotal to the development ofmultiple organ failure, but cannot be measured directly in clinical
practice. We assessed the relationship between initial arterial blood lactate concentrations and the presence of the phenomenon of
delivery-dependent oxygen consumption, both of which may indicate tissue hypoxia. Twenty-three critically illpatients with septic
shock and adult respiratory distress syndrome were studied prospectively and allocated to one of two groups according to blood
lactate concentrations. In group I, blood lactate concentration was less than the level widely accepted as significant
(2 mmol.l~'); in group 2, the concentration exceeded 2 mmol.T'. In both groups, resuscitation with colloid, blood and
vasoactive drugs resulted in significant increases in oxygen delivery; in group 1 (n = 13), mean (SEM) oxygen delivery
increased from 484 (36) to 730 (44) ml.min~'.m~! (p < 0.005) and in group 2 (n = 10) from 550 (54) to 780
(54) ml.min~',m~! (p < 0.05). In neither group was there a significant change in oxygen consumption. However, there were
individuals in both groups who exhibited pathological delivery dependence. This suggests that the absence of hyperlaclataemia
does not preclude delivery dependence of oxygen consumption with the attendant potential for tissue hypoxia.
Key words
Shock; septic.
Lungs; respiratory distress syndrome.
Metabolism; lactate.
Oxygen; consumption.
Elevated arterial blood lactate concentrations have long
been recognised as being a consequence of tissue
hypoxia [1, 2], and of having significant prognostic
importance [3-5]. However, there are many causes of
hyperlactataemia other than tissue hypoxia; these include
hypcrglycaemia, hypocapnia, toxins, liver failure and some
malignancies [1, 6]. It is generally accepted that hypcrlacta-
taemia in patients with acute cardiorespiratory failure
results from a combination of overproduction of lactate in
hypoxic tissues and of reduced clearance and
metabolism [6]. The liver and kidneys may become net
producers of lactate in shock [7]. The cardiorespiratory
findings in septic shock and adult respiratory distress
syndrome (ARDS) may include increased cardiac output
and oxygen delivery. Despite the presence of an apparently
adequate oxygen delivery there is an impediment to normal
tissue oxygen utilisation which has long been recognised
but is still not fully understood [8, 9], It has been shown
that, by increasing oxygen delivery in these patients using
fluids, blood or vasoactive drugs, oxygen consumption
(Vo2) may increase even when oxygen delivery exceeds the
330 ml.min_1.m~2 below which such a relationship is
thought to be physiological [10-13]. Delivery-dependent
oxygen consumption at these levels is a pathological state
which is in stark contrast to the norm. Recent work has
suggested that elevated blood lactate concentrations
characterise those patients with shock or ARDS who
exhibit delivery-dependent Vo2 [14, 15] although we have
previously shown that hypcrlactataemia is not a universal
finding in shock [16]. We have therefore re-examined the
association between blood lactate concentration and deli¬
very dependence in the critically ill. During resuscitation of
23 critically ill patients with septic shock and ARDS, serial
cardiorespiratory profiles with concurrent blood lactate
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concentrations were obtained and the influence of these on
the relationship between oxygen delivery and consumption
studied.
Methods
We studied 23 patients who required intensive care, inva¬
sive haemodynamic monitoring and mechanical ventilation
for the management of septic shock (n = 21) and ARDS
(n = 23). The study was reviewed and approved by the
local ethics committees. Septic shock was defined as mean
arterial pressure (MAP) < 70 mmHg with oliguria, despite
controlled volume expansion to an optimal pulmonary
artery occlusion pressure (PAOP), in the presence of posi¬
tive bacteriology. ARDS was defined as severe hypoxaemia
which required mechanical ventilation with Fto2 > 0.5 to
maintain Pao2 > 10 kPa; diffuse infiltrates on chest X ray;
shunt ratio > 30%; PAOP < 18 mmHg; and the presence
of a known risk factor.
All patients were sedated with continuous infusions of
papaveretum 3-5 mg.h-1 and midazolam 1-3 mg.h-1, and
the muscles were paralysed with atracurium. No changes in
rates of infusion of these drugs were made during the study
period, and the only adjustments to ventilator settings were
of fio2. All patients were studied during the first 6 h of
resuscitation following admission to the intensive care unit.
Femoral arterial and thcrmodilution pulmonary artery
flotation catheters (PAFC: Swan-Ganz, Baxter/Edwards,
Irvine, CA) were used in all patients for measurement of
mean arterial pressure (MAP), mean pulmonary artery
pressure (PAM), end-expiratory pulmonary artery balloon
occluded (wedge) pressure, and mean right atrial pressure
(RAP), all zeroed to the phlebostatic axis. Cardiac output
was determined by thermodilution in triplicate using 10 ml
dextrose 5% at a temperature of < 10°C. Continuous ST
segment analysis was performed using, and heart rate
measured from, 5 lead ECG monitoring (7200 series
bedside monitors, Marquette Electronics, Milwaukee, Wl).
Samples of mixed venous and arterial blood were taken for
blood gas analysis within 1 min of the last cardiac output
measurement. Haemoglobin concentration and mixed
venous and arterial oxyhaemoglobin saturations were
measured using an oximeter (Ciba Corning). The oxygen
content of arterial (CaOj) and mixed venous (Cvo2) blood,
and oxygen delivery and consumption, were calculated
using standard formulae. By convention, cardiac output is
indexed for body surface area, and we calculated oxygen
delivery as the product of Cao2 and cardiac index (CI).
Oxygen consumption (also indexed to body surface area)
was calculated using the inverse Fick relationship: Vo2 =
cardiac index x arteriovenous oxygen content difference,
arteriovenous oxygen content difference.
At the time of arterial sampling, blood was taken for
lactate measurement. A volume of 1.5 ml of blood was
placed into preweighed glass tubes containing 5 ml of cold
(4°C) 5% perchloric acid, immediately refrigerated and
subsequently analysed. Lactate concentration was
measured using a Cobas Bio (Roche) centrifugal analyser,
monitoring the rate of reduction of NAD to NADH +
fluorimetrically at an excitation wavelength of 340 nm in
0.5 M glycine buffer (pH 9.6) in the presence of 0.2 M
hydrazine hydrate and lactate dehydrogenase. Lactate stan¬
dards from 50-1200 mmol.l-1 were used. Whole blood
lactate concentration was then calculated after correcting
for dilution of the blood sample with 5% perchloric acid.
The assay had a sensitivity of 0.05 mmol.l-1 and a coeffi¬
cient of variation of 5.8-7.9% depending on the concentra¬
tion range. We have previously validated the use of arterial
rather than mixed venous samples for lactate
measurement [17].
Following baseline measurements, further controlled
volume expansion was performed in all patients after com¬
parison of the haemodynamic profile with previously
described therapeutic goals: MAP > 80 mmHg,
CI > 4.5 l.min-1.m-2 and oxygen delivery
600 ml.min.-l.m-2 [18, 19]. Colloid and blood were used,
depending on haemoglobin concentration. After volume
expansion, all patients received combinations of vasoactive
drugs (Tabic 1), depending on the haemodynamic profile,
in doses titrated against the observed haemodynamic
effects with the intention of reaching the defined thera¬
peutic goals. The baseline variables were compared to the
variables associated with maxima! oxygen delivery within
the first 6 h of resuscitation. Patients were allocated into
one of two groups on the basis of the initial blood lactate
concentration (group 1, lactate <2 mmol.l-'; group 2,
lactate > 2 mmol.l-1). This threshold for significant
hyperlactataemia is that described by several
investigators [2, 20],
Statistical analysis
All results are expressed as mean (SEM). Baseline data
from the two groups of patients were compared by means
of the Wilcoxon rank sum test, and the paired data
obtained before and after resuscitation were compared with
the Wilcoxon signed rank test. Differences were considered
significant at p < 0.05.
Results
The 23 patients (11 female) were each studied on one
occasion. The mean age was 55 years (range 36-81).
Clinical data, including admission APACHE II scores, are
shown in Table 1, and haemodynamic and oxygen trans¬
port data are detailed in Tables 2 and 3. Baseline measure¬
ments were compared in the two groups. Heart rate,
oxygen delivery and lactate concentrations were signifi¬
cantly higher in group 2.
Following resuscitation, there were significant compar¬
able increases in cardiac index, mixed venous oxygen
saturation and oxygen delivery, and decreased oxygen
extraction, in both groups. There was a significant increase
in MAP (p < 0.05) only in group I. There were no signifi¬
cant changes in mean Vo2 or lactate concentration in either
group, although there were marked individual changes in
Vo2 in some patients in both groups (Figs 1-4). There was
one death during the study period (patient 16). In group 1,
six of 13 patients survived to leave hospital; three out of 10
survived in group 2.
Discussion
It has been recognised for many years that inefficient
utilisation of oxygen is a fundamental defect in septic
shock [8]. This finding has been confirmed recently, and a
similar situation has been described in ARDS [12, 19]. The
pathophysiological abnormality is characterised by depen-
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Table 1. Clinical details: group 1.
Patient Age Sex Primary diagnosis
Vasoactive drug
APACHE II (/rg.kg-1.min-1) Outcome






2. 63 F Pneumonia
Cardiorespiratory arrest
Septic shock
15 DOB 10 S
3. 68 M Faecal peritonitis
ARDS
22 DOB 3 S











6. 54 F Pneumococcal pneumonia
SS, ARDS
10 NOR 0.07 NS
7. 72 M SS 28 DOB 15
NOR 0.28
NS
8. 57 M Perforated diverticulum
ARDS
3 DOB 5 S










11. 65 F SS, ARDS 21 DOB 5 NS
12. 64 F SS (entcrococci), ARF 25 DOB 15 NS
13. 45 M Necrotising fasciitis, SS, ARDS 16 NOR 0.05 S
Clinical details: group 2.
14. 81 F Faecal peritonitis
Respiratory arrest, SS
18 ADR 0.04 NS
15. 59 F Empyema, SS f/f-haemolytic
streptococci)










17. 65 F Necrotising fasciitis
SS
20 DOB 12 S





19. 75 M Faecal peritonitis
Infarcted colon, SS
18 NOR 0.14 NS
20. 58 M Ulcerative colitis
Infarcted small bowel
21 NOR 2 NS















SS, septic shock; ARDS, adult respiratory distress syndrome; ARF, acute renal failure; DOP, dopamine; DOB,
dobutamine; ADR, adrenaline; NOR, noradrenaline; S, survivor; NS, nonsurvivor.
dence of Vo2 on oxygen delivery at levels of delivery which
arc well above the previously described critical level [13].
Oxygen consumption can thus be increased by increasing
delivery, suggesting that tissue perfusion is inadequate. The
mechanisms responsible for this phenomenon are not com¬
pletely clear but probably involve a combination of factors
including maldistribution of tissue blood flow due to
vaso-deregulation [21], an increase in capillary-to-cell diffu¬
sion distance caused by the interstitial oedema associated
with capillary leak [22] and dysfunction of organelles as a
result of the mediators and toxic elements generated and
released in the inflammatory responses of sepsis and
ARDS [23]. In addition, the demand for oxygen may be
increased by fever, shivering or rigors [24], Many investiga-
























Fig. 1. Haemodynamic, oxygen transport and blood lactate
changes during resuscitation in group 1 (initial blood lactate
< 2 mmol.l-1). MAP, mean arterial pressure; CI, cardiac index.
nitial |...Resuscitation..| Subsequent
Fig. 2. Haemodynamic, oxygen transport and blood lactate
changes during resuscitation in group 2 (initial blood lactate
> 2 mmol.l-1). MAP, mean arterial pressure; CI, cardiac index.
Table 2. Haemodynamic variables at baseline and after initial resuscitation. Data are
presented as mean (SEM).
Group 1 Group 2
(Lactate < 2 mmol.l-1) (Lactate > 2 mmol.l-1)
n = 13 n = 10
Baseline Resuscitation Baseline Resuscitation
HR (bcat.min ') 109 (6) 117(5) 128 (5)t 127 (4)
MAP (mmHg) 70(3) 78 (4)* 63 (2) 69(5)
PAOP (mmHg) 13(2) 15 (1) 13(2) 13(1)
CI (l.min~'.m 2) 3.7 (0.4) 5.0 (0.2)* 3.9 (0.4) 4.9 (0.3)*
MAP, mean arterial pressure; HR, heart rate; PAOP, pulmonary artery occlusion
(wedge) pressure; CI, cardiac index; difference from baseline: *p < 0.05; between group
comparison: fp < 0.05.
Table 3. Lactate and oxygen transport variables at baseline and after initial resuscitation. Data arc
presented as mean (SEM).
Group 1 Group 2
(Lactate < 2 mmol.l-1: n = 13) (Lactate > 2 mmol.l-1: n = 10)
Baseline Resuscitation Baseline Resuscitation
Oxygen delivery (ml.min-1.m~2) 484 (36) 730 (44)** 549 (54)f 779 (54)*
Oxygen consumption
(ml.min~'.m~2) 137 (7) 147 (6) 145 (12) 133 (6)
OER (%) 29 (2) 21 (D* 28 (3) 18 (2)*
Svo,
Qs/Qt (%)
69 (2) 77 (1)* 71 (3) 80 (2)*
28 (3) 32 (3) 27 (3) 34 (3)
Lactate (mmol.l ') 1.2 (0.1) 1.1 (0.1) 3.7 (0.4)t 3.7 (0.4)
OER, oxygen extraction ratio; Svo2, mixed venous oxyhaemoglobin saturation; Qs/Qt, pulmonary shunt
fraction; difference from baseline: *p < 0.05, **p < 0.005; between group comparison: f < 0.05.
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Fig. 3. Oxygen delivery and oxygen consumption changes during
resuscitation in individual patients in group 1.
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Fig. 4. Oxygen delivery and oxygen consumption changes during
resuscitation in individual patients in group 2.
tors have confirmed this phenomenon [9-12, 14, 15]. In
some of these studies, it has been suggested that Vo2 rises
significantly only in those individuals with severe tissue
hypoxia, as evidenced by critically elevated blood lactate
concentrations. This is in accordance with the study of
Duff el al. [8] who showed that their septic patients with
the highest lactate values had the lowest Vo2 levels. There
is, however, some disagreement about the value of Iryper-
lactatacmia as a predictor of supply-dependency in sepsis
and ARDS. Vincent el al. [14] have used low-dose dobuta-
minc (5 /tg.kg"'.min-1) to perform a short oxygen flux test
in an attempt to disclose supply dependency of Vo2 in
stable patients with heart failure or sepsis. Dobutamine
resulted in significant increases in CI and oxygen delivery
but Vo2 increased only in those patients with elevated
blood lactate concentrations. Gilbert et al. [25] also
demonstrated increased Vo2 with increased oxygen delivery
in response to infused catecholamines in septic patients
with elevated lactate concentrations. However, previous
work has suggested that the relationship between tissue
hypoxia and hyperlactataemia in shock is much less clear-
cut than may have been suggested [16]. Indeed, there is a
subgroup of patients with the clinical and haemodynamic
features of shock who have normal lactate concentrations.
We undertook the present study in the light of these
controversies and because of the possibility that unrecog¬
nised tissue hypoxia may be present even in the absence of
a critically elevated lactate concentration. We chose to
include unstable patients during initial resuscitation in
contrast to previous investigators who studied relatively
stable, resuscitated patients. We were interested parti¬
cularly in the relationship between oxygen delivery and
consumption in patients without hyperlactataemia over this
initial period. The timespan of study (up to 6 h, mean 3.2)
was similar to that of previous work [15], although it might
be suggested that the overall oxygen demand could change
substantially over the study period described. This is a valid
point, although work with continuous monitoring of mixed
venous oxygen saturation and continuous on-line Vo2
measurement shows that oxygen demand can change
significantly from minute to minute in otherwise apparently
stable patients [24, 26]. Unlike other investigators, we have
rigorously standardised other factors which may affect Vo2
or lactate independently. Patients with hypcrglycaemia and
liver failure were excluded. The contribution of work of
breathing to Vo2 and lactate production has been shown to
be considerable [27], and so all patients in our study were
sedated and their lungs ventilated mechanically.
We allocated our patients to groups on the basis of blood
lactate concentration rather than the type of resuscitation
therapy received. Previous studies have concentrated on the
use of either volume or vasoactive drugs. In both groups,
significant increases of CI and oxygen delivery were
achieved, but in the hypcrlactataemic patients the increase
in blood pressure achieved was not significant despite the
enthusiastic administration of fluids and vasopressors. We
have suggested previously that hypcrlactataemia will be
cleared reliably in the majority of shock patients only when
flow, oxygen delivery and blood pressure arc increased
concurrently [16]. This hypothesis is supported by the
results of those studies in which CI and oxygen delivery
have been increased with no accompanying improvement in
MAP from low levels [3]. In patients who remained hypo¬
tensive despite significantly increased blood flow, lactate
concentrations remained high or increased further, with
100% mortality.
In our study, the inability to improve flow and MAP
together in patients 14, 16, 18, 19 and 20 was associated
with increasing lactate concentrations and death. The
influence on the response to therapy of the underlying
disease process, the inability to eradicate sepsis and pre¬
existing severe cardiorespiratory dysfunction have all been
suggested as potential reasons for the poor outcome in
these patients.
Examination of the relationship between oxygen delivery
and consumption in individual patients reveals another
tantalising discrepancy. The pooling of data for statistical
analysis obscures individual idiosyncratic responses of Vo2
to oxygen delivery. In particular, Vo2 increased by between
17 and 35% in six patients with normal lactate concentra¬
tions. There were no increases in lactate, and this suggests
that the increase in Vo2 was not demand-led by a catecho-
lamine-induccd rise in metabolism. It is possible that unre¬
cognised tissue hypoxia is present in critically ill patients
even in the absence of critically elevated blood lactate.
Since the production of hypcrlactataemia in experimental
models often requires combinations of severe anaemia,
hypoxacmia, reduced cardiac output and profound hypo¬
tension, the finding of elevated lactate concentrations in
clinical situations is likely to indicate an advanced degree of
tissue hypoxia. The finding of normal lactate concentra¬
tions in patients with acute cardiorespiratory failure due to
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sepsis and ARDS may not preclude the presence of a tissue
oxygen debt. As blood lactate appears to be a fairly
insensitive marker of tissue hypoxia, we are currently re¬
evaluating excess lactate, a potentially more sensitive
guide [1]. Justifiable concerns on the effects of vasoconstric¬
tors on regional blood flow and hence tissue oxygenation
have been voiced, and recent work has documented the
unpredictability of splanchnic blood flow responses, high¬
lighting the need to withdraw vasoconstrictors as early as
possible [28].
Basic therapy in these patients should therefore be
directed to improving oxygen delivery and blood pressure
concurrently, whilst attempting to correct or remove the
underlying cause. The levels of oxygen delivery and MAP
required in any individual situation remain very difficult to
determine although a randomised study has shown an
improvement in survival when supranormal oxygen deli¬
very is achieved [29]. It appears clear that the finding of a
normal blood lactate concentration should not encourage
complacency, since this docs not exclude supply depen¬
dency. Further research into the effects of independent
factors such as sedation, paralysis and mechanical ventila¬
tion on the relationship between oxygen delivery and
consumption is required to further unravel the complex
pathophysiology.
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Erratum Slip: Thesis submitted for the Degree of Doctor of Medicine
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Cardiorespiratory and Metabolic Studies in Shock and Critical Illness
1. In all of the clinical studies appropriate Local Medical Ethics Committee approval
was sought and obtained.
2. In the animal studies a Home Office Project Licence was obtained for the work
performed. In addition, Dr Allan D. Cumming and myself both obtained Personal
Licences for Procedures on Living Animals. Regular Home Office visits took place
over the course of the experiments.
3. Page 61: the normal range for lactate on the analyser in ICU at the University
Hospital of South Manchester is 0.6 to 1.2 mmol/l, and that in Edinburgh is 0.4 to 1.2
mmol/l.
4 Page 74: It has been demonstrated that B-agonists, in particular adrenaline, can
increase blood lactate concentrations by a direct metabolic action. The exact nature
of this effect is unclear but probably involves an effect on lactate dehydrogenase,
NADH or on prevailing glucose concentrations. Thus, it should be noted that an
increase in blood lactate concentration in the presence of increased circulating
concentrations of adrenaline or noradrenaline (endogenous or exogenous) may be
due to a metabolic rather than a hypoxic mechanism.
5. Page 103: Sedation level medians: Time zero 2.5, 30 mins 5, 1 hour 5.25,
3 hours 5.25, 6 hours 5.25.
6. Page 129: Randomisation of subjects in the Protocol Study was by means of
pre-prepared envelopes. These were supplied from the manufacturer of the
aprotinin, along with the placebo bottles of vehicle. The investigators were blinded to
the contents of the vials being administered, the bottle to be used being determined
by the number obtained from the envelope.
7. Page 155: It should be made clear that some results from the patients used for
this study had already been reported in previous chapters. This study should be
regarded as a sub-group analysis of the earlier studies.
8. Page 156: Lactate measurement in relation to DO2A/O2 changes: it was hoped
that lactate or excess lactate would prove a marker for tissue hypoxia as evidenced
by delivery dependence of VO2 on DO2. In Chapter 4 it was shown that this is not
the case for lactate alone. In Chapter 8 a small number of patients in whom excess
lactate was calculated were examined to see if this relationship were any more
predictive. In these individuals elevated excess lactate did not have any clear
relationship to delivery dependent VC>2- In this small group no increased sensitivity
of excess lactate concentrations over lactate alone could be demonstrated.
Graham R. Nimmo, Glasgow February 1996.
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Hemodynamic, renal, and hormonal actions of
aprotinin in an ovine model of septic shock
ALLAN D. CUMMING, BSc, MB ChB, MRCP, MD; GRAHAM R. NIMMO, MB ChB, MRCP
Background and Methods: Previous studies
documentedactivationofprotease enzymes such
as the plasma kallikrein-kinin system in endo-
toxemia and sepsis, both in experimental ani¬
mals and inpatients.We investigated the actions
of aprotinin (a protease inhibitor that binds to
plasma kallikrein) on systemic hemodynamics
and renal function, in an ovine model of septic
shock. Aprotinin was infused intravenously in
high dosage (1 x 106 kallikrein inhibitor units
[KIU] loading, 200,000 KlU/hr), commencing 30
mins after surgical induction of sepsis (cecal
ligation and puncture).
Results: In the control group (n = 6), there
were significant decreases with time in BP and
systemic vascular resistance, an increase in pul¬
monary artery pressure, reductions in creati¬
nine clearance and sodium excretion, and an
increase in plasma renin activity. In aprotinin-
treated animals (n = 6), none of these changes
occurred. Therewere significantbetween-group
differences (controls vs. treatment) for mean
arterial pressure, pulmonary artery pressure,
and plasma renin activity.
Conclusions: In this large animal model of
septic shock, which reproduces the important
features of clinical sepsis, treatment with apro¬
tinin after the initiation of sepsis appears bene¬
ficial in relation to systemic hemodynamics, re¬
nal function, andhormonal stimulation, with no
evidence ofadverse effects. (Crit CareMed 1992;
20:1134-1139)
Key Words: septic shock; aprotinin; renal
function; acute renal failure; kallikrein; kinin;
renin; protease inhibitors; endotoxins; hemo¬
dynamics
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Among the mediator systems known to be activated
in endotoxemia and sepsis are a number of protease
enzymes, activation ofwhich is known to be associated
with important biological effects (1). For example,
there is an association between endotoxemia and sep¬
sis, and activation of the plasma kallikrein-kinin sys¬
tem. In septic shock, Colman andWong (1) and others
(2, 3) described reduced plasma concentrations of
plasma prekallikrein, increased "kallikrein-like
activity," and decreased kallikrein-inhibitory activity,
probably as a result ofendotoxin-induced activation of
the Hageman factor. Kinins could mediate several
important features ofseptic shock; inparticular, kinins
are potent systemic vasodilator peptides, but constrict
the pulmonary circulation in most species (4). They
cause increased capillary permeability and stimulate
release ofarachidonic acid from cellmembranes, lead¬
ing to increased prostaglandin and thromboxane syn¬
thesis (4). However, it is uncertain whether the re¬
duced plasma prekallikrein in sepsis is wholly due to
kallikrein-kinin system activation, or, in part, reflects
reduced prekallikrein synthesis (5). It is also unclear
whetherkallikrein-kinin activation is directly involved
in the pathogenesis of septic shock. Previous studies
(6-8) of the response to experimental endotoxin infu¬
sion failed to support this hypothesis, althoughbecause
ofthe lack ofpotentand specific kallikrein-kinin antag¬
onists, direct evidence is lacking. Aprotinin (Trasylol,
Bayer,Wuppertal, FRG) is a serine protease inhibitor
with some kallikrein-inhibitory activity (9). The affin¬
ityofaprotinin for kallikrein is, however, less than that
affinity for some other proteases (9), and previous
studies (10) of this agent used doses of aprotinin that
are now recognized to inhibit plasma kallikrein poorly,
ifat all. We (11) studied the effect ofaprotinin, at a dose
known to achieve maximal plasma kallikrein inhibi¬
tion, in a large animal (ovine) model of intraperitoneal
and systemic sepsis that reproducesmanyofthe impor¬
tant features of clinical septic shock.
Sepsis and acute renal failure are frequently associ¬
ated, and <50% ofcases ofacute renal failure are caused
by septicemia (12). The pathogenesis ofthis syndrome
is poorly understood, but recent studies (13, 14) sug¬
gested that the systemic arterial vasodilation that
occurs in early sepsis may be the principal stimulus
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causing the kidney to retain solutes andwater, leading
to functional renal failure associated with reduced
glomerular filtration and sodium retention. Our own
studies (11, 14) suggested that this renal response
may reflect renin-angiotensinactivation, togetherwith
reduced activity of the intrarenal tissue kallikrein-
kinin system, which normally acts to preserve renal
function during hypoperfusion. Therefore, it was im¬
portant to discoverwhetheraprotinin treatment,which
could further reduce renal kallikrein activity, ad¬
versely affected renal function in intraperitoneal and
systemic sepsis. The overall hypothesis of the study
was that aprotinin therapy would prevent or amelio¬
rate hypotension and systemic vasodilation in sepsis,
and that these beneficial actions on the systemic circu¬
lation would outweigh any effect of local renal tissue
kallikrein inhibition.
MATERIALS AND METHODS
This study was approved under a project license by
the Home Office, and conformed to UK Government
regulations regarding the care of experimental ani¬
mals. The technique ofsurgical induction ofperitonitis
was modified from that ofWichterman et al. (15), as
previously described (11, 14). Twelve healthy sheep,
aged 12 to 18 months and weighing 40 to 50 kg,
required general anesthesia and cannulation of the
common carotid artery, and the pulmonary artery via
the external jugular vein with a triple-lumen pulmo¬
nary artery flotation catheter. The bladder was cathe-
terized per urethra. After recovery from anesthesia,
animals were intravenously volume-loadedwith 4 L of
lactated Ringer's solution over 24 hrs. After control
hemodynamicmeasurements andblood andurine sam¬
pling, the animals underwent a second general anes¬
thetic; peritonitis was induced by cecal ligation and
puncture. Postoperatively, all animals received 50 mg
pethidine iv, and were continued thereafter on an iv
infusion of pethidine (50 mg/6 hrs). Intravenous infu¬
sion oflactatedRinger's solution (150mL/hr) continued
for the duration of the experiment, and the rate of
additional fluid administration was adjusted to main¬
tain pulmonary artery occlusion pressure (PAOP) at
baseline values. Hemodynamic measurements were
made hourly, and blood and urine collections were
made four hourly after induction of sepsis.
Animals were supervised continuously during the
study. Any animal seen to be restless, agitated, or
showing other evidence of discomfort or distress, de¬
spite pethidine infusion, was killed immediately by iv
injection ofpentobarbital. Animals surviving through
12 hrs were killed as above; an open renal biopsy was
taken at the time of death.
Hemodynamic variables measured were: mean
arterial pressure, central venous pressure, mean pul¬
monary artery pressure, PAOP, and thermodilution
cardiac output. Cardiac index and systemic vascular
resistance index were derived by standard formulas.
In the treatmentgroup (n = 6), aprotininwas infused
intravenously, commencing 30 mins after the comple¬
tion ofsurgical induction ofperitonitis. A loading dose
of 1 x 106 kallikrein inhibitor units was given, followed
by 200,000 kallikrein inhibitor units hourly through¬
out the study. In control animals (n = 6), the saline
vehicle alone was infused at the same rate.
Blood samples were taken from the aortic cannula.
Plasma concentrations of creatinine, sodium, and os¬
molality values were measured by standard autoana-
lyzer techniques. Plasma renin activity wasmeasured
by radioimmunoassay. Urine volume was recorded.
Urine kallikrein concentration was measured by the
method of Amundsen et al (16). The assay measured
the urine activity against the chromogenic substrate S-
2266 (H-D-Val-Leu-Arg-pNA, AB Kabi Diagnostica,
Stockholm, Sweden), for which urine kallikrein is
highly specific. An aprotinin buffer was added to a
sample blank for each sample. A total of500 pL ofbuffer
was added to 400 pL urine and incubated at 37°C for 5
mins; 100 pL ofS-2266 was added and incubated for 30
mins. The reaction was stopped by the addition of 100
pL 50% acetic acid. The absorbance ofeach sample was
read against its blank at 405 nm. Results were ex¬
pressed as nkat/L, 1 nkat being the amount ofglandu¬
lar kallikrein that cleaves 0.05 pmol of substrate/min
under the given conditions. This value was calculated
as nkat/L = 146 x absorbance. Interassay coefficient of
variationwas 8.2%, and intra-assay coefficient ofvari¬
ation was 4.5%.
Kidney tissue was examined by light microscopy,
using standard methods (17). For the purposes of
analysis, for each variable, the values included were
those values at baseline (presepsis) and observations
made at 4 and 8 hrs postoperatively and at the termi¬
nation of the study (12 hrs postoperatively). Two-way
analysis ofvariance for repeatedmeasures was used to
assess the significance of changes with time for each
variable in the treatment and the control groups, and
the significance of between-group (aprotinin treat¬
ment) effects.All statistical procedureswereperformed
using the SPSS-PC statistical package on an IBM 55SX
computer. Values for p < .05 were considered signifi¬
cant. Results are shown as mean ± sem.
RESULTS
As in the studies (11, 14) performed to establish and
validate this experimental model, animals developed a
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polymicrobial peritonitis and bacteremia. Organisms
grown on blood culture included: Escherichia coli,
Serratia, Enterobacter, Pseudomonas, andBacteroides
species. Autopsy showed generalized purulent perito¬
nitis and an inflammatory mass in the right lower
quadrant. PAOP wasmaintained in the range of 10 to
20 mm Hg during the study (mean for controls 14.1 ±
1.6mm Hg; aprotinin group 13.4 ± 2.2 mm Hg,p > .05).
There was no clinically important difference in the
amount offluid given in the two groups (controls 4.3U
12 hrs; aprotinin group 3.9 L/12 hrs,/? > .05).
Results for systemic hemodynamics and renal func¬
tion at baseline and during the study are shown in
Figures 1 and 2. In the control animals (n = 6), there
were clinically important decreases with time in BP
(Figure 1A) and in systemic vascular resistance index
(Figure 16), an early increase in pulmonary artery
pressure (Figure 1C), and reductions in creatinine
clearance (Figure 2A) and fractional sodium excretion
(Figure 26). None of these variables altered signifi¬
cantly in the aprotinin-treated animals (n = 6). Cardiac
index and urine volume did not change significantly
with time in either group. There was a statistically
significant effect of aprotinin treatment in a two-way
analysis of variance for the variables, mean arterial
pressure (p < .05), and pulmonary artery pressure (p <
.01).
In the control group, urine kallikrein excretion
tended to decrease during sepsis, and there was a
significant increasewith time in plasma renin activity;
these changes were noted in prior studies (14) of this
model. Aprotinin treatment was associatedwith lower
urine kallikrein excretion during sepsis, although the
difference was not statistically significant. Plasma
renin activity did not increase significantly in the
aprotinin-treatedgroup, andplasma renin activitywas
significantly lower in this group at the conclusion ofthe
study (Table 1).
No consistent or significant changes in renal histol¬
ogy were noted in treatment or control groups, in
keepingwith previous studies. The changes that were
observed included: mild tubular dilation, occasional
foci of tubular regeneration, and patchy interstitial
infiltrate of mononuclear cells. These changes were
evenly distributed between treatment and control
groups.
DISCUSSION
Studies of pharmacologic intervention in clinical
septic shock are complicated by a lack of presepsis
baseline parameters, problems in assessing the stage
and severity of the shock syndrome, and the multiple
treatments required. The experimentalmodel ofsepsis
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Figure 1. A) Mean arterial pressure (MAP) in control and
aprotinin-treated groups; B) systemic vascular resistance index
(SVRI) in control and aprotinin-treated groups; C) pulmonary
artery (PA) pressure in control and aprotinin-treated groups. All
values are mean ± sem. NS, nonsignificant. Note the decrease in
MAP and SVRI at 12 hrs in the control group only, and the
increase in PA pressure at 4 hrs in control group only. Significance
values refer to change over time for control and treatment groups.
utilized in this study overcomes these difficulties and
differs from most other experimental models of sepsis
and endotoxemia in that it reproduces the state of
volume-loaded, hyperdynamic, and vasodilated septic
shock typically seen in clinical practice (18). The use of
an ovine model allows detailed hemodynamicmonitor¬
ing and provides sufficient blood and urine sample size
to permit assessment of renal function and vasoactive
hormone systems.
The initial events that trigger systemic vasodilation
in sepsis are unclear. However, bacterial endotoxins
are potent activators of the plasma "contact systems,"
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Figure 2. A) Creatinine clearance in control and aprotinin-
treated groups; B) fractional sodium excretion in control and
aprotinin-treated groups. All values are mean ± sem. NS,
nonsignificant. Note the decrease in creatinine clearance and
fractional sodium excretion at 12 hrs in the control group only.
Significance values refer to change over time for control and
treatment groups.
through the Hageman factor; these contact systems
include the plasmakallikrein-kinin system (5). Plasma
kallikrein is a serine protease, generated from an
inactive precursor (prekallikrein) by the action of a
Hageman factor fragment—prekallikrein activator; it
acts primarily on high-molecular weight kininogen to
form bradykinin (5). It is known that the plasma
kallikrein-kinin system is activated in septic shock,
andkinins couldmediate the systemicvasodilationand
increased capillary permeability seen in sepsis (4). We
were unable to measure plasma prekallikrein or
plasma kallikrein activity in this experimental model
because of the very low activity of sheep kallikrein
against the chromogenic substrate, S2302, which was
used tomeasure plasmaprekallikrein/kallikreinactiv¬
ity (19). However, we (3) previously measured plasma
prekallikrein in nine patients with septic shock and
acute renal failure. All patients had values below the
normal range, suggesting activation of the plasma
kallikrein-kinin system, and the survivors showed a
return to normal during recovery (3). Therefore,
Table 1. Urine kallikrein excretion rate and plasma renin
activity in control and aprotinin-treated groups (mean ± sem)
Control Aprotinin
Baseline Sepsis Baseline Sepsis
Urine kallikrein (nkat x 10"3 /min)
2.67 ± 1.40 1.67 ± 0.91 1.76 ± 1.00 0.70 ± 0.49
Plasma renin activity
(ng/mL/hr)
0.21 ± 0.01 6.34 ± 0.92° 0.20 ± 0.01 1.78 ± 0.696
(ng/L/sec)
0.06 ± 0.003 1.76 ± 0.25° 0.06 ± 0.003 0.49 ± 0.196
°p < .05 from baseline; bp < .05 from controls.
studies ofthe effect ofprotease inhibition in the exper¬
imental model of sepsis were of interest.
Aprotinin is a polypeptide protease inhibitor that is
derived from bovine lung. It is active against a number
of serine proteases, including trypsin, chymotrypsin,
plasmin, and plasma and tissue kallikreins. Some
studies (10) showed benefit from its use in acute pan¬
creatitis, and aprotinin is now widely used to inhibit
blood loss during cardiac surgery. Our results suggest
that the hypotension and systemicvasodilation in early
septic shock are prevented by aprotinin. This finding
could be due to inhibition of any of the above protease
enzymes, and our results do not allow discrimination
between them. It is also possible that inhibition of
neutrophil-derived proteases could be involved (20).
Plasma kallikrein is known to be generated in septic
shock and to be associated with appropriate biological
effects. Experimental iv injection of kallikrein pro¬
duces a picture that resembles septic shock, with
hypotension and increased capillary permeability (21).
It is possible that the beneficial effects seen in our
studies reflect, at least in part, inhibition ofendotoxin-
induced kallikrein activity. Studies (22) using more
selective inhibitors ofthe plasma kallikrein-kinin sys¬
tem, such as the recently synthesized kinin antago¬
nists, are of interest in this respect. Recent findings
using these agents in small animal models ofendotox-
emia tend to support a role of kinin generation in
endotoxemic shock.
While aprotinin has been suggested to be useful in a
wide range of disease states, to date it has not become
routine therapy in any clinical situation. This finding
probably is due, at least in part, to the use of inappro¬
priately low dosages in previous studies (9, 10), such as
the trials in acute pancreatitis. The dose regimes used
in these studies were calculated on the basis of the
affinity of aprotinin for glandular kallikrein (Ki 9 x
10 n), but the affinityofaprotinin for plasmakallikrein
is considerably lower (Ki 3 x 10"®) (9). It is likely that in
previous studies, adequate inhibition of the plasma
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kallikrein-kinin system was not achieved (10). Recent
work (23) demonstrated the feasibility and safety of
using doses ofaprotinin on the order of 20-fold higher
than dosages used previously, whichwill achievemax¬
imal plasma kallikrein inhibition (10). We used such a
high dose in these studies, with apparent efficacy and
no evidence of adverse effects.
As described above, the affinity of aprotinin for
glandular (including renal) kallikrein is greater than
for plasma kallikrein. In our studies, urine kallikrein
excretion, which is thought to reflect activity of the
renal kallikrein-kinin system, was lowest while the
animalswere receiving aprotinin. It isbelieved that the
renal kallikrein-kinin system, which is anatomically
and functionally distinct from the plasma system,
promotes renal vasodilation and increased sodium
excretion (20). Therefore, it is theoretically possible
that aprotinin could adversely affect renal function
during sepsis. However, we found evidenceofimproved
renal function in the aprotinin group in our study. It
has been suggested that the renal vasodilator function
of the renal kallikrein-kinin system only becomes im¬
portant in the face of reduced renal perfusion and/or
activation of the renin-angiotensin system, in a man¬
ner analogous to the role of renal prostaglandins
(21, 24). Kinins are a potent stimulus to the release of
renal vasodilator prostaglandins (24). It seems likely
that in our study, any potential adverse effect of renal
kallikrein inhibition was outweighed by the improve¬
ment in systemic hemodynamics, and therefore, in
renal perfusion and in the reduced plasma renin activ¬
ity in the treatment group.
The increase in plasma renin activity in controls,
which is a typical feature ofexperimental septic shock
(14), was prevented by aprotinin treatment. This in¬
crease probably reflects the maintained systemicBP in
the treatment group. However, it should be noted that
-kallikrein may be an important activator ofprorenin.
Kinins are known to stimulate renin release, and
aprotinin has been shown to reduce plasma renin
activity in normalman (25). It has been suggested (26)
-that renin and angiotensin II are important in the
■pathogenesis ofacute renal failure, and angiotensin II
-potentiates sympatheticnervous systemactivity,which
may also be important in the sepsis/acute renal failure
-syndrome. Prevention of renin-angiotensin stimula-
ionmay represent an additional beneficial outcome of
—iprotinin treatment in sepsis.
The apparent effect of aprotinin in preventing the
ncrease in pulmonary artery pressure, maximal at 4
irs postoperatively, is of some interest. It has been
shown (8) that the increased pulmonary lymph flow, at
■2 to 6 hrs after administration ofendotoxin to sheep, is
•educed by protease inhibition. It seems likely that
changes in pulmonary hemodynamics and permeabil¬
ity during sepsis reflect primarily cellular mecha¬
nisms, such as stimulation of neutrophils by comple¬
ment activation (27). Our results suggest that
pulmonary hypertensionmay reflect activation ofpro¬
tease enzymes against the active aprotinin. These
enzymes could include neutrophil enzymes, although
the affinity of aprotinin for neutrophil elastase and
cathepsin G is relatively low (9). Tissue kallikrein
recently was detected in the cytoplasm of human
neutrophils (28). It is known that kinins have differing
effects in various vascular beds, and cause pulmonary
vasoconstriction in most species (4). This effect of
aprotinin could have a beneficial effect on the course of
septic shock, since itwould be predicted to reduce lung
water and improve right ventricular performance.
Further studies are in progress toestablish the effect
ofaprotinin in established hypotensive septic shock. It
seems clear that more selective and effective protease
inhibitors will become available for assessment in the
future, although it is possible that the relatively broad
inhibitory spectrum of aprotinin may prove to be ad¬
vantageous in the context of sepsis.
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Sampling site for blood lactate
estimation: arterial or mixed venous?
Clinical investigation
G R NIMMO, I R ARMSTRONG, I S GRANT
Abstract
It has been suggested that in patients with severe
pulmonary pathology arterial lactate concentrations
exceed mixed venous levels as a result of lactate
production in the diseased lung.1 This study was
performed to examine the relationship between arterial
and mixed venous (pulmonary arterial) whole blood
lactate levels in critically ill patients. We studied 22
consecutive admissions to a general intensive care unit on
one occasion each. All patients required systemic and
pulmonary arterial catheterisation for the management
of critical illness with lung involvement. Simultaneous
arterial and mixed venous samples were drawn and
analysed immediately on an automated analyser.
There was no significant difference between lactate
levels in arterial (2.1 ± 0.3 mmol/1) and mixed venous (2.0
± 0.32 mmol/1) blood. The bias between arterial and
mixed venous values was 0.09 and the limits of
agreement (±2SD) were ±0.38 mmol/1. The degree of
correlation was excellent (r = 0.99).
There is no clinically important difference between
mixed venous and arterial lactate. The arterial site for
sampling blood to measure lactate remains relevant and
practical.
Introduction
Blood lactate measurements have been used widely in the
management and investigation of critical illness.2"4 Most
clinicians and investigators have measured arterial lactate
levels although there has been debate over the relative merits
of plasma versus whole blood samples.5 It has been shown
that patients suffering from lung cancer and pulmonary
tuberculosis produce lactate in locally diseased areas of lung
and that occasional patients have a significantly higher
arterial lactate on the basis of this.1 However, some
investigators have used mixed venous samples preferentially
to assess lactate levels in critically ill patients.6 Despite one
previous study, the choice of sampling site for blood lactate
measurement has not been satisfactorily resolved.7 We
—performed this study in an attempt to answer this question.
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Twenty-two patients, mean age 60 years, range 39-80, were
studied. All patients were mechanically ventilated, had
arterial and pulmonary artery catheters in situ for standard
clinical monitoring and were admitted consecutively into the
study. Underlying diagnoses were: septic shock (n = 16),
ARDS (n = 18), severe acute left ventricular failure (n = 4)
and pneumonia (n = 2). Some patients fell into two
diagnostic groups. Arterial and mixed venous samples were
drawn simultaneously into heparinised syringes and
immediately analysed using an automated analyser (Clandon
Scientific, Farnborough, UK). Statistical analysis was by the
graphical method of Bland and Altman8 and standard
correlation coefficient. The technique of Bland and Altman
requires the plotting of information derived from pairs of
data points, the mean of the two values being plotted against
their difference. The results are expressed as bias (mean
difference) and limits of agreement (mean difference ± 2
SD). The study was approved by the local ethics committee.
Results
The arterial lactate levels were 2.1+ 0.31 mmol/1 and the
mixed venous 2.0 ± 0.32 mmol expressed as mean ± SEM.
Arterial blood lactate
Figure 1 Relationship between arterial and mixed
venous lactate concentrations (r = 0.99).
8
ULTRASOUND-GUIDED POSITIONING OF TEMPORARY PACING
If the catheter is introduced via the femoral artery the
balloon can be detected as soon as it enters the inferior vena
cava. If it is introduced via the superior vena cava, it cannot
be seen until it has entered the right atrium. Once the tip of
the pacing catheter has been located, an attempt can be made
to place it against the wall. As the present results show, this
was successful in almost all cases, as electrocardiography
showed effective stimulation at a good or at least acceptable
stimulation threshold. Minor corrections of the catheter
position were nevertheless performed in some of these cases
to achieve an even better stimulation threshold. Subsequent
X-ray follow-up revealed that the tip of the catheter need not
necessarily lie in the apex of the right ventricle for
satisfactory stimulation results.
Problems in insertion occurred only when the balloon was
overfilled with contrast medium and burst. Because
Echovist® was developed for intravascular administration,
serious toxic side-effects or micro-emboli are improbable in
such an event. Furthermore, no such effects have been
observed on intravascular administration of much larger
amounts and higher concentrations.8
Ultrasound-guided positioning of a temporary pacing
catheter was thus successful in almost 90% of cases. This
readily available and safe procedure can be used as an
alternative when a pacing catheter cannot be positioned
under fluoroscopic control.
As an additional study in three patients confirmed,
catheterisation of the pulmonary artery is also made easier
with the above-described method. This applies in particular
to intensive care patients in whom flow-directed positioning
of such a catheter is unsuccessful and in whom radiographic
monitoring is difficult, for example because of mechanical
ventilation.
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; degree of correlation was excellent (r = 0.99) as
icted in Figure 1. As shown in Figure 2 the bias was 0.09
limits of agreement ± 0.38 (-0.47 to 0.29) which are well
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-ate difference versus mean concentration.
:ussion
hester and colleagues demonstrated the potential for
ased lung to produce lactate.' They concluded that this
a reflection of increased lung metabolism and
:ulated that the degree of arteriovenous difference in
ite might reflect the extent of diseased lung. We have
i unable to demonstrate any difference between arterial
mixed venous lactate in a group of critically ill patients
much higher mean lactate levels than in the Rochester
y and with quite different pathology,
ven that there is no agreed threshold level for
erlactaemia and that there is a persisting lack of
ensus as to which sampling site is more appropriate, our
ings would tend to confirm that there is no clinically
ificant difference between the two sites. Our findings are
eeping with those of Weil and colleauges who
onstrated apparently close agreement between arterial
central venous lactate concentrations in 12 patients
ied prospectively and between mixed venous
9
(pulmonary arterial) lactate concentrations in 23 patients
analysed retrospectively.7 In our study, however, only one
paired sample was analysed from each consecutively
enrolled patient, removing the possibility of bias. It would
appear from these results that arterial lactate is at least as
useful as mixed venous in these patients. It is also of interest
to note that those investigators who have suggested levels of
lactate which might be deemed significant have used arterial
measurements.2"*
Since serial measurements are of greater utility in the
monitoring of shock than single measurements9'10 it seems
prudent to choose one site and repeat measurements from it.
However, arterial sampling for blood lactate determination
remains clinically relevant and practical.
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Evaluation of alpha-l-antichymotrypsii
as an indicator for infections in multi-
traumatised patients
R FUSSLE, J BISCOPING, D ZEILER, G MICHAELIS, A SCHURHOLZ, A SZIEGOLEIT
Summary
Serum concentrations of alpha-l-antichymotrypsin
(ACT) and C-reactive protein (CRP) were determined to
evaluate the predictive value of these acute phase
reactants with regard to infective complications in
polytraumatised patients. Because trauma itself
stimulates the synthesis of both proteins, a series of
patients with well-defined injuries was used as additional
controls. Therefore, in addition to polytraumatised
patients with and without infections, both variables were
measured in the serum of patients having had extensive
orthopaedic surgery. Serum concentrations of both
proteins increased within 24-48 hrs after accidental or
iatrogenic tissue damage. In correlation with the severity
of their injuries, multi-traumatised patients reached
higher serum concentrations than patients with hip joint
operations. However, in polytraumatised patients
suffering from infections, concentrations of ACT
increased to maximum values of 1.3-1.6 g/1. Often the
increase of ACT began before the episode of infection
became clinically evident. However, whereas CRP values
often varied widely from day to day in the same
individual, ACT values above 1.2 g/1 reliably indicated an
infectious complication in poiytraumatised patients. The
results suggest that ACT could be used as an aid to the
diagnosis of infective complications in multi-traumatised
patients.
Introduction
Various inflammatory stimuli result in the initiation of the
so-called 'acute phase response'.1'2 In addition to infections,
other stimuli include physical trauma, bums, intoxications or
neoplasms.3"5 One of the basic features of the acute phase
reaction is the increase in certain serum proteins6'8
collectively denominated as acute phase proteins (APP).
Most of these proteins are synthesised by hepatocytes,
stimulated by various cytokines ie interleukin-1, interleukin-
6 or tumour necrosis factor.910 Serum levels of some APPs
are furthermore influenced by steroid therapy, oestrogens,
impaired renal function and phenotypic variants.6,11 One of
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the most widely studied APPs is C-reactive protein (CRP)
Hitherto, little attention has been paid to another A
alpha-l-antichymotrypsin (ACT), a serum glycoprotein ■
a molecular weight of about 59 kDa.16 In healthy individ-
its serum concentration ranges from 0.2 to 0.6 g/1.'
synthesis by hepatocytes is stimulated by sev
cytokines.17-18 The main function of ACT is to inf
chymotrypsin-like proteases.19 Furthermore, ACT is abH
modulate the immune response by inhibition of the nat
cytotoxic activity of killer lymphocytes20 and enhancer
of the antibody response.21
In burned patients, and post-abdominal and heart surg-
serum concentrations of ACT markedly increased withii
hrs of the tissue injury.4'5,22 However, as yet, li
information exists about non-infectious and infect
influences in multi-traumatised patients, in which high le
of ACT may be induced by severe tissue injuries. There
CRP and ACT were measured in the sera of mi
traumatised patients with and without infections in ordt-
define those concentrations that differentiate between ti
injuries and infectious complications. To quantify
reaction strictly due to tissue injury, a group of orthopa=
patients was included in this study for comparison.
Methods
Patients
The study comprised 42 multi-traumatised patients adm
to the surgical intensive care unit of the Universit
Giessen requiring mechanical ventilation for at least
days. Patients suffering from hepatic injury or hej
failure during their stay on the intensive care unit 1
excluded from the study. To study the influence of ti
injuries on ACT serum concentrations a group o
orthopaedic patients with uncomplicated recovery aftei
joint operations (endoprosthetical hip joint replacen
duration of operation 75-325 minutes) was include
controls. Patient characteristics and clinical data are giw
Table 1.
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Acid-base responses to high-volume haemofiltration in the critically ill
G. R. Nimmo1, S. J. Mackenzie1, S. Walker2, M. Nicol2 and I. S. Grant1
'Intensive Therapy Unit, Western General Hospital, and 2Department ofClinical Biochemistry, Royal Infirmary and
University of Edinburgh, Edinburgh, UK
Abstract. We have studied the acid-base and cardiore¬
spiratory effects of intermittent pumped high-volume
venovenous haemofiltration (HVHF) using replace¬
ment fluid containing lactate as the source of bicarbon¬
ate in critically ill patients. We demonstrated significant
hyperlactataemia throughout the procedure, but there
was no deterioration in acid-base status, haemo-
dynamics, or oxygen delivery. These observations sug¬
gest that the worsening of acidosis and the hypotension
that have been described with this technique [1] can be
avoided by appropriate monitoring and resuscitation
prior to haemofiltration, and may be due to unrecog¬
nized inadequacies in the oxygen transport system.
Key words: haemofiltration; acute renal failure; acid-
base disturbance
Introduction
The last decade has witnessed major changes in the
use of renal replacement therapy (RRT), particularly
in unstable and severely ill patients [2]. This has been
in great part due to the improved haemodynamic
stability which we and others have demonstrated with
haemofiltration as opposed to haemodialysis [3,4].
Since the introduction of continuous spontaneous
haemofiitration by Kramer there has been a rapid
adoption of haemofiltration techniques in intensive-
care units and acute nephrology wards [5]. Refinements
and advances in the form of continuous (spontaneous
or pumped) haemofiltration and intermittent machine-
pumped HVHF have logically followed [6,7], The
choice of treatment modality will be influenced by
factors such as the patient's clinical state and under¬
lying diagnosis, and local differences such as the type
of unit and the availability of staff trained in the use
of different types of RRT. We use HVHF with lactate-
containing replacement fluid for our patients with
acute renal failure (ARF) as part of multiple-organ
failure. It has been suggested that these patients with
Correspondence and offprint requests to: Dr I. S. Grant, Intensive
Therapy Unit, Western Generai Hospital, Crewe Road, Edinburgh
EH42XU
cardiovascular instability may not tolerate lactate
administration because of failure to metabolize lactate
[1], and may suffer haemodynamic deterioration as
a result.
We investigated the acid-base and cardiorespiratory
effects of treatment with HVHF and lactate-containing
replacement fluid in 12 critically ill patients with
multiple-organ failure.
Subjects and methods
Twelve patients with established multiple-organ failure
undergoing intermittent pump-driven HVHF were each
studied on one occasion. Clinical details of the patients,
including admission Apache II scores,, are given in Table 1.
Haemofiltration was undertaken as treatment for acute renal
failure (ARF) in 11 patients and in an attempt to improve
gas exchange in one patient with severe adult respiratory
distress syndrome (ARDS). All patients were mechanically
ventilated and had femoral arterial lines and thermodilution
pulmonary artery flotation catheters for standard clinical
monitoring. Cardiorespiratory status was optimized before
haemofiltration in all patients. Fluids and vasoactive drugs
were titrated to achieve previously described therapeutic
goals [8], (cardiac index:CI>4.5 1/min/m2; oxygen
delivery:D02 > 600 ml/min/m2; mean arterial blood
pressure:MAP>70 mmHg). Eleven patients required vasoac¬
tive drugs, and in nine of these a combination of catecholam¬
ines (adrenaline or dobutamine with noradrenaline) was
necessary to reverse hypotension and maintain high cardiac
output. The study period was from just before haemofiltra¬
tion until 1 h after its finish. During this period there were
no changes to sedation or ventilator settings, or increases in
catecholamine infusion rates, although three patients
required reductions in these because of increasing blood
pressure during HVHF. Extra fluid administration by bolus
was not required in any patient.
Haemofiltration was performed using a Gambro AK 10
system with a FH 77 hollow-fibre filter, and vascular access
was through a double-lumen catheter in an internal jugular
or subclavian vein. A blood flow rate of 200-300 ml/min
and transmembrane pressure of 300-400 mmHg were used
to achieve an initial filtration rate of 100-120 ml/min
although the filtration rate tended to decline as the treatment
progressed.
Anticoagulation was with heparin administered into the
afferent limb of the circuit to achieve an activated clotting
time (ACT) 30 s above baseline, or over 180 s. The replace-
© 1993 European Dialysis and Transplant Association-European Renal Association
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Table 1. Clinical data
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Sex Age Diagnosis APACHE II Outcome
1 F 63 Shock, rhabdomyolysis 43 S
2 F 53 ARDS, septic shock 21 S
3 M 80 Septic shock, ARDS 29 NS
4 M 63 Septic shock, ARDS 21 NS
5 F 54 Septic shock, ARDS 18 S
6 M 77 Septic shock, ARDS 41 NS
7 F 58 Septic shock 27 S
8 M 72 Acute pancreatitis, septic shock 20 NS
9 F 68 Candida, septic shock, ARDS 29 NS
10 F 65 Septic shock, ARDS 25 NS
11 M 73 Septic shock, ARDS 33 NS
12 M 68 Septic shock, liver failure 21 NS
ment fluid was Haemofiltrasol 22 (Gambro) containing lact¬
ate 45 mmol/1, Na+ 140 mmol/1, Ca2+ 1.6mmol/l, Mg2 +
0.75 mmol/1, CP 100 mmol/1 with potassium added as
required. The mean duration of treatment was 3 h 50 min
(range 2 h 30 min to 6 h 15 min) and mean lactate infusion
was 696 mmol (range 450-1080 mmol).
Prior to haemofiltration a full cardiorespiratory profile
was obtained. Heart rate, mean arterial pressure (MAP),
central venous pressure (CVP), and end-expiratory pulmon¬
ary artery balloon occluded pressure (PAOP) were recorded.
Cardiac output was measured by thermodilution using an
average of three injections of 10 ml cooled (<10°C) 5%
dextrose. Cardiac index (CI) and systemic vascular resistance
index (SVRI) were calculated from standard formulae. In all
patients simultaneous samples of arterial and mixed venous
(pulmonary arterial) blood were obtained within 1 min of
the last cardiac output measurement. Oxygen tension (p02),
oxyhaemoglobin saturation (sOz), carbon dioxide tension
(pC02), hydrogen ion concentration ([H+]), and haemo¬
globin concentration were measured by a Corning 278 blood
gas analyser and a Corning 2500 co-oximeter. Arterial and
mixed venous oxygen contents were calculated using standard
formulae, and in conjunction with CI measurements, oxygen
delivery (D02) and oxygen consumption (V02) were derived.
At the time of blood sampling 1.5 ml of arterial blood was
placed into preweighed glass tubes containing 5 ml 5%
perchloric acid, immediately refrigerated and subsequently
analysed for whole blood lactate concentration by an enzym¬
atic method monitoring the rate of formation of NADH
from NAD in the presence of lactate dehydrogenase. The
assay was carried out in 0.5 M glycine buffer (pH 9.6)
containing 0.2 M hydrazine hydrate and 5.4 mM EDTA. The
reaction was monitored fluorimetrically on a Cobas Bio
(Roche) centrifugal analyser and whole blood lactate calcu¬
lated assuming a whole blood density of 1.06. Interassay
coefficient of variation was < 10% over the working range.
All measurements were repeated hourly during HVHF and
at 1 h after treatment.
Statistical analysis was by a Wilcoxon signed rank sum
test comparing pretreatment values with those at each hour
during and following HVHF. All results are expressed as
mean ±sem.
Results
The results for the ARDS patient were similar to the
11 ARF patients so the results are presented together,
and summarized in Tables 2 and 3. Haemofiltration
was well tolerated in all patients. There were minor
falls in MAP, CI and DOz but these were not statistic¬
ally significant. SVRI and V02 showed increases during
the treatment, but these changes were not significant.
Lactate levels rose quickly (pre: 1.7 + 0.3 mmol/1;
1 h: 5.6 + 0.4 mmol/1; PcO.OOOl)) and were still elev¬
ated, although not significantly (2.6 + 0.4 mmol/1; P =
0.06)), 1 h after HVHF. Baseline arterial and mixed
venous [H+], [HC03] and pC02 were not significantly
different. Arterial and mixed venous [H+] tended to
decrease, and [HC03] tended to increase although none
of these achieved statistical significance. There were no
significant changes in blood gas measurements. Four
of the 12 patients survived.
Discussion
In this and a previous study [4] we have demonstrated
that HVHF is well tolerated in a potentially unstable
group of patients with multiple-organ failure. In our
previous group of patients there were significant
declines in CVP and CI with blood pressure maintained
by vasoconstriction. In the present study we have not
confirmed these findings, and this probably reflects the
clinical and haemodynamic heterogeneity of small
groups of critically ill patients. What we have confirmed
is the haemodynamic stability of HVHF in these
patients.
The mechanisms for the handling of increased blood
lactate in critically ill patients with multiple-organ
failure are widely discussed, but are commonly misun¬
derstood [9-11]. The arterial blood lactate level (ABL)
is a reflection of the balance of lactate entering the
circulation (exogenous or endogenous) and lactate
removal, mainly by the liver. In shock, sepsis, and
ARDS splanchnic blood flow is abnormal and the
ability of the tissues to utilize oxygen is impaired
[12,13]. In view of this there are theoretical concerns
over the ability of the liver to handle the large, acute
lactate load which is administered during HVHF.
Davenport and colleagues have shown that in their
patients with ARF, with or without liver failure, there
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Table 2. Effects of HVHF on cardiorespiratory status
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Pre 1 hour 3 hours 1 hour post
HR (b.p.m.) 106.4 + 3.9 103.2 + 3.9 107 + 5 106 + 4.7 NS
CI (1/min/m2) 4.8 + 0.2 4.1 ±0.3 (/> = 0.07) 4.2 + 0.3 4.7 + 0.3 NS
CVP(mmHg) 15.8 + 1.2 13.3 + 1.2 14.5+1.2 14.8+1.6 NS
MAP (mmHg) 75.8 + 3.9 72 + 4.1 73.6 + 4.5 76.3 + 3.9 NS
PAOP(mmHg) 14.3 + 0.9 13.5 + 0.9 13.7 + 0.9 14.8+1 NS
SVRI (dynes/cm5m2) 1034 + 69 1183 + 107 1197+105 1097 + 82 NS
D02(ml/min/m2) 718 + 44 641+45 647 + 47 684 + 48 NS
V02(ml/min/m2) 150 + 7.25 149 + 7 160 + 8 154 + 6 NS
Table 3. Effects of HVHF on lactate, blood gas and acid base status
Pre
Lactate(mmol/l) 1.7+ 0.3
H +(mmol/l) 50 + 3
PC02(kPa) 6.2 + 0.5
Arterial P02(kPa) 13+1
HC03(mmol/l) 23.7 + 2
S02(%) 94+1
H + (mmol/l) 51 + 3
PC02(kPa) 6.9 + 0.5
Mixed venous P02(kPa) 5.4+ 0.3
HC03 (mmol/1) 23.3 + 2
S02(%) 74+ 2
***P <0.001
were significant declines in MAP and serum (arterial)
bicarbonate [1]. In the hepatorenal group there was a
significant increase in [H + ].
In contrast, our studies have not shown any signific¬
ant hypotension, although in both of our studies the
initial MAP was lower than their ARF group, and
equivalent to the hepatorenal group. In our current
study we have shown that there is no deterioration in
arterial or mixed venous acid-base status during
HVHF, despite higher peak lactate levels:
6.9 ±0.3 mmol/1 at 3 h. We chose to measure mixed
venous gases and acid-base status on account of the
studies of Adrogue et al. [15] and Weil's group [16],
which have suggested that the central or mixed venous
sampling site is more sensitive to the acid-base changes
in the microcirculation than is systemic arterial sam¬
pling. We have shown that this is not the case for
blood lactate levels [17]. In the current study we showed
no significant difference between arterial and mixed
venous acid-base parameters throughout the study
period, and there were no adverse effects on [H + ] or
[HC03] in our patients.
It has been suggested that the adverse acid-base
responses and hypotension seen in previous studies
may be due to reduced tissue oxygen delivery [1], This
seems likely, as it has been shown repeatedly that
clinical assessment of the cardiorespiratory system in
critically ill patients is inaccurate [18,19]. It is widely
accepted that MAP may be reasonably maintained
despite low cardiac filling pressures, CI and D02. In
our patients these variables were measured prior to
1 hour 3 hour 1 hour post
5.6 + 0.4*** 6.9 + 0.3*** 2.6 + 0.4 NS
51+3 48 + 2.7 43 + 2 NS
5.7 + 0.4 5.6 + 0.4 6.1+0.4 NS
13 + 1 15 + 1.5 13 + 1.5 NS
20.9+1 21.9+1 25.8+1 NS
94+1 95 + 1 94+1 NS
53 + 3 49 + 3 45 + 2 NS
6.2 + 0.5 6.3 + 0.6 6.7 + 0.6 NS
5.3 + 0.3 5.2 + 0.3 5.2 + 0.2 NS
20.7+1 22.2+1.3 25.8 + 1 NS
72 + 2 72 + 2 73 + 2 NS
haemofiltration, and appropriate resuscitation was car¬
ried out in an attempt to increase CI and D02 whilst
maintaining MAP near normal.
In contrast to our study population, that of
Davenport and co-workers contained six patients with
overt hepatic failure. These patients are notoriously
resistant to resuscitation, even with high doses of
vasopressors. It would, however, be of interest to study
this group of patients in the manner which we have
described, perhaps adding acetylcysteine infusion in
those with hepatic failure secondary to self-poisoning
with paracetamol [20].
The results of this study suggest that HVHF with
lactate-containing fluid may be a satisfactory form of
RRT in critically ill patients. In our patients it was
accomplished without deterioration in acid-base status
or cardiorespiratory function, despite theoretical objec¬
tions concerning the exogenous lactate load. This may
be a reflection ofprior resuscitation, aiming to maintain
high D02 and normal MAP, but further study is
required to confirm this.
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Haemodynamic and oxygen transport effects of propofol infusion in
critically ill adults
G. R. NIMMO, S. J. MACKENZIE and I. S. GRANT
Summary
The effects of a sedative infusion of propofol on haemodynamics and oxygen transport were examined in critically ill adult
patients. Ten patients receiving mechanical ventilation for treatment of septic shock and respiratory failure were given a
decreasing rate propofol infusion designed to achieve and maintain a stable sedation level. Full cardiovascular and oxygen
transport variables, arterial blood lactate concentrations and sedation scores were measured before infusion and at 1, 3 and 6 h
after starting the infusion. There were significant reductions in mean (SEM) heart rate (97.3(2.9) to 85.7(3.9) beat.min~'
p < 0.05), mean arterial pressure (87.6(3.7) to 76.2(4.1 )mmHg p < 0.05) and systemic vascular resistance index (1461(137)
to 1327(141) dyne.s.cm'5.m~2 p < 0.05), with no significant change in cardiac filling pressures. There were no significant
changes in cardiac output, oxygen delivery, oxygen consumption or arterial blood lactate concentrations. Controlled propofol
sedation is well tolerated in appropriately monitored and resuscitated critically ill adult patients, and appears to have no major




Maintenance of tissue oxygen delivery at a rate sufficient to
meet demand is pivotal to a successful outcome in critical
illness. In many clinical situations, such as septic shock (SS)
ind adult respiratory distress syndrome (ARDS), there is a
defect of tissue oxygen utilisation so that oxygen consump¬
tion (Vo2) is dependent on oxygen delivery, even when the
Hatter is normal or supranormal [1,2]. In low cardiac output
states, such as cardiogenic shock, oxygen extraction is
—generally maintained or increased with resultant reduction
n mixed venous oxyhaemoglobin saturation (Svo2). In
:ither situation the balance of oxygen delivery to consump-
.ion is critical, and may be crucially affected by changes in
jither oxygen delivery or tissue oxygen demand. Factors
vhich can affect demand include sedation, muscle relaxa-
ion and mechanical ventilation.
Propofol is being increasingly used as a sedative agent in
he intensive care unit. Like other sedatives it has the
potential to affect the oxygen supply/demand relationship
toth detrimentally by decreasing cardiac output and thus
txygen delivery, and beneficially by reducing oxygen
lemand. When used for induction and maintenance of
tnaesthesia, it has been shown to have a number of haemo-
lynamic effects including substantial reductions in heart
ate, cardiac output, arterial blood pressure and systemic
vascular resistance [3]. However, the precise cardiorespira¬
tory effects of subanaesthetic doses used for sedation in
critically ill patients dependent on vasoactive drugs for
haemodynamic stability have not been investigated rigor¬
ously. The aim of this study was to document the effects of
a sedative infusion regimen of propofol on haemo¬
dynamics, oxygen transport and blood lactate.
Furthermore, in an attempt to unravel the mechanism of
any effect on Vo2, resuscitation with fluid and/or vasoactive
drugs would be used after 3 h sedation to restore mean
arterial blood pressure (MAP), cardiac output and oxygen
delivery to baseline values. Subsequently, any residual
decrease in Vo2 could then be attributed to a decrease in
oxygen demand. Blood lactate concentrations were
measured as a further index of the adequacy of tissue
oxygenation.
Methods
Ten severely ill adult patients receiving mechanical ventila¬
tion and with femoral and pulmonary artery catheters in
situ for standard monitoring were studied with the
informed consent of their next of kin and the approval of
the local ethics committee. All had been resuscitated
initially using combinations of colloid fluid and blood to
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achieve optimal pulmonary artery occlusion pressure
(PAOP) with the addition of an inotrope and/or vaso¬
pressor to achieve a stable cardiac index (CI) > 4
l.miru'.m-2 with MAP > 80 mmHg. They had all become
haemodynamically stable, and were receiving unchanged
doses of vasoactive agents for at least 2 h before the start of
the study.
All patients received papaveretum at a fixed infusion rate
for 6 h before and throughout the study, other sedation
having been discontinued several hours earlier; the study
began when the patients required further sedation. No
muscle relaxants were used. Immediately before
commencing the propofol infusion baseline measurements
were made of heart rate (HR), mean arterial pressure, mean
central venous pressure (CVP), mean pulmonary artery
pressure (PAM), end-expiratory pulmonary artery occlu¬
sion pressure and cardiac output measured in triplicate
using 10 ml of 5% dextrose with a measured in-line
temperature < 10°C (Series 7000 monitor, Marquette,
Milwaukee). Patients' height and weight were measured
and the following derived variables were calculated using
standard formulae; cardiac index (CI), stroke volume (SV),
stroke volume index (SVI), ventricular stroke work index
(right: RVSWI; left: LVSWI), systemic vascular resistance
index (SVRI) and pulmonary vascular resistance index
(PVRI).
Femoral and mixed venous (pulmonary arterial) blood
were sampled for measurement of blood gas tensions,
hydrogen ion concentration, haemoglobin concentration
and oxyhaemoglobin saturations. Oxygen delivery and
consumption were calculated, the latter using the inverse
Fick relationship. Simultaneously, assessment was made of
conscious level using the Ramsay sedation score [4] and
arterial whole blood lactate concentration was measured
using an automated analyser (Clandon Scientific,
Farnborough, UK).
Propofol was infused according to a decreasing infusion
rate regimen designed on the basis of known pharmaco¬
kinetic data to rapidly achieve and maintain a blood con¬
centration of 1 gg.mU1 [5]. The infusion ran at
4mg.kg~'.h~' for lOmin, 3mg.kg~'.h~' for 50 min and
then 2mg.kg_l.h~' for the remaining 5 h of the study.
Cardiovascular measurements were repeated 10 and 30 min
after commencement of propofol infusion, and then all
measurements (haemodynamic, oxygen transport, lactate
and sedation score) were repeated at 1 h, 3 h and 6 h. In six
patients modified pulmonary artery catheters (PACs) with
fast thermistors were inserted and right ventricular ejection
fraction (RVEF) and volumes were measured (REF-1,
Baxter-Edwards, California, USA). No patient had to be
withdrawn from the study because of clinically important
decreases in MAP or cardiac output. After 3 h of propofol
sedation, cardiac output and oxygen delivery were restored
to as near baseline as possible using a combination of fluid
(plasma protein solution) to restore PAOP, and/or vaso¬
active drugs as appropriate.
Statistical analysis was carried out using the Wilcoxon
signed rank test to compare paired data at baseline and 3 h.
All values are expressed as mean (SEM). Variables at 6 h
were not analysed since manipulation had resulted in a
restoration to initial values.
Results
The clinical details of the 10 patients studied are shown in
Table 1, and the cardiorespiratory data at the individual
study points are detailed in Table 2. Heart rate, MAP,
cardiac index and SVRI are shown in Figure 1, and oxygen
delivery, Vo, and Ramsay sedation score in Figure 2.
Infusion of propofol was associated with significant reduc¬
tions in HR, mean arterial pressure and systemic vascular
resistance index. Stroke volume and, in the six patients
Table 1. Details of patients.
APACHE
Patient No. Age (years) Weight (kg) Score Diagnosis Inotrope Therapy at 3h









3 48 80 21 G-I haemorrhage
Septic shock
Noradrenaline Noradrenaline
4 70 75 21 Acute pancreatitis
Septic shock
Dobutamine Dobutamine















8 67 45 31 Septic shock
Acute renal failure
Dopamine Dopamine













ARDS, adult respiratory distress syndrome; G-I, gastro-intestinal.
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Table 2. Mean (SEM) cardiovascular and oxygen transport variables, whole blood lactate, and sedation scores
before and during propofol infusion.
Before 30 min 60 imin 3 h 6 h
HR; beat.min 1 97.3 (4.0) 93.6 (2.9) 91.5 (3.6) 85.7 (3.9)* 96.0 (5.3)
MAP; mmHg 87.6 (3.7) 78.4 (3.4) 79.8 (3.7) 76.2 (4.1)* 85.2 (2.7)
CVP; mmHg 12.4 (1.5) 11.1 (1.2) 11.3 (1-2) 11.3 (1-0) 12.4 (1.2)
PAWP; mmHg 14.2 (1.5) 11.5 (1.6) 12.1 (1.4) 12.7 (1.5) 13.4 (1.5)
CI; l.min. '.m 2 4.44 (0.42) 4.43 (0.45) 4.3 (0.39) 4.13 (0.36) 4.36 (0.40)
SVI; ml.min "2 46.2 (4.8) 48.3 (5.6) 48.2 (4.6) 49.2 (4.5) 47.2 (5.7)
LVSWI; g.m.m 2 46.1 (5.8) 43.0 (4.0) 42.4 (3.9) 41.1 (3.0) 46.0 (5.8)
RVSWI; g.m.m 2 13.3 (2.0) 11.7 (1.9) 11.6 (1.6) 11.6 (1.5) 11.5 (2.0)
RVEF%; (n = 6) 38.7 (4.8) 39.5 (5.9) 42.0 (6.1) 37.5 (4.9) 33.7 (5.3)
SVRI; dynes.s.cmAm 2 1461 (137) 1360 (166) 1405 (180) 1327 (141)* 1435 (132)
Oxygen delivery; ml.min '.m-2 660 (66) 632 (58) 596 (54) 641 (70)
Vo2; ml.min~'.m-2 132 (9) 130 (8) 122 (5) 130 (6)
Lactate; mmol.L1 0.98 (0.11) 1.09 (0.14) 1.07 (0.12) 1.07 (0.11)
Sedation score 2.65 (0.27) 4.65 (0.42) 4.8 (0.50) 5.0 (0.29)** 4.7 (0.42)
HR, heart rate; MAP, mean arterial pressure; CVP, central venous pressure; PAWP, pulmonary artery wedge
pressure; CI, cardiac index; SVI, stroke volume index; LVSWI, left ventricular stroke work index; RVSWI, right
ventricular stroke work index; RVEF, right ventricular ejection fraction; SVRI, systemic vascular resistance index;
Vo2 oxygen consumption.
*p < 0.05 3 h vs baseline values.
**p < 0.01 3 h vs baseline values.
where it was measured, the RVEF was unchanged. There
were no significant changes in CVP or PAOP across the
group, but in three patients (nos. 2, 7 and 10) there were
marked decreases requiring fluid infusion to restore filling
pressures and cardiac output at 3 h but not before. In
parallel with cardiac output, there was a trend towards a
reduction in oxygen delivery at 3 h, but this did not achieve
statistical significance. There was a similar trend in Vo2. No
significant change was noted in blood lactate concentra¬
tions. As anticipated, the mean (SEM) Ramsay sedation
0 0.5 1 3 6
Time (h)
-Fig. 1. Mean (SEM) values for heart rate, mean arterial pressure,
cardiac index and SVRI during propofol infusion in 10 severely ill
adult patients on mechanical ventilation. HR, heart rate; MAP,
mean arterial blood pressure; CI, cardiac index; SVRI. systemic
vascular resistance index. *p < 0.05.
score at 3 h changed significantly from 2.65(0.27) to
5.0(0.29).
The therapeutic interventions required to restore cardiac
output and oxygen delivery are shown in Table 1, and their
effects on haemodynamics and oxygen transport in Table 2
and Figures 1 and 2. HR, MAP and Do2 were successfully
restored to baseline, oxygen delivery and Vo2 rising in
parallel, and there were no changes in lactate concentra¬
tions or sedation level.
Discussion
We have demonstrated that propofol infusion, given in an
infusion regimen designed to achieve rapidly and maintain
a blood level of 1 pg.mH1, is not associated with clinically
significant haemodynamic or oxygen transport effects in
adequately resuscitated adult critically ill patients.
The haemodynamic effects of propofol anaesthesia have
been extensively investigated and are well documented [3].
Propofol induction of anaesthesia produces a dose-related
reduction in blood pressure which has been attributed both
to reduced cardiac output and to a reduction in SVRI [6,7].
0 1 3
Time (h)
Fig. 2. Mean (SEM) values for oxygen delivery (-■-), oxygen
consumption (--#--), and Ramsay sedation score (—O—) during
propofol infusion in 10 severely ill patients. **p < 0.01.
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The mechanism of the reduction in cardiac output is a
direct depression of myocardial contractility [7], which
according to some workers may be coupled with decreased
preload [8]. Nevertheless, many investigators have found
no effect on preload, attributing the fall in cardiac output
to a direct negative inotropic effect alone [6,7],
During infusion maintenance of anaesthesia SVRI tends
to increase back towards baseline or above, especially with
surgical stimulation, and cardiac output remains below
baseline [6,9], Heart rate tends to decline during propofol
maintenance, due both to increased vagal tone and to the
resetting of baroreceptor reflex activity [10].
Propofol has recently been introduced as a sedative agent
for use in Intensive Care. Initial studies have reported a
hypotensive effect, sufficient in one study to prompt
infusion rate reductions in some patients [11], Other inves¬
tigators have found little difference in cardiovascular effects
when comparing propofol with midazolam [12], Given the
accepted importance of the maintenance of supranormal
cardiac output and oxygen delivery, whilst concurrently
assuring an adequate MAP in the treatment of patients
with many types of critical illness [13], it is surprising that
until now there has been little detailed data on the cardio¬
respiratory effects of propofol in such patients.
We have shown that propofol is well tolerated in a group
of extremely sick patients who are dependent on vasoactive
drugs. The study protocol avoided the use of bolus doses
since it is our experience that even doses as low as
0.5mg.kg_l given intravenously over 1 min may lead to
significant hypotension. The infusion protocol was based
on pharmacokinetic data from critically ill patients, and
was geared to achieve and maintain a blood concentration
of around 1 |ig.ml_1 [5]. In fact all patients were excessively
sedated at this concentration, probably reflecting their
severity of illness (APACHE II mean 23; range 15-31) since
it has been shown that the higher a patient's APACHE II
score the less will be the sedation requirement [14]. At the
end of the study period, propofol infusion rates were
reduced to clinically appropriate rates.
In no patient did the infusion rate require reduction from
the protocol as a result of severe adverse haemoaynamic
effects. The decrease in blood pressure was acceptable,
remaining close to the value aimed for with resuscitation,
while cardiac output did not decrease to a statistically
significant degree. Interestingly, stroke volume and RVEF
were maintained, any reduction in cardiac output being
attributable to the reduction in HR. It may be that after-
load reduction led to maintenance of stroke volume despite
myocardial depression. Although pooled group data on
filling pressures did not show any overall change, three
patients suffered substantial reductions of PAOP which,
without volume expansion, would have led to reduced
cardiac output. Overall, our results show that propofol in
sedative dosage is free from significant myocardial depres¬
sant effects, but that hypotension occurs due to the com¬
bination of a reduction in heart rate (and hence cardiac
output) and a slight reduction in SVRI, possibly as a
consequence of reduced sympathetic activity. The finding
of three patients with falls in PAOP suggests that in less
well fluid resuscitated patients, venodilatation and reduced
filling pressure is a potential problem. Reattainment of the
baseline values of cardiac output proved straightforward,
requiring fluid in three patients and small increases in
inotrope infusion rate in seven patients.
The importance of achieving and maintaining a high
oxygen delivery when treating critically ill patients has been
emphasised by a number of workers, on account of the
phenomenon of pathological delivery-dependent oxygen
consumption, which has been documented both in septic
shock and ARDS [1,2], and the increased survival asso¬
ciated with attainment of optimal oxygen delivery in septic
shock [15]. Delivery dependence is due to an inability of
some tissues to regulate oxygen extraction normally, and
may imply a persistent tissue oxygen debt, with oxygen
demand in excess of actual consumption. We have recently
shown that this abnormality may be present despite normal
blood lactate concentrations [16].
In the normal human where oxygen consumption meets
demand, sedation, anaesthesia, muscle relaxation and
assisted ventilation should all reduce Vo2 because of the fall
in requirements. Similarly, in patients with low flow condi¬
tions, such as cardiogenic shock, where critical reductions
in oxygen delivery are present and Vo, is maintained by
avid oxygen extraction, mechanical ventilation will reduce
the oxygen cost of breathing, and thus tissue oxygen
requirements, and will improve the oxygen supply/demand
balance [17], It is less clear, however, how sedation affects
the balance of oxygen supply, utilisation and demand in
critical illnesses such as septic shock and ARDS. The fact
that sedation is generally associated with decreased myo¬
cardial oxygen demand, and with reduced cerebral meta¬
bolic rate for oxygen, suggests that there should be a
beneficial effect on whole body Vo2. Conversely, if the
sedation also results in falls in cardiac output and oxygen
delivery in the presence of pathological delivery-dependent
oxygen consumption, Vo2 may decrease to a greater extent
than demand, with aggravation of the oxygen shortfall.
This study does not reveal a significant reduction in
oxygen delivery associated with propofol sedation.
However, there is a trend towards a parallel reduction in
both oxygen delivery and Vo2. Therapeutic interventions
which restored oxygen delivery also tended to increase Vo2,
although sedation level was unchanged. No significant
changes in blood lactate concentrations, which might have
helped clarify the effects on tissue oxygenation, occurred.
In critically ill patients with pathological delivery-depen¬
dent Vo2, sedation may lead to reductions in Vo2 which are
linked to changes in oxygen delivery and not oxygen
demand, but in the low dosage used in this study the
changes were small.
On balance, it is unlikely that changes in sedation (even
from Ramsay level 2-3 to 5) as in this study, significantly
affect the oxygen demand/consumption balance. Extreme
agitation and conversely cardiac depression should be
avoided, and patients in whom oxygen delivery is markedly
reduced should be mechanically ventilated if evidence of a
tissue oxygen debt is apparent e.g. elevated lactate concen¬
tration or critically low Svo2.
In summary, controlled propofol sedation in the stated
dosage is well tolerated in appropriately monitored and
resuscitated patients, even when they require cardio¬
vascular support with catecholamines. It is likely that there
is no clinically significant effect on global oxygen transport.
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The subjective effects of low-dose propofol
A double-blind study to evaluate dimensions of sedation and consciousness with low-dose propofol
C. WHITEHEAD, L. D. SANDERS, G. OLDROYD, T. K. HAYNES, R. W. MARSHALL,
M. ROSEN and J. O. ROBINSON
Summary
In this study the subjective effects (sedation and mood) of subanaesthetic doses ofpropofol were examined in 28 healthy male
volunteers. A computer model was used to predict the infusion profiles necessary to obtain steady state propofol plasma
concentrations of 0.3 pg.ml~', 0.6 ng.ml~', 0.9 pg.mlObjective measures ofsedation from saccadic eye movement and choice
reaction time gave significant dose responses at each level but a battery of psychometric tests failed to show dose-related
subjective responses. Ofparticular note in the subjective data is the lack of a difference between groups or even of a consistent
trend within the data. This suggests that a low concentration ofpropofol in plasma does not induce euphoria or a sense of well-
being. The anecdotal evidence available for mood changes with propofol therefore remains unsubstantiated.
Key words
Anaesthetics, intravenous; propofol.
Measurement techniques', psychometyric tests.
Sedation is frequently associated with altered states of
consciousness and drowsiness. But the term sedation has
been defined as 'a state in which pre-existing anxiety is
removed or lessened or in which signs of anxiety do not
develop in circumstances in which they would be expected
to do so' [1]. Thus sedation need not be synonymous with
altered consciousness.
Three dimensions of sedation have been suggested:
consciousness, calmness and comprehension [2]. Whilst
these may have an intuitive attractiveness, a better basis for
further work would be established by the collection of data
on the subjective aspects of sedation which could then be
formed into a suitable set of working dimensions.
It has been shown that propofol provides suitable seda¬
tion as an adjunct to spinal blockade [3]. It has been
compared with midazolam and shown to produce a more
rapid recovery with less amnesia [4—7]. When used as an
anaesthetic agent, recovery from propofol is much quicker
than from other agents [8,9], with some benefits persisting
up to 2 days following anaesthesia with propofol as the sole
agent [10].
Over the past 3 years there have been several letters
published in the medical journals describing unusual emer¬
gences from propofol. For example, doctors from the
Middlesex Hospital reported experiencing amorous
advances from female patients [11]. This experience was
echoed by other clinicians [12,13] and was not only limited
to female patients [14], Occasional more serious problems
have also been reported; one woman experienced a very
realistic postoperative hallucination of a sexual assault [15],
whilst a male patient became very distraught by an
unpleasant wartime dream [16]. However, it should be
noted that in these cases propofol was not the only agent in
use and there is no evidence that propofol was responsible,
even as a facilitator. In a study of more than 300 male
patients following anaesthesia induced with propofol, no
erotic dreams were reported [17].
Apart from amorous and disinhibited behaviours it has
also been noted, albeit anecdotally, that patients who are
anaesthetised with propofol seem not only to recover
rapidly, but often experience an increased sense of well-
being [18] or a mild euphoric state [19]. A straw poll of our
colleagues endorsed this. It is possible that this sense of
well-being arises from a feeling of relief that the operation
is over, an effect which may be dissipated in other patients
who are feeling unwell in response to the anaesthetic. It has
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